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SAMMENDRAG PÅ NORSK 
Introduksjon: 
Maksimalt oksygenopptak (?̇?O2max) benyttes for å kvantifisere et individs aerobe kapasitet og 
kardiorespiratorisk form, og regnes som hovedvariabelen ved gjennomføring av en klinisk 
arbeidsbelastningsundersøkelse (CPET). Det er imidlertid begrensede referanseverdier for både  ?̇?O2max 
og andre kardiorespiratoriske variabler som benyttes for å tolke undersøkelsen. Videre foreligger det lite 
kunnskap om ende-kriterier for vurdering av maksimal innsats ved bestemmelse av ?̇?O2max, spesielt hos 
kvinner og eldre. 
?̇?O2max er svært sentral hos pasienter med ikke-småcellet lungekreft. Mange pasienter har i 
utgangspunktet en dårlig kardiorespiratorisk form med en lav ?̇?O2peak, og denne vil forverres ytteligere 
som følge av operasjon. En predikering av pasientens postoperative funksjonelle status (lungefunksjon 
og ?̇?O2peak) benyttes derfor i de Europeiske retningslinjene for å vurdere om pasienten tåler operasjon. 
Nøyaktigheten av denne predikeringen er imidlertid lite undersøkt.  
Etter lungekirurgi er det lite man kan gjøre for å bedre lungefunksjonen. Systematisk trening kan derfor 
være en viktig tilleggsbehandling for å forbedre kardiorespiratorisk form, daglig funksjon og livskvalitet 
hos pasienten. Imidlertid er kunnskap om hvordan pasienten takler hard trening og effekten av denne 
etter kirurgi tilnærmet fraværende. 
Hensikten med studien var å: 
1. Kartlegge kardiorespiratorisk respons under maksimalt arbeid på tredemølle hos en 
representativ norsk populasjon, bestående av kvinner og menn i alder 20 til 85 år. 
2. Kartlegge ende-kriterier for å kunne vurdere om et individ har oppnådd en reell ?̇?O2max. 
3. Evaluere effekten av lungekreftkirurgi med hensyn til kardiorespiratorisk form målt på 
tredemølle, samt undersøke validiteten mellom predikert ?̇?O2peak  og målt ?̇?O2peak. 
4. Studere effekten av et høy-intensivt utholdenhets- og styrketreningsprogram med hensyn til 
?̇?O2peak, lungefunksjon, muskelstyrke, funksjonell form, kroppssammensetning og livskvalitet hos 
pasienter etter nylig gjennomgått lungekreftkirurgi. 
Deltakere og metode 
I 2008 gjennomgikk 3,485 personer fra hele Norge en objektiv måling av fysisk aktivitet i 
Kartleggingsstudien, KAN1. Av disse møtte 904 deltakere opp til en helseundersøkelse for bl.a måling av 
kardiorespiratorisk form via en CPET på tredemølle. 759 deltakere fullførte CPET tilfredsstillende basert 
på definerte ende-kriterier (artikkel I), og 859 deltakere fullførte CPET til frivillig utmattelse (artikkel II). 
Videre gjennomgikk 70 pasienter med nylig påvist lungekreft målinger av lungefunksjon og CPET før 
operasjon og fire til seks uker etter operasjon. Endring i kardioespiratorisk form ble vurdert, og den 
målte ?̇?O2peak  etter operasjon ble validert opp mot den estimerte ?̇?O2peak mht nøyaktighet og presisjon 
(artikkel III). Til sist ble 61 lungekreftpasienter randomisert til en treningsgruppe eller kontrollgruppe, 
hvor man undersøkte effekten av et høyintensivt utholdenhet- og styrketreningsprogram (60 min, tre 
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ganger pr uke i 20 uker). Primærutfallsmål var endring i ?̇?O2peak. Andre utfallsmål var endring I 
lungefunksjon, muskelstyrke, funksjonell form, total muskelmasse og livskvalitet. 
 
Hovedresultater og konklusjon 
Artikkel I) ?̇?O2max (mL∙kg–1∙min–1) var 40.3 ± 7.1 hos kvinnene og 48.6 ± 9.6 hos mennene i den yngste 
alderskohorten (20 til 29 år), og ble redusert med 8 % etter fylte 30 år hos begge kjønn per tiår. 
Maksimal hjertefrekvens ble redusert med 6.3 slag∙min–1 per tiår. Oksygenpulsen var 33 % lavere hos 
kvinnene, og ble redusert med 5 % og 3 % hos henholdsvis kvinner og menn per tiår. Kvinnenes 
maksimale minuttventilasjon var 66 % av mennenes, og ble redusert med alder etter 40 til 49 år hos 
begge kjønn.  Pustereserven var høyere hos kvinnene enn hos mennene (henholdsvis 30 ± 13.7 % vs 23 ± 
12.8 %, P < 0.001). Nye referanseverdier for maksimal CPET utført på tredemølle ble presentert i 
aldersgruppen 20 til 85 år. 
Artikkel II) Maksimal blodlaktatkonsentrasjon og respiratorisk utvekslingsratio (RER) ble redusert med 
økende alder, til tross for at deltakernes subjektive grad av utmattelse (BORG skala) forble uendret. En 
valgt blodlaktat konsentrasjon ≥ 8 eller ≥ 6 mmol∙L-1 og/eller RER ≥ 1.15 som kriterium for maksimal 
innsats under CPET gav en høyere ?̇?O2max, men utelukket et betydelig antall deltakere fra analysen. Nye 
anbefalinger for maksimal innsats ble gitt i henhold til alder og kjønn. 
Artikkel III) Hos lungekreftpasientene var ?̇?O2peak 23.9 ± 5.8 mL∙kg–1∙min–1 (80.6 ± 16.7 % av forventet) før 
operasjon, og ble redusert til 19.2 ± 5.5 mL∙kg-1∙min-1 (P < 0.001) etter operasjon. Oksygenpulsen var den 
sterkeste prediktor for endring i ?̇?O2peak; r2=0.77. Seks måneder etter operasjon forble ?̇?O2peak uendret  
(-3 ± 15 %, P = 0.27). Predikering av postoperativ ?̇?O2peak basert på antall resekterte lungesegmenter viste 
lav presisjon i forhold til reell ?̇?O2peak. 
Artikkel IV) Pasientene som deltok i treningsgruppen etter operasjon for lungekreft hadde signifikant 
større økning i VO2peak (18.9 %), diffisjonskapasitet for karbonmonoksid i lungene (5.2 %), 1RM i bein 
press (23 %), funksjonell funksjon og livskvalitet, sammenliknet med pasientene i kontrollgruppen. Høy-
intensiv utholdenhet og styrketrening var godt tolerert untatt under pågående kjemoterapibehandling. 
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SUMMARY 
Introduction:  
Maximal oxygen uptake (?̇?O2max) is used to quantify an individual’s exercise capacity and is recognized as 
the main variable for measurement during cardiopulmonary exercise testing (CPET). There are limited 
reference values for ?̇?O2max and other cardiorespiratory fitness variables measured during CPET. There 
are also few typical criteria for ascertaining that the subject has achieved the maximum effort needed to 
ensure a valid measurement, especially among women and elderly people. 
In patients with Non-Small-Cell lung cancer (NSCLC), ?̇?O2max is a cornerstone in the preoperative 
evaluation. Many patients have poor physical fitness, which may decline further after surgery. The 
accuracy of the predicted postoperative functional outcome (pulmonary function and ?̇?O2max) 
recommended in the European risk assessment guidelines has not been investigated thoroughly. After 
lung surgery, there is little that can be done to improve lung function and the area for gas exchange, and 
exercise training may be the single most important aspect of adjuvant treatment to increase daily 
function and quality of life. However, knowledge about the feasibility and effects of training after lung 
resection is limited. 
 
The overall objectives of this thesis were to: 
1. Determine the cardiorespiratory response during maximal treadmill exercise in a well-described 
representative sample of 20-to 85-year-old men and women in Norway.  
2. Identify the end criteria for determining that a subject has reached ?̇?O2max. 
3. Evaluate the effect of lung cancer surgery on cardiorespiratory fitness measured on a treadmill, 
and to assess the agreement between the predicted postoperative peak oxygen uptake (?̇?O2peak) 
and actually measured postoperative ?̇?O2peak. 
4. Study the effect of high-intensity endurance and strength training on ?̇?O2peak, pulmonary 
function, muscular strength, functional fitness, body composition, and quality of life in a 
randomised controlled trial of newly resected NSCLC patients. 
 
Participants and methods:  
In 2008, 3,485 individuals from all parts of Norway underwent objective measurement of physical 
activity in the KAN1 study. From this sample, a total of 904 men and women undertook a CPET; 759 
successfully completed a maximal treadmill exercise test based on defined maximum end criteria (paper 
I), and 859 participants completed the test until voluntary exhaustion (paper II). Furthermore, 70 NSCLC 
patients completed measurement of pulmonary function and CPET before and 4–6 weeks after surgery. 
In these patients, the changes in cardiorespiratory fitness were evaluated and were used to predict 
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postoperative ?̇?O2peak (paper III). Finally, 61 lung cancer patients were randomised into a training or 
control group, and the effect of high-intensity endurance and strength training were assessed (60 min, 
three times a week, 20 weeks) (paper IV). The primary outcome was the change in ?̇?O2peak. Other 
outcomes included changes in pulmonary function, muscular strength, functional fitness, total muscle 
mass, and quality of life. 
Main results and conclusions   
Paper I) In the 20- to 29-year old age group, ?̇?O2max (mL∙kg–1∙min–1) was 40.3 ± 7.1 in women and 48.6 ± 
9.6 in men. A linear decline (8 % per decade) was observed after age 30 years in both sexes. Maximal 
heart rate decreased with age by 6.3 beats∙min–1 per decade. The maximal O2 pulse was 33 % lower in 
women and decreased with age by 5 % and 3 % per decade for women and men, respectively. Women’s 
maximal ventilation was 66 % that of men and decreased with age after 
40 to 49 years in both sexes. Breathing reserve was higher in women than in men, (30 ± 13.7 % vs 23 ± 
12.8 %, respectively, P < 0.001). New reference values for maximum CPET on a treadmill were derived for 
ages 20 to 85 years. 
Paper II) Post exercise blood lactate concentration and the respiratory exchange ratio (RER) decreased 
with age, even though the subjective ratings of exertion related to age remained unchanged. Choosing a 
blood lactate concentration of  8.0 or  6 mmol∙L–1 and/or RER  1.15 to indicate a maximum effort 
yielded a higher ?̇?O2max but excluded a significant number of participants from the analysis. Suggestions 
for new recommendations for end criteria were given according to age and sex. 
Paper III) The average ?̇?O2peak in lung cancer patients was 23.9 ± 5.8 mL∙kg–1∙min–1 (80.6 ± 16.7 % 
predicted) before surgery, and decreased to 19.2 ± 5.5 mL∙kg-1∙min-1 (P < 0.001) after surgery. The O2 
pulse was the strongest predictor for change in ?̇?O2peak; adjusted linear squared r2 = 0.77. Six months 
after surgery, the ?̇?O2peak remained unchanged (-3 ± 15 %, P = 0.27). Predicting postoperative ?̇?O2peak 
based on the number of lung segments removed showed poor precision when compared with actually 
measured postoperative ?̇?O2peak. 
Paper IV) After lung cancer resection, the patients in the exercise group who completed the supervised 
high-intensity endurance and strength training program had significantly larger increases in VO2peak (18.9 
%), diffusion capacity of the lung for carbon monoxide (5.2 %), 1RM in leg press (23 %), functional fitness, 
and quality of life compared with the controls. High-intensity endurance and strength training was well 
tolerated except during chemotherapy. 
 
Key words: Cardiorespiratory fitness, cardiopulmonary exercise testing, maximal oxygen uptake, peak 
oxygen uptake, normal response, blood lactate concentration, respiratory exchange ratio, non-small-cell 
lung cancer, surgery, predicted postoperative function, high-intensity exercise training, randomised 
controlled trial.
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ABBREVIATIONS 
(Ca-Cv) O2 difference  Arteriovenous oxygen difference 
BMI    Body mass index 
BTS    British Thoracic Society 
BP    Blood pressure (mmHg) 
CI    Confidence interval 
COPD    Chronic obstructive pulmonary disease 
CPET    Cardiopulmonary exercise test 
CPM    Counts per minute 
CRF    Cardiorespiratory fitness 
DLCO    Diffusion capacity of the lung for carbon monoxide (mmol∙kPa-1∙min-1) 
DO2    Oxygen-delivery capacity 
ECG    Electrocardiogram 
ERS    European Respiratory Society 
ESTS    European Society for Thoracic Surgery 
FEV1    Forced expiratory volume after 1 second (L) 
FVC    Forced vital capacity (L) 
FFM    Fat free mass 
[Hb]    Haemoglobin concentration 
HR    Heart rate (beat∙min-1) 
[La-]    Blood lactate concentration 
MET    Metabolic equivalent, equal to 3,5 mL oxygen per body weight per min 
MVPA    Moderate to vigorous intensity physical activity 
MVV    Maximal voluntary ventilation (L∙min-1) 
NSCLC    Non-Small-Cell lung cancer 
O2-pulse   Oxygen pulse (mL∙beat-1) 
PRT    Progressive resistance training 
RCT    Randomised controlled trials 
RER    Respiratory exchange ratio 
SD    Standard deviation 
SpO2    Oxygen saturation measured by pulse oximeter (%) 
?̇?CO2    Carbon dioxide output 
?̇?E    Minute ventilation (L∙min-1) 
?̇?E/VCO2   Ventilatory equivalent for ?̇?CO2 
?̇?O2    Oxygen uptake (mL∙kg-1∙min-1 or L∙min-1) 
?̇?O2max    Maximal oxygen uptake 
?̇?O2peak    Peak oxygen uptake, used when defined criteria for maximum effort is 
    not fulfilled 
Qmax    Maximal cardiac output
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1.0 INTRODUCTION 
In general, maximal oxygen uptake (?̇?O2max) has been shown to be an excellent predictor for mortality 
and long-term survival,4,5 and is recognized as the gold standard variable measured during 
cardiopulmonary exercise testing (CPET).2,6 There are limited reference values for ?̇?O2max and other 
cardiorespiratory fitness variables used in the clinical settings. In addition, agreement about the end 
criteria for determining that a subject has achieved a maximum effort to ensure a valid ?̇?O2max is lacking, 
and current guidelines do not take into account age and sex differences. 
Maximal or peak oxygen uptake (?̇?O2peak) is also an important variable in patients with Non-Small-Cell 
lung cancer (NSCLC).1 Many patients have poor cardiorespiratory fitness and a low ?̇?O2peak, which may be 
a contraindication for life-saving surgical treatment. ?̇?O2peak declines significantly after lung resection in 
most patients, 7-9 although the extent of and reason for this decline are unclear. After surgery, the loss of 
lung tissue is irreversible, and there is little that can be done to improve lung function and the area for 
gas exchange. Thus, exercise training may be the single most important factor for recovering some of the 
lost cardiorespiratory fitness needed to restore physical function and quality of life after surgery. 
The first part of this thesis suggests a new set of reference values for CPET and new recommended 
criteria for determining that the subject has achieved maximum effort. The second part of the thesis 
investigates the changes in cardiorespiratory fitness early in the recovery from NSCLC surgery, predictors 
of postoperative functional outcomes (e.g pulmonary function and ?̇?O2peak), and studied the effects of 
high-intensity endurance and strength training on ?̇?O2peak, pulmonary function, muscular strength, total 
muscle mass, functional fitness, and quality of life after lung cancer surgery.
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2.0 GENERAL BACKGROUND INFORMATION 
2.1 Cardiopulmonary exercise testing 
CPET is a commonly used and reliable noninvasive method to measure the cardiac and respiratory 
responses during a continuous graded exercise test from rest to maximum effort. CPET is normally 
conducted in a clinical setting in hospitals and health institutions. Several physiological variables are 
measured before, during, and after exercise. These include pulmonary function, minute ventilation (?̇?E), 
gas exchange, ?̇?O2max or ?̇?O2peak, oxygen saturation, ECG features, and blood pressure (BP) (Figure 1). 
CPET also involves determination of the cardiopulmonary reserve and ventilatory limitation, and is used 
in the assessment of the risk of postoperative dyspnea. CPET is also a good method for detecting 
asymptomatic heart failure and coronary artery disease.10,11 Thus, CPET is indeed useful  in the clinical 
setting for studying a patient’s exercise limitations and their causes.12 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cardiopulmonary exercise test by up-hill 
walking on the treadmill. Private photo with 
permission. 
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2.2 Maximal oxygen uptake 
?̇?O2max or ?̇?O2peak* is considered the most important of the measurements taken during CPET.13  ?̇?O2max 
was first described by Hill and Lupton in the 1920s14 and is defined as “the highest rate at which oxygen 
can be taken up and utilized by the body during severe exercise.”15 In accordance with the Fick 
principle,16,17 ?̇?O2max is the product of maximal cardiac output (Qmax) and arteriovenous oxygen difference 
((Ca–Cv) O2 difference). Both maximal heart rate (HRmax) and arterial oxygen content are unrelated to 
aerobic exercise capacity;18 thus, variation between individuals in oxygen delivery to the working muscles 
reflects differences in stroke volume. 
Fick equation:16,17 
?̇?O2max = Qmax ∙ (Ca-Cv) O2 difference,  where Qmax is a function of HRmax and stroke volume 
 
Although ?̇?O2max is measured in liters of oxygen per minute (L∙min–1), it is usually expressed in milliliters 
of oxygen per kilogram of body weight per minute (mL∙kg–1∙min–1). ?̇?O2max quantifies an individual’s 
aerobic exercise capacity and provides valuable diagnostic and prognostic information about the 
cardiorespiratory system. It is also a useful predictor of postoperative complications after pulmonary 
resection surgery19 and for assessing the timing of cardiac transplantation surgery.20 
?̇?O2max is task specific and is best measured during dynamic work that uses large muscle groups, such as 
walking or running.21 Consequently, ?̇?O2max is 10–20% higher during uphill walking and running 
compared with cycling in both healthy individuals22,23 and in patients with lung disease.24 This is because 
recruitment of the quadriceps muscle is increased during uphill walking,25,26 and therefore, cardiac 
output may not be at its maximum. In addition, untrained subjects will usually terminate cycling exercise 
because of quadriceps fatigue.22 ?̇?O2max is related to factors such as fitness level, genetics, age, sex, body 
size, hemoglobin concentration [Hb], and muscle mass,21 and is affected by the presence of diseases or 
medications that influence these components.27 
Endurance-trained individuals have a superior capacity to both deliver and utilize oxygen compared with 
untrained individuals, and cardiac output can be nearly twice as high in an elite athlete compared with 
an untrained person.28  
------------------------------------------------------------------------------------------------------------------------------------------- 
* In the present thesis, ?̇?O2peak is used when pre-defined criteria for maximum effort is not fulfilled 
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Figure 2 shows four different physiological factors that can limit an individual’s ?̇?O2max. The first three 
factors (pulmonary diffusing capacity, cardiac output, oxygen-delivery capacity) are usually classified as 
“central factors” and the fourth (skeletal muscles) as “peripheral factor”.15 In normal individuals, 75–85 
% of ?̇?O2max is limited by central factors during whole-body work and about 20 % by peripheral factors.29 
?̇?O2max in a young male elite endurance athlete may exceed 90 mL∙kg-1∙min-1.30 ?̇?O2max at any age is 10–20 
% lower in females than in males, in part because of a lower [Hb],31 more body fat,32 and a smaller heart 
in females.33 
Longitudinal studies of healthy people have shown that the training-induced increase in ?̇?O2max is 
primarily caused by an increase in Qmax and not by an increase in systemic (Ca–Cv) O2 difference.15,34 
However, peripheral factors may be more important during exercise involving smaller muscle groups.29 
Correspondingly, cardiac output decreases after prolonged bed rest35 and long-term use of beta-
blockers.36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2. Limiting factors for maximal oxygen uptake in 
a healthy individual. Adapted from Blomqvist & Saltin.3 
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It is reasonable to assume that lung cancer surgery affects all of the physiological factors mentioned 
above. Such effects can be direct because of removal of lung tissue and blood loss, and thus reduced 
diffusion and oxygen-carrying capacity, or indirect because of inactivity imposed by prolonged bed rest 
and severe pain, which leads to reduced cardiac output and loss of muscle mass. The extent of and exact 
mechanisms underlying these changes are not known. Decrements in the four factors mentioned above 
are accelerated by the use of chemotherapy and/or radiation, which affects all pathways of oxygen 
transport from the lungs to the working muscle.37,38 The oxygen-delivery capacity (DO2) may thus be 
affected. DO2 may be expressed as follows;39 
DO2 = cardiac output ∙ (Hb ∙ 1.39 ∙  SaO2) + (PaO2 ∙ 0.003) 
 
Cardiac output (predominantly stroke volume) is the main factor in the equation that can be 
manipulated by exercise training to keep the DO2/?̇?O2 ratio constant in the working muscles. Exercise 
training may also lead to an increase in total blood Hb content because of an increase in blood volume.40 
 
2.2.1 Maximal oxygen uptake, mortality and survival 
?̇?O2max is a strong predictor of postoperative morbidity and mortality.4,5 This is also the case in patients 
with cardiopulmonary diseases such as cardiovascular disease41 and in lung cancer patients.19,42 In 
general, the change in physical fitness correlates strongly with the risk of mortality. Unfit individuals who 
improve their fitness status have shown a 35 % lower mortality risk compared with those who remain 
unfit.43,44 Thus, survival improves significantly when an unfit person becomes fit, and even small 
improvements in fitness level are associated with a significantly lowered risk of premature death.45 
Correspondingly, ?̇?O2max is a good predictor of long-term survival. For example, an increase of only 3.5 
mL∙kg-1∙min-1 (corresponding to 1 MET*) is associated with 12 % and 17 % improvements in survival for 
men5 and women4, respectively. Muscular strength, another important aspect of physical fitness, has 
shown to be independently and inversely associated with mortality in COPD patients,46 in cancer 
patients,47 and from all causes,48 even after adjusting for cardiorespiratory fitness. Strength training may 
also increase ?̇?O2max, especially in severely deconditioned adults.49 
------------------------------------------------------------------------------------------------------------------------------------------- 
* Metabolic equivalent, equal to 3,5 mL oxygen per body weight per minute 
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2.2.2 Mechanisms of training effects on maximal oxygen uptake 
In the scientific literature, an increase in ?̇?O2max is the gold standard to demonstrate an aerobic training 
effect, and  is a precise measurement to use when developing an exercise prescription or intervention.15 
The magnitude of the increase after an intervention depends on a number of factors such as the training 
intensity, duration, and frequency, duration of the program, and the initial fitness status.50 The increase 
in stroke volume following exercise training leads to a reduced heart rate (HR) during submaximal 
exercise, which is caused by increases in left ventricular size, myocardial contractility, end-diastolic 
volume, and blood and plasma volumes.51,52 The oxygen-carrying capacity increases because of an 
increase in total blood Hb content, and the skeletal muscles may also require less blood flow because of 
an increase in the (Ca–Cv) O2 difference.40 In addition, the capillarity of skeletal muscle increases, which 
improves the maximum muscle blood flow capacity and surface area available for gas exchange.53 
Exercise training also delays blood lactate production and accumulation during exercise in both healthy 
individuals and patients with lung disease.54 Thus, fit muscles may require lower pulmonary ventilation 
than unfit muscles.55 Table 1 presents a summary of the systematic reviews and meta-analyses of the 
changes in ?̇?O2max after an exercise intervention in people with various conditions.56-61 
Table 1. Systematic reviews and meta-analyses on the effect on maximal oxygen uptake (?̇?O2max) after 
exercise training in healthy elderly and in patients with chronic disease. 
Author Population 
RCT included 
(n) 
Participants 
(n) 
Mean baseline 
?̇?O2max 
Increase in ?̇?O2max 
(mL∙kg-1∙min-1 and %) 
Huang et al. 
(2005)57 
Healthy elderly 41 2102 23.2 3.4 16 % 
Beauchamp et al.  
(2010)56 
Lung disease 8 388 Not reported -0.01 Not reported 
Jones et al. 
(2011)58 
Adult cancer 
patients 
6 571 Not reported 2.9 Not reported 
Valkeinen et al. 
(2010)60 
Coronary heart 
disease 
21 922 Not reported 2.3 12 % 
Weston et al. 
(2013)59 
Lifestyle induced 
cardio-metabolic 
disease 
10 273 
HIIT:22.5 
MICE: 22.6 
HIIT:5.4 
MICE:2.6 
HIIT:19.4 % 
MICE:10.3 % 
Boule et al. 
(2003)61 
Type 2 diabetes 
mellitus 
7 266 22.4 NR 13 % 
HIIT= High-Intensity Interval Training, MICE= Moderate Intensity Continuous Training, n=number, RCT=randomised controlled 
trial 
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2.3 Other variables measured during CPET 
In addition to ?̇?O2max, other variables can be measured directly before, during, and after CPET. The 
primary variables ?̇?O2, ?̇?CO2, tidal volume (Vt), respiratory rate (RR), and HR are used to derive 
secondary variables such as the respiratory exchange ratio (RER) (?̇?CO2/?̇?O2), ?̇?E (Vt  RR), oxygen pulse 
(O2 pulse; ?̇?O2/HR), breathing reserve (maximal voluntary ventilation (MVV) – ?̇?E/MVV), and the 
equivalents of ?̇?O2 and ?̇?CO2 (?̇?E/?̇?O2 and ?̇?E/?̇?CO2). Figure 3 shows an overview of the analyzers used 
during CPET and the primary and derived variables. This thesis focuses mainly on the variables measured 
during maximal exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Overview of analyzers and variables during a CPET. 
Adapted from Cooper & Storer. 2 
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2.3.1 Ventilatory limitations and breathing reserve 
The pulmonary transport of oxygen includes ventilation, diffusion into blood, and the chemical reaction 
with Hb.3 Jones and coworkers showed many years ago that there is a poor relationship between 
exercise capacity and FEV1.62 This is because oxygen uptake from the lung to the working muscles is 
affected by many other factors such as cardiac output, arterial pO2, Hb concentration, and leg blood 
flow.55 However, lung diseases can affect the ventilatory responses during exercise. Alterations in lung 
mechanics occurring in both obstructive and restrictive lung diseases lead to a reduction in ventilatory 
capacity, as measured by MVV. If severe enough, these reductions lead to early exercise limitations. 
Ventilatory limitation is normally defined as a breathing reserve < 15 %,2 calculated as (MVV – 
?̇?Epeak/MVV) ∙ 100, where ?̇?Epeak denotes the maximum ?̇?E achieved during CPET. 
 
 
2.3.2 Ventilatory efficacy 
Cardiopulmonary disease may also be associated with increased physiological dead space in the lungs, 
which must be compensated for by an increase in ?̇?E. This situation is reflected by an increased 
ventilation-to-work ratio and thus a steeper ?̇?E/?̇?O2 slope during exercise. 
Ventilatory inefficiency is measured as the linear relationship between ?̇?E and CO2 production (?̇?E/?̇?CO2 
slope) and is considered a strong and independent prognostic predictor of survival in patients with heart 
failure,63,64 and in other patients with mild to moderate exercise limitation. A slope steeper than  34 
indicates an abnormal response.65 ?̇?E/?̇?CO2 slope is a marker of pulmonary hypertension in COPD 
patients, for whom a higher value is associated with reduced survival.66 In lung cancer patients, Torchio 
and coworkers have shown that a steep ?̇?E/?̇?CO2 slope before surgery may be an independent predictor 
of mortality, even in the presence of acceptable physical function.67 This finding has not been confirmed 
by others. 
 
2.3.3 Oxygen pulse 
The exercise O2 pulse is the volume of oxygen taken up by the pulmonary blood per heartbeat and 
provides valuable information during CPET. O2 pulse is derived from a rearrangement of the Fick 
equation as follows: 
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?̇?O2max = SV ∙HR ∙ (Ca-Cv) O2 difference   → 
?̇?O2max /HR = SV ∙ (Ca-Cv) O2 difference   →  ?̇?O2max /HR = O2 pulse 
O2 pulse = SV ∙ (Ca-Cv) O2 difference 
The increase in O2 pulse during CPET is usually smaller in patients with the most impaired ventricular 
responses during work,68 and appears as a low O2 pulse in combination with normal oxygen saturation 
(SpO2) and Hb concentration. Hence, if SpO2 and the Hb concentration are normal, the O2 pulse may be a 
marker of stroke volume. The (Ca–Cv) O2 difference changes almost linearly from rest to maximal exercise 
both in fit normal subjects69 and in patients with heart failure.70 During hypoxemia (e.g., in a patient with 
lung disease), the (Ca–Cv) O2 decreases by 1 % for each 1 % decrease in SpO2 below 96 %.2 Hence, 
patients with reduced oxygen delivery because of reduced oxygen content (e.g., hypoxemia, anemia, 
carboxyhemoglobin) may also have a low O2 pulse. 
 
2.3 Maximum effort during CPET 
During CPET, the subject’s motivation and effort, the equpiment and the technician’s skills are important 
for ensuring valid and reliable results when for instance we want to compare groups in large 
epidemiological studies, and for the accurate interpretation of a maximal test in patients. An ability to 
achieve a maximum effort during CPET is also important in the pre-evaluation for lung cancer surgery 
because the patients’ ?̇?O2max may influence the choice of treatment (surgery vs. palliative care).1,71 
Epidemiological studies and randomised controlled trials (RCTs) have shown that the end criteria for a 
maximum effort vary in current practice, which can be confusing. For example, the review by Howley and 
coworkers from 1995 found that 17 different criteria were used in 29 published articles.72 Unfortunately, 
little has changed since then, and knowledge about how these different end criteria are affected by sex 
and age is scarce. In addition, ACSM’s Guidelines for Exercise Testing and Prescription states that using a 
plateau in oxygen uptake has fallen into disfavor because a plateau is inconsistently seen during 
continuous graded exercise tests and is confounded by variations in the definitions and sampling.73 Thus, 
there is a need to develop consensus on the choice of criteria for determining whether a subject or 
patient has achieved ?̇?O2max. 
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2.4 Non-Small-Cell lung cancer 
Lung cancer has been the most common cancer in the world for several decades. Globally, 1.61 million 
people are diagnosed each year, and the incidence is increasing, especially among women and in 
developing regions such as Asia and Africa.74 There are differences between populations.75 In Norway, 
the total incidence was 2856 in 2013;  the rate is decreasing in men, but is increasing among females.76 
Lung cancer is also the most common cause of cancer death and accounted for > 1.38 million deaths 
(18.2 % of the total) in 2008.74 In Norway, 2162 patients died of lung cancer in 2013.76 Thus, lung cancer 
still has a very high fatality rate, and the ratio of mortality to incidence is 0.76. Despite improved 
treatment strategies in recent years, the 5-year survival rate is < 15 %.76 
2.4.1 Treatment 
Surgical resection is the preferred treatment given with a curative intent whenever possible and offers 
the best prospect of long-term survival.77 After surgery, the 5-year relative survival rate is up to about 50 
% for the most favorable tumor stages.78 However, at the time of diagnosis, only 23 % of all NSCLC 
patients were offered surgery in Norway between 2000 to 2007. 78 For those who do not fulfill the 
criteria for surgery, the treatment options are chemotherapy and/or radiation therapy, and in a 
subgroup of patients also immunotherapy.79 The prognosis for survival for those who do not receive 
surgery is less than 8–10 %.78 Thus, surgery improves survival considerably. 
2.4.1.1 Surgery 
In Norway, surgical treatment of lung cancer is performed by board-certified thoracic surgeons at the 
university hospitals and involves the surgical excision of cancerous tissue from the lung with the 
intention of curing the patient. The surgery is accomplished through a muscle-sparing, nerve-sparing 
lateral thoracotomy or through video-assisted thoracoscopic surgery (VATS) without any rib spreading. 
The main surgical procedures are: 
1) Pneumonectomy: removal of an entire lung 
2) Lobectomy: removal of an entire lobe 
3) Bi-lobectomy: removal of two entire lobes 
4) Wedge resection: removal of part of a lobe 
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The duration of the hospital stay after surgery varies but is shorter for lobectomy or VATS compared with 
pneumonectomy.80 Fortunately, there have been improvements in the NSCLC resection rate (16 % 
between 1996 to 2000 and 23 % between 2001 to 2007), and postoperative mortality (4.8 % in men and 
1.7 % in women). However, the waiting time from final diagnositic prosedure until surgery has increased 
from 29 to 40 days over the past 20 years.78 
 
2.5 Preoperative evaluation for surgery 
The European guidelines for preoperative functional evaluation in candidates for radical lung resection 
are produced by two different task forces.1,81 The European Respiratory Society/European Society for 
Thoracic Surgery (ERS/ESTS) guidelines are aimed at stratifying peri-operative risk of death and major 
cardiopulmonary complications, and at accepting or excluding patients from surgery.1,82 The British 
Thoracic Society/Society for Cardiothoracic Surgery (BTS/SCTS) guidelines focus more on discussing the 
risks of postoperative functional dyspnea and impaired quality of life with the patient and then letting 
the patient decide if he/she accepts the risk of surgery and its potential impacts on lifestyle.81,82 For 
predicting the risk of peri-operative or in-hospital deaths, the BTS/SCTS guidelines recommend use of the 
Thoracoscore 83 instead of FEV1, whereas the ERS/ESTS task force suggests a more frequent measure of 
?̇?O2max. The latter is preferred because ?̇?O2max has been reported as being a better predictor of 
postoperative morbidity and mortality than are FEV1 and carbon monoxide lung diffusion capacity 
(DLCO).19,42,84,85 Hence, ?̇?O2max is now a pivotal measure in the ERS/ESTS algorithm in those patients with 
an FEV1 or DLCO < 80 % of predicted (Figure 4, page 12).1 
The use of CPET to evaluate the risk of NSCLC surgery has been examined extensively.19,42,67,85-88 
However, the recent guidelines for the cutoff values are based mainly on data collected more than 15 
years ago,85,86 which may not be accurate because of  improvement in surgical techniques and in peri-
and postoperative care. Most investigations still focus on male patients,67,88,89 with women comprising 
only 12 % of the populations in the most recently published studies.67 In addition, the ERS/ESTS and 
BTS/SCTS guidelines use absolute cutoff values for ?̇?O2max in the algorithm regardless of sex and age. 
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The requirement for acceptance for surgery is thus higher in women despite their lower incidence of 
morbidity and mortality.78,90 This may exclude women from life-saving surgery which is an important 
aspect given the increasing prevalence of lung cancer in the female population.91 
  
Figure 4. Bollinger-Algorithm for the assessment of 
cardiopulmonary reserve before lung resection in lung cancer 
patients. Adapted from ERS/ESTS clinical guideline on fitness 
for radical therapy in lung cancer patients.1 
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2.6 Effects of surgery on physical function 
The majority of investigations studying the change in ?̇?O2max from before to after surgery have reported 
a decrease in ?̇?O2max of both clinical and statistical significance, most pronounced after pneumonectomy 
(Table 2, page 14). However, the timing of the measurement of ?̇?O2max ranges from 3 to 12 months after 
surgery. If the objective is to stratify the patient’s risk of early postoperative morbidity, there is a need 
for more knowledge about the change in ?̇?O2max measured earlier after surgery. An evaluation time 
closer to the time when most complications occur may provide more accurate information for 
characterizing these patients in the more critical phase shortly after discharge from hospital. 
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2.6.1 Predicting postoperative function 
Knowledge about lung cancer surgery focuses mainly on morbidity and mortality risks, and the factors 
that affect functional outcomes, such as pulmonary function and ?̇?O2max after surgery are poorly 
characterized. This is unfortunate because the health status after surgery can become significantly 
impaired92 and may include poor physical function and dyspnea from which patients fail to recover.93 
Some patients would not forgo surgery because the other options are encumbered with poorer 
prognosis, and it is important to be able to predict the functional outcomes as accurately as possible and 
to identify the associations between impairments in pulmonary function and cardiorespiratory fitness. 
Lung function, in particular FEV1, DLCO, and predicted postoperative (ppo) FEV1 and DLCO, have 
traditionally been the key measures in the functional pre-evaluation for lung cancer surgery. These 
variables are thus included in the algorithms in both the European and American guidelines, by using the 
segment method.1,71,81 The segment method is based on the principle that the amount of functional loss 
of lung segments is equivalent to the loss of FEV1 and DLCO;  
ppo =  𝑝𝑟𝑒𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑣𝑒 𝑣𝑎𝑙𝑢𝑒  
(19 − 𝑛 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠  𝑟𝑒𝑠𝑒𝑐𝑡𝑒𝑑)
19 − 𝑛𝑜𝑛𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠
 
 
However, the use of lung function measurement has been questioned, especially in patients with severe 
COPD who show improvements in respiratory mechanics and elastic recoil because of the “lobar volume 
reduction effect.”7 In addition, the ppo segment method for predicting postoperative pulmonary 
function has been shown to produce conflicting results in terms of accuracy94 and the validation of this 
method has  been performed months after surgery, when the most important complications have 
resolved.7,95,96 
For assessment of postoperative cardiorespiratory fitness, the ERS/ESTS guidelines also include the ppo 
?̇?O2peak in the algorithm and state that a ppo ?̇?O2max < 10 mL∙kg–1∙min–1 or 35 % of predicted is a 
contraindication for major pulmonary resection (Figure 4, page 12).1 Consequently, this cutoff requires 
an accurate estimation to avoid excluding patients from life-saving surgery based on inaccurate data. 
However, from a physiological point of view, the relationship between ppo ?̇?O2peak  and actually 
measured postoperative ?̇?O2peak does not seem reasonable because ?̇?O2peak is determined by both 
central (pulmonary diffusing capacity, cardiac output, oxygen-carrying capacity) and peripheral factors 
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(skeletal muscle factors), as discussed in detail on page 14. This cutoff also requires that the exercice test 
is performed to maximum in CPET involving the dynamic use of large muscle groups (e.g. treadmill). In 
many cases, it appears that the ?̇?O2peak reported is submaximal because of the low peak HR relative to 
the predicted HRmax.42,89,97,98 Further studies are needed to validate the use of the ppo calculated by the 
segment method after surgery. 
 
2.7 Training interventions in NSCLC patients 
Exercise rehabilitation seems to be important for patients after resection of lung cancer because of their 
physical impairments prior to surgery, further loss in fitness after treatment, and knowledge that the 
physical fitness is associated with the prognosis after resection.42,99,100 However, to our knowledge, 
before the start of data collection for this thesis, only three studies have investigated the effect of 
exercise training in NCSLC patients undergoing surgery (Table 3). None of these studies used a 
randomised design,97 and only one study measured cardiorespiratory fitness by a directly measure of 
?̇?O2peak. In addition, the number of participants included was low,101 the exercise duration was 
short,101,102 and the exercise intensity was low or moderate in all studies. Furthermore, the endurance 
exercise training comprised mainly continuous training of 20–45 min cycling, which is inappropriate in 
this population because of their poor leg strength and dyspnea, which is even more pronounced after 
surgery.81,103 Exercising for shorter periods at a higher intensity reduces the ventilatory response and 
allows the patient to recover between intervals, which may be more suitable for patients after lung 
resection. Muscular strength is generally poor, especially in COPD patients,55 and this can make cycling 
difficult for patients because of leg discomfort. However, no study has included resistance training in the 
exercise program. Importantly, even though the training effect was conflicting in these three studies, no 
adverse events were reported, and the feasibility of and adherence to the training program were 
adequate.  
During and after the data collection in the present study, four RCT studies were published (Table 3, page 
17). The results of these studies are discussed further in the Discussion section. 
  
 
B
A
C
K
G
R
O
U
N
D
 IN
FO
R
M
A
TI
O
N
 
__
__
__
__
_
__
_
__
_
__
__
_
__
__
__
__
__
_
__
_
__
_
__
__
_
__
__
__
__
__
_
__
_
__
_
__
__
_
__
__
__
__
__
_
__
_
__
_
__
__
  
-1
7
- 
 Ta
b
le
 3
. 
In
ve
st
ig
a
ti
o
n
s 
st
u
d
yi
n
g
 t
h
e 
ef
fe
ct
 o
f 
ex
er
ci
se
 r
eh
a
b
ili
ta
ti
o
n
 a
ft
er
 N
SC
LC
 s
u
rg
er
y 
b
ef
or
e 
a
n
d
 a
ft
er
 s
ta
rt
 o
f 
th
e 
p
re
se
n
t 
st
u
d
y 
(a
b
o
ve
 a
n
d
 
b
el
o
w
 t
h
e 
b
lu
e 
lin
e,
 r
es
p
ec
ti
ve
ly
).
 
 A
u
th
o
r,
 y
e
ar
 
N
u
m
b
e
r 
o
f 
su
b
je
ct
s 
(M
/F
) 
Lo
ca
liz
at
io
n
 
(C
o
u
n
tr
y)
 
FE
V
1
 
 
D
L C
O
 
 
St
u
d
y 
d
e
si
gn
 
Ty
p
e
 o
f 
e
xe
rc
is
e
 
In
te
n
si
ty
 
Fr
e
q
u
e
n
cy
 a
n
d
 
le
n
gt
h
 o
f 
in
te
rv
e
n
ti
o
n
 
(P
ri
m
ar
y)
  
o
u
tc
o
m
e
s 
Ef
fe
ct
s 
 S
p
u
it
 e
t 
al
. 
 2
0
0
6
 
8
/2
 
N
et
h
er
la
n
d
s 
5
5
 %
 
4
5
 %
 
N
o
n
 
ra
n
d
o
m
is
ed
 
p
ilo
t 
En
d
u
ra
n
ce
  
St
re
n
gt
h
 
2
0
 m
in
 n
o
n
-s
to
p
 a
t 
6
0
 %
 
3
x1
5
 r
ep
et
it
io
n
s 
at
 6
0
 %
 
o
f 
1
R
M
 
5
 d
/w
ee
k 
fo
r 
8
 
w
ee
ks
 
6
 M
W
D
 (
m
) 
P
ea
k 
cy
cl
in
g 
lo
ad
 (
w
at
t)
 
M
ed
ia
n
 e
ff
ec
t:
1
4
5
 
M
ed
ia
n
 e
ff
ec
t:
 2
6
 
 C
es
ar
io
 e
t 
al
. 
 2
0
0
7
 
2
5
 *
 
It
al
y 
1
.6
 L
 
N
R
 
N
o
n
 
ra
n
d
o
m
is
ed
 
co
n
tr
o
lle
d
 t
ri
al
 
C
yc
lin
g 
3
0
 m
in
 n
o
n
-s
to
p
 a
t 
7
0
-8
0
 
%
 o
f 
p
ea
k 
w
o
rk
 lo
ad
 
5
 d
/w
ee
k 
fo
r 
4
 
w
ee
ks
 
P
u
lm
o
n
ar
y 
fu
n
ct
io
n
 
6
 M
W
D
 (
m
) 
Si
gn
if
ic
an
t 
ef
fe
ct
 
A
ve
ra
ge
 e
ff
ec
t:
9
5
 
 J
o
n
es
 e
t 
al
.  
 2
0
0
8
 
1
0
/9
 
U
SA
 
7
1
 %
 
8
3
 %
 
N
o
n
 
ra
n
d
o
m
is
ed
 
p
ilo
t 
C
yc
lin
g 
2
0
 –
 4
5
 m
in
 n
o
n
-s
to
p
 a
t 
6
0
-7
0
 %
 o
f 
p
ea
k 
w
o
rk
 
lo
ad
. I
n
te
rv
al
 t
ra
in
in
g 
in
 
fo
u
r 
se
ss
io
n
s 
 
3
 d
/w
ee
k 
fo
r 
1
4
 
w
ee
ks
 
𝑉
O
2p
ea
k 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
 
 A
rb
an
e 
et
 a
l. 
 2
0
1
1
 
5
1
 
U
n
it
ed
 
ki
n
gd
o
m
 
1
.9
 L
 
N
R
 
R
an
d
o
m
is
ed
 
co
n
tr
o
lle
d
 t
ri
al
 
W
al
ki
n
g 
A
d
ap
te
d
 h
o
m
e 
st
re
n
gt
h
en
in
g 
p
ro
gr
am
 
In
-p
at
ie
n
t 
se
ss
io
n
s 
H
o
m
e 
b
as
ed
 p
ro
gr
am
: 
w
al
ki
n
g 
in
 t
h
e 
p
ar
k 
St
re
n
gt
h
 t
ra
in
in
g 
5
 d
ay
s 
D
ai
ly
 f
o
r 
1
2
 w
ee
ks
 
6
 M
W
D
 (
m
) 
Q
u
ad
ri
ce
p
s 
st
re
n
gt
h
 
(k
g)
 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
 
 P
ed
d
le
- 
 M
cI
n
ty
re
 e
t 
al
. 
 2
0
1
2
 
7
/1
0 
C
an
ad
a 
7
7
 %
 
N
R
 
N
o
n
 
ra
n
d
o
m
is
ed
 
co
n
tr
o
lle
d
 t
ri
al
 
R
es
is
ta
n
ce
 t
ra
in
in
g 
 
B
re
at
h
in
g 
Fr
o
m
 6
0
 %
  t
o
 8
5
 %
 1
R
M
  
3
 d
/w
ee
k 
fo
r 
1
0
 
w
ee
ks
 
M
u
sc
u
la
r 
st
re
n
gt
h
 
 
6
M
W
D
 
Le
g 
p
re
ss
: 3
2
 k
g 
ch
es
t 
p
re
ss
: 1
5
 k
g 
8
6
 m
 
 S
ti
gt
 e
t 
al
. 
 2
0
1
3
 
4
0
/9
 
N
et
h
er
la
n
d
s 
8
5
 %
 
N
R
 
R
an
d
o
m
is
ed
 
co
n
tr
o
lle
d
 t
ri
al
 
C
yc
lin
g 
M
u
sc
le
 t
ra
in
in
g 
6
0
 –
 8
0
 %
 o
f 
p
ea
k 
 
w
o
rk
 lo
ad
 
2
 d
/w
ee
k 
fo
r 
1
2
 
w
ee
ks
 
Q
O
L 
P
u
lm
o
n
ar
y 
fu
n
ct
io
n
 
6
 M
W
D
 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
 
B
G
D
: 9
4
m
 
 A
rb
an
e 
et
 a
l. 
 2
0
1
4
 
7
2
/5
9 
U
n
it
ed
 
ki
n
gd
o
m
 
2
.5
 L
 
N
R
 
R
an
d
o
m
is
ed
 
co
n
tr
o
lle
d
 t
ri
al
 
C
yc
lin
g 
H
o
m
e 
w
al
ki
n
g 
p
ro
gr
am
 
6
0
 –
 9
0
 %
 o
f 
H
R
R
 
B
o
rg
 1
3
-1
5 
 
D
ai
ly
 f
o
r 
4
 w
ee
ks
 
P
h
ys
ic
al
 a
ct
iv
it
y 
Q
O
L 
IS
W
T 
Q
u
ad
ri
ce
p
s 
fo
rc
e
 
 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
s 
 
 S
al
h
i e
t 
al
. 
 2
0
1
4
 
2
4
/4
¶
 
B
el
gi
u
m
 
8
5
 %
 
7
5
 %
 
R
an
d
o
m
is
ed
 
co
n
tr
o
lle
d
 t
ri
al
 
R
es
is
ta
n
ce
 t
ra
in
in
g 
N
R
 
3
 d
/w
ee
k 
fo
r 
1
2
 
w
ee
ks
 
M
C
SA
 
Q
u
ad
ri
ce
p
s 
fo
rc
e
 
Si
gn
if
ic
an
t 
ef
fe
ct
 
N
o
 s
ig
n
if
ic
an
t 
ef
fe
ct
 
* 
ac
ti
ve
 p
ar
ti
ci
p
an
ts
, ¶
 o
n
ly
 1
5
 o
f 
th
e 
in
cl
u
d
e
d
 p
at
ie
n
ts
 u
n
d
er
w
e
n
t 
su
rg
e
ry
 
B
G
D
 =
 b
et
w
e
en
-g
ro
u
p
 d
if
fe
re
n
ce
, D
L C
O
 =
 D
if
fu
si
o
n
 C
ap
ac
it
y 
fo
r 
C
ar
b
o
n
 M
o
n
o
xi
d
e 
in
 t
h
e 
Lu
n
g,
 F
EV
1 
= 
Fo
rc
ed
 E
xp
ir
at
o
ry
 V
o
lu
m
e 
af
te
r 
1
 s
ec
, H
R
R
 =
 H
ea
rt
 R
at
e 
R
es
er
ve
 (
H
R
m
ax
-
H
R
re
st
) 
∙ %
 in
te
n
si
ty
 +
 r
es
t,
 IS
W
R
 =
 In
cr
em
en
ta
l S
h
u
tt
le
 W
al
k 
Te
st
, M
W
D
 =
 M
in
u
te
 W
al
ki
n
g 
D
is
ta
n
ce
, M
C
SA
 =
 M
u
sc
le
 C
ro
ss
 S
ec
ti
o
n
al
 A
re
a,
 N
R
 =
 N
o
t 
R
ep
o
rt
ed
, R
M
 =
 R
ep
et
it
io
n
 
M
ax
im
u
m
, 𝑉
O
2
p
ea
k 
= 
P
ea
k 
O
xy
ge
n
 U
p
ta
ke
,  
Q
O
L=
 Q
u
al
it
y 
o
f 
Li
fe
 
BACKGROUND INFORMATION 
_____________________________________________________________________________________ 
 
-18- 
 
3.0 NEED OF NEW INFORMATION 
As shown in Table 4, reference values during CPET have previously been reported, either for ?̇?O2max 
alone,104-108 or in combination with other cardiorespiratory variables typically used during a CPET. 109-114 
However, the majority of these studies are old,104,106,108-111,113 are based on small samples, are without 
randomly selected participants,106,109,110,115,116 and the number of elderly and female participants are low 
or absent. 110-112,116 To interpret the results of a CPET, normative reference values are thus required, 
derived from the same subjects and using similar test-methods. 
 
Table 4. Reference values in different populations published from 1960 and after start of the present 
study (above and below the blue line, respectively). 
 Author Population Country Gender 
Number 
(n) 
Age 
(year) 
Ergometer 
 Åstrand, 1960 117 Healthy Sweden, US F/M 44 6-65  Cycle 
 Bruce et al., 1973 118 General 
population 
US F/M 157/138 29-73 Treadmill 
 Drinkwater et al., 1975 109 Healthy US F 109 6-68 Treadmill 
 Jones et al., 1985 115 Students Canada F/M 100 15-71 Cycle 
 Hansen et al., 1984 110 Shipyard 
workers 
US M 265 34-74 Cycle 
 Vogel et al., 1986 116 US Army US F/M 1889 17-55 Treadmill 
 Inbar et al., 1994 111 Healthy 
workers 
Israel M 1424 20-70 Treadmill 
 Fairbarn et al., 1994 119 Healthy Canada F/M 231 20-80 Cycle 
 Paterson et al., 1999 108 Healthy Canada F/M 298 55-86 Treadmill 
 Neder et al., 1999 120 Sedentary Brazil F/M 120 20-80 Cycle 
 Davis et al., 2002 107 Sedentary US F/M 230 20-70 Cycle 
 Nelson et al., 2010 112 Healthy Canada M 816 30-69 Treadmill 
 Aspenes et al., 2011 121 Healthy Norway F/M 4631 20-90 Treadmill 
 Loe et al., 2013 122 Healthy Norway F/M 3816 20-90 Treadmill 
F = female, M= male, n = number, US=United State of America 
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A valid ?̇?O2max and defining cardiopulmonary reserve during CPET are important and depend entirely on 
the individuals’ ability to cope with exhaustion, especially when the result determines whether a patient 
gets access to potentially curative treatment strategies. The technicians’ skills and the subjects’ 
motivation and effort are important requirements to ensure valid and reliable results when comparing 
groups in large epidemiological surveys, as well as for the accurate interpretation of a maximal test for 
both athletes and patients. The classical plateau described by Taylor and coworkers is recognized as the 
gold standard to determine a true ?̇?O2max.123 However, this criterion is based on old measurement 
techniques, different protocols and are developed from athletes, children or adolescents, and is thus not 
straight forward to use in practical settings. During the preoperative evaluation for lung cancer, maximal 
effort is especially important to secure a valid ?̇?O2max. Poor effort gives lower values, and may in the 
worst case lead to misinterpretation during the preoperative evaluation. Thus, new recommendation for 
maximal effort during CPET is needed. 
 
Not surprisingly, many lung cancer patients are deconditioned with poor cardiorespiratory fitness.85 
After surgery, the health status becomes further impaired,92 with dyspnoea failing to recover.93 It is, 
however, important to know the effect of lung cancer surgery on CRF related to the extent of the 
operation, for preventing further impairment, and for predicting the functional outcomes as accurate as 
possible. Therefore, an evaluation of the changes in CRF from before to after surgery, and the ability to 
predict postoperative outcomes is needed. In addition, individual exercise training for reversing the 
negative effects of treatment may be especial important for these patients. However, knowledge about 
feasibility and effects after high-intensity endurance- and strength training are lacking. 
 
  
 
BACKGROUND INFORMATION 
_____________________________________________________________________________________ 
 
-20- 
 
3.1 Aims  
 
Based on the above, the specific aims of the present thesis were as follows: 
 
Part one – normative variables in healthy individuals 
1. To determine the cardiorespiratory response during maximal exercise in a well-described 
representative national sample of 20- to 85-year-old men and women (paper I). 
 
2. To describe the different end criteria used for defining ?̇?O2max during a maximal progressive 
graded exercise test on the treadmill in a healthy sample of 20-to 85-year-old men and women, 
and to explore if the choice of end criteria has an impact on the ?̇?O2max value (paper II). 
 
 
 
Part two – lung cancer surgery, cardiorespiratory fitness and effects of exercise training 
3. To evaluate the effect of lung cancer surgery on cardiorespiratory fitness measured on a 
treadmill, and to assess the agreement between predicted postoperative and actually measured 
postoperative ?̇?O2peak values (paper III). 
 
4. To evaluate the effects of high-intensity endurance- and strength training shortly after lung 
cancer surgery on ?̇?O2peak, pulmonary function, muscular strength, total muscle mass, daily 
physical functioning and QoL through a randomised controlled trial (paper IV).  
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4.0 PARTICIPANTS AND METHODS 
4.1 Study design  
The thesis is based on two separate studies – “Physical Activity among Adult and Older People Study” 
(KAN1) (paper I and II), and “Fitness Activity and Lung Cancer Study” (FALC) (paper III and IV). Paper I and 
II are based on a multicenter cross-sectional study, while paper III had a longitudinal prospective study 
desing, and paper IV had a single blinded randomised control design (Table 5). Totally 759 participants 
were included in paper I and 804 participants in paper II, 70 patients were included in paper III and 68 
patients in paper IV. 
Table 5. Design of the four included papers 
Paper Number Design 
I 759 Cross-sectional multicenter study 
II 804 Cross-sectional multicenter study 
III 70 Longitudinal prospective study 
IV 68 Single blinded randomised controlled trial 
 
 
 
Paper I and II 
In paper I and II, we performed a cross-sectional multicenter study involving nine regional test 
laboratories throughout Norway (Figure. 5, page 22). The laboratories were chosen based on population 
density involving universities or college universities that had a sport science curriculum. One laboratory  
had to be withdrawn before start due to lack of equipment (nr 8, Figure 5, page 22). The Norwegian 
School of Sport Sciences in Oslo coordinated the study. 
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Paper III 
This was a longitudinal prospective designed study investigating 70 patients who underwent lung cancer 
surgery at Oslo University hospital or Akershus University hospital from November 2010 to September 
2012. Patient with suspected stage I to IIIA NSCLC, who were candidates for primary surgery with 
curative intent, were invited to participate. ERS/ESTS clinical guidelines were used as a criterion for 
operability.1  
 
Paper IV 
Four to six weeks after surgery, 61 out of 68 patients were randomised into a single blind, controlled trial 
randomly allocated into two groups in a 1:1 ratio within four stratification groups; 1) no COPD - no 
treatment of postoperative chemotherapy; 2) no COPD –treatment of postoperative chemotherapy; 3) 
Figure 5. Map of Norway showing the nine test 
laboratories involved in paper I and II. Laboratory 8 was 
excluded due to lack of gas exchange equipment. 
1. Finnmark University College 
2. University of Nordland 
3. NTNU Trondheim 
4. Sogn & Fjordane University 
College 
5. University of Stavanger 
6. University of Agder 
7. Telemark University College 
8. Vestfold University College 
9. Oslo University Hospital 
10 Hedmark University College 
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having COPD – no treatment of postoperative chemotherapy; 4) having COPD – treatment of 
postoperative chemotherapy. The randomised treatment assignments were concealed in opaque 
envelopes by an external off-site statistician and were opened individually by the patient at the end of the 
visit.  
 
4.2 Participants 
 
Part I: 
A total of 3485 individuals from all parts of Norway underwent objective measurements of physical 
activity in the KAN1 study in 2008-09.124 They were all previously drawn from a representative sample by 
the Norwegian population registry. From KAN1, a cohort of 1,930 men and women age 20-85 years were 
randomly selected to participate to perform a CPET. A total of 904 participants met at the laboratory. In 
paper I, 759 healthy participants*, of the total 904 participants, fulfilled CPET based on defined ende-
criteria for RER and rating of perceived excertion. In paper II, 804 healthy participants, of the 904 
participants, fulfilled CPET until voluntary exhaustion. The flow chart of the recruitment strategy and 
inclusion profile for Part I (paper I and II) are presented in Figure 6, (page 24) and the baseline 
characteristics of the participants are listed in Results.  
 
Part II: 
From November 2010 throughout September 2012, a total of 106 patients were screened to participate 
in the FALC study involving NSCLC patients. Of these patients, 77 voluntaire to participate in a follow up 
after surgery and/or in the exercise RCT (Figure 7, page 25).  Unfortunately, 10 patients were not able to 
participate in the exercise trial because of a parallel ongoing study or lack of fitness centers in an 
acceptable distance from their homes, but these patients were included in paper III.  The baseline 
characteristics of the NSCLC patients are listed in Results.  
 
 
 
 
-------------------------------------------------------------------------------------------------------------------------------------------
* Healthy condition was defined as absence of any medical treated disease that could affect the participants’ fitness status (e.g 
heart disease, COPD, stroke, disability). 
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4.3 Ethics 
Paper I and II: The study was approved by th Regional Committee for Medical Ethics (REK South-Eastern 
Norway B, S-08046b) and the Norwegian Social Science Data Services AS. All individuals signed written 
informed consent forms before participating. 
 
 
 
Figure 6. Flowchart of the recruitment strategy and inclusion in part I of the thesis (KAN1 – phase 2). 
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Paper III and IV: The FALC study was conducted in accordance with the CONSORT statement for non-
pharmacologic interventions,125 and was approved by the Regional Committee for Medical Ethics before 
enrolment (REK Sør-Øst B, 2010/2008a). All participants provided written informed consents before 
surgery. No sponsor had any role in the study regarding design, data collection, analyses, interpretation of 
the data or preparation of the manuscript. The study is listed in the ClinicalTrials.gov Protocol Registration 
System (NCT01748981).  
 
Figure 7. Flowchart of the recruitment strategy and inclusion in part II of the thesis (FALC). 
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4.4 Methods and test procedures 
All participants were advised to take their regular medications prior to the investigation. In addition, all 
NSCLC patients received salbutamol and ipratropium bromide 30 min before the tests for optimizing the 
pulmonary function. Between the second and third measurement, 33% of the participants received four 
cycles of adjuvant chemotherapy. However, no NSCLC patients were receiving chemotherapy or radiation 
therapy during the test period.   
4.4.1 Anthropometry and body composition 
In all participants, height and body weight were measured to the nearest 0.5 cm and 0.1 kg, respectively, 
with participants wearing light clothing and no shoes. Body mass index (BMI) was calculated as 
weight/height2 (kg/m2).    
In paper I, percent fat for estimation of FFM was determined using a three site skin fold measurements 
by a skin fold caliper. The measurements were recorded at the chest, abdomen and thigh for the men 
and at the triceps, suprailium and thigh for the women. The following equation was used for percent fat: 
(495/body density)-450.126 Gender-specific equations were used for estimating the body density.127,128 
In paper IV, total muscle mass of the whole body were measured with the use of dual-energy x-ray 
absorptiometry in the total body scanning mode (GE Lunar Prodigy, GE Healthcare, Madison, Wisconsin, 
USA) (Figure 8, page 27).  
4.4.2 Pulmonary function 
Pulmonary function measurements by maximum expiratory flow-volume loops were conducted 
according to the American Thoracic Society/European Respiratory Society guidelines.129 Forced 
Expiratory Volume (FEV1) and forced vital capacity (FVC) were recorded. Reference values based on the 
equations from ERS 1993 update were used in all papers.130 
Ventilatory capacity was estimated by FEV1 ∙ 35 and 40 in paper I,2,131 and directly measured by MVV in 
paper III and IV. The patient was asked to breathe as fast and deep as possible for 12 seconds in a  
standing position. The highest value was recorded as maximal ventilatory capacity. For those few 
patients who did not manage the test procedure, the FEV1 ∙ 40 was used.131 
Diffusion capacity in the lungs for carbon monoxide (DLCO) (paper III and IV) were measured in a sitting 
position inhaling carbon monoxide and methane according to guidelines.132 
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4.4.3 Cardiopulmonal exercise test 
For all participants, CPET was performed by walking and running on the treadmill (Woodway, Würzburg, 
Germany) until exhaustion using a modified Balke protocol.133  All the participants underwent a pre-test 
on the treadmill to ensure that they were familiar with treadmill walking before the test began. Three to 
four minutes of warm-up and steady state measurements were conducted with an inclination set at 4 %. 
In the healthy population (Part I), the treadmill speed was set to 3.8 or 4.8 km·t-1 based on age. In the 
Figure 8. Measurements of dual-energy x-ray absorptiometry by 
scanning of the total body at Ullevål hospital. Private photo by 
permission. 
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NSCLC patients, the speed was set between 1.8 – 4.8 km·t-1 based on age or the predicted fitness level. 
After warm-up, the inclination then increased each 60 sec by two percent up to 20 % inclination for all 
participants. If the participant was still able to continue, the speed then rose by 0.5 km·t-1  until 
exhaustion. The test was ended when the participant was unable to continue, despite encouragement 
from the technician. 
Gas exchange and ventilatory variables were continuously measured by breathing into a Hans Rudolph 
two-way breathing mask (2700 series; Hans Rudolph Inc, Kansas City, USA). The mask was connected to 
the metabolic cart to assess the oxygen and carbon dioxide content of expired air for calculation of ?̇?O2. 
HR was recorded each minute from a Polar sports watcher in paper I and II, and by a 12-lead ECG record 
in paper III and IV (Cardiosoft, GE Marquette Medical Systems, Milwaukee, USA). 
The oxygen saturation was measured with a finger probe using a stationary pulse oximeter in paper III 
and IV (NONIN 8600, Medical, Inc., Minneapolis, USA).  
The rating of perceived exertion was obtained using the Borg scale6-20,134 frequently asked during the 
CPET and as soon as possible after termination.  
A capillary blood lactate sample was taken about 60 sec after termination of the exercise test in all 
participants (KDK, Japan or ABL 700 series, Radiometer, Copenhagen, Denmark).  
 
4.4.3.1 Data handling 
Maximal minute ventilation (?̇?Emax), ?̇?O2, carbon dioxide output (?̇?CO2), and the respiratory exchange 
ratio (RER) were reported as 30-second averages. Only in paper I, the participant was excluded from the 
analyses if RER < 1.10 or the Borg6–20 score was < 17.134  
The O2 pulse was calculated by dividing VO2max (in milliliters) by the maximum heart rate (HRmax). The 
breathing reserve (%) was calculated using the following equation: ([MVV - ?̇?Emax]/MVV) ∙ 100.  
Levelling off in paper I and II were defined as a plateau in ?̇?O2 as any two 30-sec ?̇?O2 values in which the 
second was not higher than the first, provided increase in ventilation at maximal effort. Participants who 
did not exhibit an increase in ventilation despite achievement of a plateau were not accepted. This was 
in order to ensure that the leveling off was caused by reaching the respiratory compensation point due 
to metabolic acidosis, and not by variation in the ?̇?E during the test (Figure 9, page 29). 
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Information about co-morbidity in the FALC study (Part II) was collected from the patient records a few 
days before surgery and by a consultant. Major cardiopulmonary complications that occurred within 30 
days after surgery were recorded, and included; atelectasis, arrhythmia, cardiac failure, myocardial 
infarct, pneumonia, pulmonary embolism, respiratory failure.135 
All CPET values obtained in paper III and IV were expressed as percentage of predicted values based on 
the equations derived from paper I.136 
In paper III, the extent of the surgery (i.e. wedge resection, lobectomy, bi-lobectomy or 
pneumonectomy) and number of functional segments actually removed were recorded after surgery, 
Figure 9. Oxygen uptake and minute ventilation plotted against time during an incremental exercise 
test. The arrows’ pointing downward indicates a drop in ventilation followed by a levelling off in 
?̇?O2 marked by a circle. The right pointing arrow indicates the expecting increase in ?̇?O2. 
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and the postoperative ?̇?O2peak was calculated using the remaining functional segment technique (page 
15).137 The functional segment calculation was estimated by bronchoscopy, lung perfusion scan or 
computed tomography. For patients undergoing wedge resection, the value 1 was used per segment.  
 
4.4.3.2 ?̇?O2peak vs ?̇?O2max 
None of the participants in paper III or IV were excluded based on specified end-criteria for reaching 
maximal effort during CPET. Thus, in the NSCLC patients, the reported ?̇?O2 value is more properly 
referred to as ?̇?O2peak rather than ?̇?O2max, even though there was evidence of fulfilling the end criteria 
recommendations (paper II) in the majority of the patients (78 %  pre surgery). 
 
4.4.4 Muscular strength and physical fitnes (paper IV) 
In paper IV, concentric leg strength was assessed by the sum of the maximum weight that could be lifted 
once (1RM) using a horizontal hip and knee extension movement with a starting angles of 90° flexion 
(leg-press). After a short warm up with light weights to ensure good quality, resistance was added until 
the participant was clearly unable to lift more, reported a symptom that required stopping, or until the 
participant refused to try to lift more.   
Maximum hand strength was measured by a grip strength dynamometer (Baseline 90 kg/Chattanooga), 
and the best of three attempts was recorded.  
Measures of daily physical functioning included, “Chair stand”,138 maximum stair run for 15 seconds and 
a modified “One foot balance test” for maximum 60 seconds while standing on a soft ground.139 
 
4.4.5 Physical activity (paper I) 
The ActiGraf GT1M activity monitor (ActiGraf, LLC, Pensacola, FL, USA) was used in paper I for 
measurements of the participants physical activity level for seven consecutive days prior to CPET.124 This 
monitor is a small accelerometer that registers vertical acceleration in counts per minute (CPM),  
expressed as the total number of registered counts for all valid days, divided by wearing time. Only data 
were included if the participants had accumulated at least 10 hours of activity recordings per day for å 
minimum of four days.124 Both CPM and steps per day were reported. 
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4.4.6 quality of life (paper IV) 
The Medical outcomes 36-Item Short Form Health Survey (SF-36) was used to evaluate quality of life 
(QoL), focusing on the physical component summary score and the mental component summary 
score.140 Higher scores indicated better QoL, ranging from 0 - 100.  
Score of dyspnoea was measured by European Organization for Research and Treatment of Cancer Core 
Quality of Life Questionnaire (EORTC QOL-C30), ranging from 0-100, where lower scores indicated lower 
dyspnoea.141  
 
4.4.7 Surgery procedure (paper III and IV) 
Surgical treatment was performed by on board-certified thoracic surgeons through a muscle-sparing, 
nerve-sparing lateral thoracotomy or through a video assisted thoracoscopic surgery without any rib 
spreading.  An epidural catheter for postoperative pain relief was offered to all patients. Chest tubes were 
routinely placed on water seal immediately postoperatively and removed when no air leak was present. 
No pre- or postoperative rehabilitation or training was provided, but all patients were regular seen by a 
physiotherapist for general mobilisation, chough assistance and mucus clearance until discharge. 
 
4.4.8 Training intervention (paper IV) 
The exercise program was given in groups and individually one by one at selected fitness centers nearby 
the patient's home, three hours per week for 20 weeks, and started one week after randomisation. 
Highly qualified personal trainers and physiotherapists were responsible for conducting the exercise 
program. The exercise program was individualized and included a cardiovascular warm-up, interval 
training, progressive resistance training (PRT), and daily inspiratory muscle training. The intervention 
focused on high-intensity training, mainly by uphill walking on a treadmill at 80-95 % of the maximal 
heart rate and PRT in three series at 6-12 RM by leg press, back extension, seat row, chest press and 
front raises.  
The first four weeks, the patients were introduced to the program while focusing on safety, techniques 
and familiarization. The endurance intensity and strength load were then continuously increased based 
on the patients’ improvement, cooping of dyspnea, and feelings of well-being or fatigue on each exercise 
day. Patients in the control group were not given any advice about exercise beyond general information 
from the hospital. 
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4.4.9 Quality control (paper I-IV) 
In paper I and II, three types of metabolic carts were used in the nine test centers: Jaeger Oxycon Pro 
(Würsburg, Germany; n = 2), Vmax SensorMedics (Yorba Linda, California, USA; n = 6), and the Moxus 
Modular VO2 system (Philadelphia, USA; n = 1). In paper III and IV, Vmax SensorMedics (Yorba Linda, 
California, USA) was used. To ensure valid measurements, all analyzers were volume- and gas-calibrated 
according to the manufacturers’ recommendations each morning and throughout the day. The 
calibration factor was always corrected for humidity and room temperature. The analyzers were also 
checked for measurement precision and accuracy at two different points with a standardized motorized 
mechanical lung (Motorized Syringe with Metabolic Calibration Kit, VacuMed, Ventura, USA) (Figure 10), 
and/or a human calibrator. Based on the results, a correction factor was calculated for each gas analyzer 
in paper I and II to ensure reliable and comparable data between the test laboratories. The average 
calculation factor was 0.990 SD ± 4.76 (range 0.925 to 1.059).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 10. Checking the precision and accuracy of the metabolic equipment at the University of 
Agder, Kristiansand, using a motorized mechanical lung (VacuMed, Ventura, USA). 
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All lab technicians involved in the data gathering were experienced technicians and rigorously trained in 
the test procedures, both locally and at regular inter-laboratory meetings. In addition, the nine 
treadmills involved in this thesis were pre-programmed to ensure that identical exercise Balke protocols 
were used both in the healthy participants and in the NSCLC patients. 
 
4.5. Statistics 
Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS software, 
version 21.0; IBM Corp., Armonk, NY, USA). 
Demographic data are presented as mean ± standard deviation (SD) for continuous variables, median 
and range for nonnormally distributed variables, and proportions for binary variables. Cross-sectional 
data are reported by age and sex, and are grouped into 10-year cohorts in paper I and 15-year cohorts in 
paper II. 
Analysis of variance (ANOVA) was used to evaluate differences in the cardiorespiratory variables 
between age groups. 
Linear regression analysis was performed according to age for ?̇?O2max and HRmax in paper I. 
Differences between the sexes were analyzed using Student’s t test in papers I and II, and differences 
between pre- and postsurgery variables were analyzed using Student’s paired t test in paper III. 
Correlations were assessed using Pearson’s correlation coefficient (r) between the commonly accepted 
end criteria in paper II and between effect size and ?̇?O2peak in paper IV. 
Linear correlations (r2) and the limits of agreement through a Bland–Altman plot are reported between 
the ppo and actually measured variables in paper III. 
Simple linear regression was used to determine the relationships between the changes from before to 
after surgery in different CPET variables (independent variables) and change in ?̇?O2peak (dependent 
variable). 
Multiple linear regression was used to study the contribution to the adjusted squared multiple 
correlation coefficient by including different sets of independent variables. 
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Sample size calculations in paper IV were based on the primary outcome of a change in ?̇?O2peak of 4.0 
mL∙kg–1∙min–1, assuming an SD of 4.6 mL∙kg–1∙min–1 (estimated from the study by Kushibe and 
coworkers7). A sample size of 21 per group for 80 % power was required to detect the assumed 
difference between means with a 5 % significance level. 
Effects after exercise training were evaluated on an intention-to-treat basis. Missing values were 
imputed using a multiple-imputation model for all of the 61 randomised patients. Because dropping out 
was not expected to be related to the treatment allocation, we assumed that missing patient data at the 
end were grossly at random. Per-protocol analyses were also evaluated for the primary outcome where 
the analysis included a comparison between all exercising patients and the nonexercising patients. p 
values were calculated using the chi-square test for categorical variables and analysis of covariance 
(ANCOVA) for continuous variables. A p-value 0.05 was accepted as significant in all papers.
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5.0 SUMMARY OF RESULTS 
 
5.1 Paper I 
Reference Values for Cardiorespiratory Response and Fitness on the Treadmill in a 20- to 85-
Year-Old Population 
 
In this cross-sectional study, the objective was to study the cardiorespiratory response during maximal 
exercise in a representative national sample of healthy and well described 20- to 85-year old men and 
women. A total of 394 men and 365 women successfully achieved the ?̇?O2max (84 %) based on the end 
criteria chosen for an acceptable ?̇?O2max (RER  1.10 or a Borg score of  17). The baseline characteristics 
of all participants meeting at the laboratory are given in Table 6.  
 
Table 6. Baseline characteristics of all the voluntary participants in part I of the thesis (n=904) 
 Men 
(n=462) 
Women 
(n=442) 
Age (year) 51.0 ± 14.5 51.6 ± 15.1 
Height (cm) 179.3 ± 6.6 166.1 ± 6.4 
Weight (kg) 84.5 ± 12.0 69.9 ± 12.7 
BMI (kg∙m-2) 26.3 ± 3.4 25.3 ± 4.3 
Activity level, accelerometer (counts∙min-1)  359 ± 138 355 ± 132 
Activity level, accelerometer (steps∙day-1) 8815 ± 11791 8643 ± 2783 
Smokers, No. (%) 67 (15) 65 (15) 
Education level, No. (%) 
    Less than high school 
    High school 
    University, < 4 years 
    University, ≥ 4 years 
 
 46 (10) 
174 (38) 
109 (24) 
124 (27) 
 
 54 (12) 
141 (32) 
108 (25) 
134 (31) 
BMI = Body mass index, n = number 
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1. In the 20- to 29-year-old age group, ?̇?O2max (mL∙kg-1∙min-1) was 40.3 ± 7.1 in women and 48.6 ± 
9.6 in men, and declined linearly by 8 % per decade after age 30 years in both sexes. The 
predictive equation was described by the following equation for men: ?̇?O2max= 60.9–0.43 ∙ age  (r 
= 0.61, CI: 0.54-0.67) and for the women: ?̇?O2max= 48.2–0.32 ∙ age (r = 0.61, CI: 0.54-0.67). 
 
2. Maximal HR was 194 beat∙min-1 ± 7.8 in the 20-29-year age cohort and declined with age by ± 7.6 
per cohort. The predictive equation was described by the following equation for men: HRmax = 
220-0.88 ∙ age (r = 0.7, CI: 0.65-0.75), and for women: HRmax = 208-0.66 ∙ age (r = 0.7, CI: 0.64-
0.75). 
 
3. The maximal O2 pulse was 33 % lower in women (P < 0.001), and decreased significantly with age 
in both sexes by 5 % and 3 % per decade for women and men, respectively.  
 
4. Women’s maximal minute ventilation was 66 % that of men (P < 0.001) and decreased with age 
after 40–49 years in both sexes. The breathing reserve was 30 % (± 13.7 %) in women and 23 % 
(± 12.8 %) in men (P < 0.001), with no age-related differences. 
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5.2 Paper II 
End Criteria for Reaching Maximal Oxygen Uptake Must Be Strict and Adjusted to Sex and 
Age: A Cross-Sectional Study 
 
The objective of paper II was to describe different end criteria for reaching ?̇?O2max during a progressive 
maximal treadmill test in a healthy sample of 20-85-year-old men and women, and to explore if the 
choice of end criteria had an impact on the ?̇?O2max variable. Four hundred and fifteen men and 389 
women (93 %) fulfilled the exercise test until voluntary termination. 
 
1. Forty-one percent of the women and 42 % of the men achieved a plateau in VO2. There were no 
sex-related differences in HRmax, RER, or Borg Scale rating. The blood lactate concentration was 
18 % lower in women (P < 0.001). Both RER and blood lactate was decreasing, especially after 50 
years of age.  The maximum end criteria variables are given by gender and 15-yrs age cohort in 
paper II, Table 2.  
 
2. When using RER ≥ 1.15 or blood lactate concentration ≥ 8.0 mmol∙L-1, ?̇?O2max was 4 % (P = 0.012) 
and 10 % greater (P < 0.001), respectively when compared to voluntary termination. A blood 
lactate concentration ≥ 8.0 mmol∙L-1 excluded 63 % of the participants in the 50-85-year-old 
cohort.  
 
3. Suggestions for new recommendations for reaching maximal oxygen uptake are given in Table 7, 
page 38.  
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Table 7. New recommendations for maximal effort for haemolysed post exercise blood lactate and 
respiratory exchange ratio (RER). Both criteria must be fulfilled. 
* Measured one minutes after termination, †Does not equal values from full blood analysis,  
L = litre, RER=Respiratory Exchange Ratio, ?̇?O2=Oxygen uptake, ?̇?CO2= Carbon dioxide output 
 
 
 
Blood lactate concentration† 
(mmol∙L-1) 
RER 
(?̇?CO2/?̇?O2) 
Female  
20-49 years ≥ 7.0 ≥ 1.10 
50-64 years ≥ 5.0 ≥ 1.05 
≥ 65 years ≥ 3.5 ≥ 1.00 
Male  
20-49 years ≥ 9.0 ≥ 1.10 
50-64 years ≥ 6.0 ≥ 1.05 
≥ 65 years ≥ 4.0 ≥ 1.00 
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5.3 paper III 
Change in cardiorespiratory fitness after lung cancer surgery is not related to the amount of 
lung tissue removed 
 
The objective was to evaluate the effect of lung cancer surgery on CRF measured on a treadmill, and to 
assess the agreement between the predicted postoperative (ppo) and actually measured postoperative 
peak oxygen uptake (?̇?O2peak).  
1. Prior to surgery the ?̇?O2peak was 23.2 ± 5.6 mL∙kg–1∙min–1 in women and 24.6 ± 5.9 mL∙kg–1∙min–1 
in men, which was 84  and 76 % of predicted, respectively. The ?̇?O2peak was impaired in 56 % of 
the patients (?̇?O2peak < 80 % of predicted). 
 
2. After surgery, the ?̇?O2peak decreased by 17.4 ± 14.4 % (P < 0.001) and 33.6 ± 17.9 % (P < 0.001) in 
those who underwent lobectomy and pneumonectomy, respectively. Furthermore, the FEV1 
decreased by -17.7 ± 17.1 % (P < 0.001), the DLCO decreased by -20.1 ± 14.0 % (P < 0.001), the 
breathing reserve increased by 5.3 ± 11.1 % (P = 0.001), the oxygen saturation remained 
unchanged (P = 0.30), the O2 pulse decreased by -12.7 % (P < 0.001) and the haemoglobin 
decreased by -4.4 % (P = 0.001).  
 
3. The strongest independent association between per cent change in physiological variables after 
surgery and per cent change in ?̇?O2peak was found for the O2 pulse; adjusted simple squared r2 = 
0.756. Adding  change in FEV1, DLCO, MVV, breathing reserve, oxygen saturation at peak exercise 
and haemoglobin did not add any noticeable predicting value; adjusted r2 = 0.826.  
 
4. In the non-exercising patients (n = 23), the ?̇?O2peak decreased nonsignificantly from after surgery 
to six month after surgery (-3 ± 15 %, P = 0.27). 
  
5. There were no significant differences between the ppo and actually measured values 
(satisfactory accuracy) (Table 8, page 40). However, the segment method miscalculated the ppo 
?̇?O2peak by more than ± 10 and ± 20 % in 54 % and 25 % of the patients, respectively (Figure 2, 
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paper III). The accuracy, agreement and linear correlation between predicted postoperative 
variables for FEV1, DLCO and ?̇?O2peak are presented in Table 8. 
 
 
Table 8.  Predicted postoperative (ppo) values and actually measured 4-6 weeks after surgery for 
pulmonary function (n=63) and peak oxygen uptake (n=59). 
 
 ppo value Actually measured 
after surgery 
Difference 
ppo-
measured 
P-value Limits of 
Agreement 
Linear 
correlation 
FEV1 (% pred) 69.5 ± 19.9 72.9 ± 17.5 -3.4 ± -13.7 0.06 -23.5 to 30.2 0.55* 
DLCO (% pred) 63.6 ± 18.9 65.4 ± 18.1 -1.7 ± -12.3 0.27 - 22.3 to 25.8 0.61* 
?̇?O2peak (% pred) 63.1 ± 16.5 65.4 ± 16.9 -2.3 ± -13.3 0.20 -23.8 to 28.3  0.46* 
?̇?O2peak (mL∙kg-1∙min-1) 18.6 ± 5.4 19.2 ± 5.5 -0.6 ± -4.1 0.24 - 7.4 to 8.7 0.50* 
* Linear correlation is significant at the 0.01 level  
DLCO=carbon monoxide lung diffusion capacity, FEV1=forced expiratory volume after one second, n = number, ?̇?O2peak = peak 
oxygen uptake;  
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5.4 Paper IV 
High-Intensity training following lung cancer surgery: a randomised controlled trial 
In this trial, the effects of high-intensity endurance- and progressive resistance training were evaluated 
on ?̇?O2peak, pulmonary function, maximum strength, functional fitness, total muscle mass and QoL.  
 
1. The intention-to-treat analysis showed that the exercise group had greater increase in ?̇?O2peak 
(3.4 mL∙kg-1∙min-1 or 18.9 % between-group difference, P = 0.002), compared with the control 
group. 
 
2. The per-protocol analysis showed a between-group difference between the exercise group and 
the control group of 5.0 mL∙kg-1∙min-1 or 30.3 % (P < 0.001). 
 
3. The exercise group also improved in DLCO (5.2 % predicted, P = 0.007), 1RM leg press (29.5 kg,     
P < 0.001), chair stand (2.1 times P < 0.001), stair run (4.3 steps, P = 0.002), and total muscle 
mass (1.36 kg, P = 0.012) compared with the control group. No significant differences in balance 
were found between the groups (P = 0.33). 
 
4. The Physical component summary score and the Mental component summary score in SF-36 
were significantly higher in the exercise group compared to the control group after the training 
intervention; 51.8 ± 5.5 vs 43.3 ± 11.3 (P = 0.006) and 55.5 ± 5.3 vs 46.6 ± 14.0 (P = 0.02), 
respectively. Correspondingly, the dyspnoea score in the EORTC QOL-C30 was lower in the 
exercise group compared to the control group after the intervention; 37.0 ± 25.3 vs 58.0 ± 32.1, 
respectively (P = 0.03). 
 
5. High-intensity endurance- and strength training was well tolerated. However, all patients 
receiving chemotherapy had to postpone their training sessions until they had completed the 
treatment. 
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6.0 GENERAL DISCUSSION 
The current thesis presents normative reference values gathered during CPET to maximum on a treadmill 
(paper I), and provides new recommendations for end criteria for determining that a subject has reached 
a maximum effort during an exercise test (paper II). In NSCLC patients, ?̇?O2peak was impaired before 
surgery in 56 % of the patients and decreased significantly after surgery by an average of 20 %  (paper 
III). However, predicting the postoperative ?̇?O2peak based on the number of segments removed had poor 
precision  and was thus not valid. A high-intensity endurance- and strength training program 
counteracted the decline in ?̇?O2peak and even increased it to a level higher than that before surgery in 
more than half of the patients (paper IV). 
This part of the thesis discusses the most important findings in the context of the recently published 
literature. 
6.1 Cardiorespiratory fitness 
The ?̇?O2max in the 20-29-year-old Norwegian population was 40.3 ± 7.1 mL∙kg–1∙min–1 in women and 48.6 
± 9.6 mL∙kg–1∙min–1 in men, and declined linearly by 8 % per decade after the age of 30 years.142 These 
levels are  higher than those reported in similar studies from Canada,108,112 the United States,118,143 and 
Israel,111 but significantly lower than those reported in the Norwegian HUNT Fitness Study121,122 (Figures 
11 and 12, page 43 og 44). In 2011, Aspenes and coworkers reported ?̇?O2peak data from an impressive 
large sample of 4,631 healthy men and women aged 20–90 years. The data were collected between 
October 2006 and June 2008, and all participants exercised on a treadmill until voluntary exhaustion. The 
?̇?O2peak was about 10 % higher in all age cohorts and both sexes compared with the values in the present 
study despite the fact that we used a strict end criterion for ?̇?O2max, in contrast to the study by Aspenes 
and coworkers who used no end criterion. In addition, the HRmax was slightly higher in the HUNT Fitness 
Study (by ~3.5 beats min–1), as recently reported by Loe and coworkers.144 Conversely, the ?̇?E was similar 
and the RER was significantly lower in all age cohorts compared with the present study. Moreover, Loe 
and coworkers published another set of ?̇?O2max reference variables derived from the same HUNT Fitness 
Study dataset after excluding the 815 participants who did not exhibit a leveling off in VO2 as shown by 
an increase of > 2 mL∙kg–1∙min–1.122 Consequently, 52 % of the participants in the eldest age cohort were 
excluded. Hence, the difference between the latest HUNT Fitness Study results and ours increased in the 
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eldest age cohorts. To summarise, the HUNT Fitness Study has reported the highest ?̇?O2peak and ?̇?O2max 
data ever for all age cohorts and both sexes compared with similar population studies. The difference is 
about 15 % in the eldest age cohort, compared to our data, after excluding those who did not achieve a 
leveling off in VO2. 
To explain the differences between the two Norwegian studies conducted at the same time and in the 
same country, it has been argued that the health status differed between our population and the 
participants in the HUNT Fitness Study.145 However, the absolute difference in ?̇?O2max values between 
the studies was fairly consistent across age strata (Figures 11 and 12, page 43 and 44), implying that the 
health aspect may be less important. Other causes may be related to differences in activity levels, 
recruitment strategies, exclusion criteria, and technical aspects such as the use of stationary (three 
types) versus mobile gas analyzers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 11. Population based measurement of peak- or maximal oxygen uptake in healthy men related to age. 
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6.1.1 Choice of reference values 
The availability of normative reference values is limited, especially in elderly women, which highlights 
the importance of updating the reference values. The choice of reference values when calculating the 
percent predicted values is, however, a challenging task, and many factors must be considered such as 
the population included, age and sex, mode of exercise used, variables included, and physical activity 
level. According to our reference values,142 the average ?̇?O2peak in the present lung cancer patients was 
80 % ± 17 % of predicted. When applying the reference values from Loe et al,122 the ?̇?O2peak in percent of 
predicted was reduced to 68 ± 15 % of predicted. The ERS/ESTS guidelines recommend a cutoff limit of 
>35 % of ppo ?̇?O2peak for accepting patients for surgery (Figure 4, page 12). Using the reference values 
from the HUNT Fitness Study would have meant that eight patients (11 %) in our study would have been 
rejected for surgery, which could have had a serious impact on the prognosis of these patients. However, 
Figure 12. Population based measurement of peak- or maximal oxygen uptake in healthy women related to age. 
 
GENERAL DISCUSSION 
_____________________________________________________________________________________ 
 
-45- 
 
this argument still does not provide a clear answer about which reference values to choose. The HUNT 
Fitness Study has an impressively large sample size covering all ages and both men and women, which 
increases its credibility. In contrast to the results published from the HUNT Fitness Study,121,122,144 the 
present reference values were derived from tests that included the most common exercise variables 
used when interpreting CPET. These were measured during a continuous graded exercise test and also 
included measures of pulmonary function, BP and blood lactate concentration. In addition, the 
participants’ activity levels were objectively measured by accelerometers. However, which one to be 
used is up to other to judge. 
 
6.2 End criteria for determining that maximal oxygen uptake is achieved 
There is at present no consensus regarding the criteria for ensuring that a maximum effort is achieved 
during exercise testing, especially among women and the elderly. The standards used have either been 
too low, too high, or not specified, which may increase the likelihood of underestimating or 
overestimating ?̇?O2max. This makes it difficult to compare different populations and to accurately assess 
patient outcomes based on clinical exercise testing. Consequently, we have presented new end criteria 
recommendations for ?̇?O2max (Table 7, page 38) using the RER and postexercise blood lactate 
concentration based on age and sex differences derived from the original database. A high RER during 
maximum effort indicates a high level of anaerobic metabolism and has traditionally been the most-used 
secondary criterion for determining that ?̇?O2max has been achieved if there is no leveling off of ?̇?O2.72 In 
addition, RER is easy to supervise during and at the end of the test, which may be important in terms of 
the motivation and assessment of patient effort. However, RER may be influenced by the individual’s 
breathing pattern, in contrast to the lactate concentration, which is a variable that cannot be 
manipulated, is easy to measure, and has high measurement accuracy.146 Thus, including lactate 
concentration in the recommendation gives a more objective reflection of exercise intensity. 
One reason why we did not use the classical leveling-off definition described by Taylor and coworkers123 
was because the continuous graded exercise protocol typically used during CPET may lead to the 
appearance of several ?̇?O2 plateaus during the test, which may preclude the recording of a valid ?̇?O2max 
(Figure 9, page 29). This is particularly important during clinical exercise testing using a continuous 
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graded exercise protocol or when testing elderly frail individuals. A “true” leveling off was achieved in 
only 42 % of the participants in paper II. 
 
6.2.1 End-criteria for determining that ?̇?O2max has been achieved in NSCLC patients 
Because of severe obstruction, COPD patients may exhibit ventilatory limitations before the 
cardiovascular system has reached its maximum capacity,2 which would lead to less reliance on 
anaerobic metabolism during exercise, and thereby lower RER and lactate concentration compared with 
patients with cardiovascular disease and healthy individuals.147 It is reasonable to assume that this is also 
the case for lung cancer patients with COPD, whose limited exercise capacity because of impairments in 
ventilatory mechanics may increase after surgery. Thus, it is not surprising that, before surgery, 16 lung 
cancer patients did not fulfill our recommendation for determining that a maximum effort had been 
achieved, even though most patients knew upfront that a poor outcome would exclude them from life-
saving treatment, which should have motivated them to maximal effort. However, these patients had 
some important characteristics such as significantly higher smoking pack-years (42 vs 24), lower DLCO (71 
% vs 83 % predicted), higher VE/?̇?CO2 (35 vs 32), lower peak HR (132 vs 148 beats∙min–1), and lower 
cardiorespiratory fitness (?̇?O2peak of 67 % vs 83 % predicted). In other words, these patients had a poorer 
health status compared with those who fulfilled the end criteria. Unexpectedly, ventilatory function did 
not contribute to exercise limitations because the patients had an average breathing reserve of 35 %, 
which excludes the “COPD argument” discussed previously. Taken together, our results show that some 
NSCLC patients cannot stress their cardiovascular system to maximum effort and thus fail to meet our 
recommendations, probably because of their poor health and physical condition and not because of 
limited ventilatory mechanics. 
The lower RER and blood lactate accumulation in these patients may also be explained by dyspnea 
(which is common in these patients), loss of type II skeletal muscle fibers, and a lower capacity for 
anaerobic glycolysis.21 Nevertheless, maximum effort is still essential for meeting the guidelines’ 
recommended criteria for surgery, and it is thus important to motivate the patient as much as possible 
during CPET. Several recent lung cancer investigations seem to have a low requirement regarding 
maximum effort during CPET. This is reflected by the markedly lower peak HR and ?̇?O2peak values 
compared with those of Norwegian NSCLC patients, 42,89,96-98,148 even though the age, body mass, 
pulmonary function, and percentages of patients with comorbidities were comparable with those of 
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other NSCLC populations. Thus, we recommend that typical end criteria variables for determining that 
?̇?O2peak has been achieved should be reported in future studies to allow comparisons between studies 
and between populations. 
After surgery, 36 patients (56 %) did not fulfill our recommendations for criteria for determining that a 
maximum effort was achieved, even though the rating on the Borg scale6–20 was slightly higher (17.6 vs 
17.3). Furthermore, the breathing reserve increased significantly, indicating no ventilatory limitation, 
even though a substantial amount of lung tissue had been removed in most patients. One reason for the 
lower ability to exert a maximum effort after surgery may relate to the significant loss of muscle mass, 
especially in the upper body/torso (data not shown). This loss of muscle mass may cause fatigue in the 
respiratory muscles at an earlier stage, thus increasing the feeling of dyspnea. Further investigations are 
required to address this question fully. 
 
6.3 cardiorespiratory fitness in the lung cancer patient 
CPET with measurement of ?̇?O2peak has been examined extensively in lung resection candidates, and 
several studies have concluded that a low preoperative ?̇?O2peak relative to body mass is associated with a 
high risk of cardiopulmonary complications.85 In addition, evidence for a relationship between 
cardiorespiratory fitness and survival has increased, and there is a strong association between 
cardiorespiratory fitness and survival.42,99 
 
6.3.1 Peak oxygen uptake prior to surgery – method a challenge? 
In the FALC population, the ?̇?O2peak was 23.6 ± 6.0 mL∙kg–1∙min–1 before surgery and ranged from 11.4 to 
45.3 mL∙kg–1∙min–1 (43–116 % of predicted). Despite an impaired ?̇?O2peak in 56 % of the patients, the 
cardiorespiratory fitness level was clearly higher compared with other populations reported from 
Italy,19,88,89,149 Switzerland,150,151 the United Kingdom,87,152 North America,42,86,96,97 and Japan.9,153 The high 
cardiorespiratory fitness level may indicate fewer cardiopulmonary complications compared with other 
populations given the association between ?̇?O2peak and the risk of surgery. However, this was not the 
case; 20 patients in the Norwegian population exhibited 24 moderate to severe cardiopulmonary 
complications including three deaths (data not previously shown), which is similar to other reports.19,87,88 
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Hence, we do not have any indications that our Norwegian lung cancer patients are more fit than other 
NSCLC populations, and the age, pulmonary function, and percentage of patients with comorbidities and 
cardiopulmonary complications were similar to those of other NSCLC populations.19,42,86,88,89 Thus, one 
may speculate that the higher ?̇?O2peak in our population reflects the exercise mode used. All studies 
mentioned above used cycle ergometry, in contrast to the use of uphill walking on a treadmill in our 
study. Uphill walking is common, a more functional and dynamic exercise mode compared with cycling 
and involves greater activation of more muscle mass because of the increased recruitment of the 
quadriceps muscle.25,26,154  Simultaneously, it generates lower blood pressure and blood lactate 
accumulation, and a higher cardiac output, which contribute to a 10–20 % higher ?̇?O2peak.22,24,25 It is thus 
surprising that only a limited number of studies have used CPET on a treadmill ergometer when 
categorizing risk for patients being screened for NSCLC surgery.67,87 We therefore recommend treadmill 
testing for preoperative measurement of ?̇?O2peak in these patients in future. 
 
6.3.2 Sex differences and risk stratification 
?̇?O2max relative to body weight (mL∙kg–1∙min–1) was significantly lower by ~20 % in healthy women 
compared with healthy men (paper I), which is consistent with the results from the HUNT Fitness 
Study.121,122 By contrast, there was no significant sex difference in ?̇?O2peak in the NSCLC patients in this 
study. When expressed as a percentage of the predicted value, ?̇?O2peak was in fact 11 % higher in women 
even though the age span and pulmonary function were similar in men and women. These differences 
may be one reason why there were fewer cardiopulmonary complications after surgery in the women 
(three women with complications) than in the men (17 men with complications) (data not shown). This 
sex difference has not been taken into consideration in the latest guidelines.1,71,81 Thus, the demand to 
achieve an acceptable ?̇?O2peak during risk stratification is more difficult for women, even though the 
incidence of complications is lower.78,90 This might suggest that future guidelines should focus more on 
the percentage of predicted ?̇?O2peak rather than absolute value, which is similar to the guideline 
recommendations for FEV1 and DLCO.1,71,81 Further investigation should address this question fully. 
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6.3.1 Agreement between predicted and observed variable 
One major procedure in all preoperative guidelines for lung cancer surgery is the split-function technique 
using the segment method to predict postoperative pulmonary function.1,71,81 This method is based on 
the principle that the number of resected functional lung segments corresponds to the loss of FEV1 and 
DLCO.1,71,81 However, the correlation between the ppo and actually measured FEV1 is variable, and the r- 
values previously reported range from 0.67 to 0.9.1 Moreover, the ERS/ESTS guidelines also include ppo 
?̇?O2peak in the algorithm, despite the fact that ?̇?O2peak is generally limited more by cardiac output than by 
pulmonary function.29 Based on the interpretation of the change in pulmonary function and the results 
of CPET in the present thesis, we support the concept that a reduction in ?̇?O2peak seems to reflect a 
reduction in cardiac function, and not by a decrease in pulmonary function after resection in NSCLC 
patients. Furthermore, we found that although the calculation of ppo ?̇?O2peak was quite accurate, the 
precision was poor. This was also the case for FEV1 and DLCO (Table 8, page 40). Thus, the prediction of 
postoperative FEV1, DLCO, and  ?̇?O2peak from the number of lung segments removed should be 
questioned. 
 
6.4 Effects of Surgery 
Consistent with other investigations,9 the ?̇?O2peak decreased significantly 4–6 weeks after surgery. The 
largest decrease occurred in those patients who underwent a pneumonectomy. However, the 
correlation between the reduction in ?̇?O2peak and amount of lung segments removed was low. In 
addition, most patients had an excellent ventilatory reserve after surgery, and the SpO2 during maximum 
exercise was unchanged, even though DLCO decreased significantly. We found that the O2 pulse was the 
strongest predictor of a change in ?̇?O2peak. Hence, adding the changes in FEV1, MVV, breathing reserve, 
DLCO, SpO2, and Hb concentration to the multiple regression models resulted in only a modest increase in 
the predictive value. 
Not surprisingly, the feeling of dyspnea increased after surgery, even though the breathing reserve 
increased significantly. The increased dyspnea despite the greater breathing reserve may be caused by 
the increased work of breathing, which is the case after lung cancer surgery.155 This could divert a greater 
proportion of oxygenated blood from the muscles of locomotion to the muscles of ventilation, and thus 
lead to early exhaustion during exercise. If so, ?̇?O2peak should not be affected, but the feeling of dyspnea 
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may be increased because of the increased oxygen cost in the ventilatory muscles. We found a clinically 
significant loss of muscle mass in the trunk after surgery, as measured by dual-energy x-ray 
absorptiometry (data not shown), which might have exacerbated the feeling of dyspnea. There was also 
a clinically and statistically significant loss of total muscle mass and muscular strength from before to 
after surgery (Figure 2, paper IV). We have not found other investigations of the changes in muscle mass 
and muscular strength from before to after surgery. 
In the nonexercising patients who underwent testing 6 months after surgery (n = 23), FEV1 increased 
significantly by 7 %, whereas DLCO, ?̇?O2peak, and 1 RM in leg press strength remained unchanged 
compared with the measurements performed 4–6 weeks after surgery (papers III and IV). Given the large 
effects of surgery on the loss of cardiorespiratory fitness, muscular strength, and total muscle mass, it 
seems logical to focus on early mobilization and exercise rehabilitation after surgery. 
 
6.5 Effects of exercise 
Before the start of data collection in this thesis, only three studies had examined the effects of exercise 
in patients undergoing lung resection.97,101,102 As mentioned in the introduction/background section none 
of these used a randomised design, and only one study by Jones and coworkers measured ?̇?O2peak 
directly by gas exchange.97 Jones and coworkers assessed the effects of a training program and focused 
on increasing ?̇?O2peak using a single-group design. Nineteen patients completed the study, which 
comprised three aerobic sessions per week for 14 weeks on a bicycle ergometer. Despite excellent 
adherence to exercise training, intention-to-treat analysis showed a nonsignificant increase in ?̇?O2peak by 
1.1 mL∙kg–1∙min–1. This was despite the fact that the participants were younger and had better 
pulmonary function and a lower ?̇?O2peak compared with the patients included in this thesis, which makes 
the negative results somewhat surprising. However, there are some important factors that may explain 
the discrepancy between the results. First, the intervention in our study had greater total work 
performed/strain during the intervention, and a 4-week longer intervention period. Second, the mode of 
endurance training differed between the studies. Third, FALC included progressive resistance training in 
the intervention, which was not included in the study by Jones but may have contributed to a greater 
increase in ?̇?O2peak in the study presented in the current thesis. It is known that resistance training can 
increase ?̇?O2peak, especially in severely deconditioned adults.49,156 
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Four RCTs have been published recently (Table 3, page 17).157-160 The results of these studies are 
conflicting and these studies could not document positive training effects.161 This could probably be due 
to short interventions, 157,158,160 poorly maintained or low exercise intensity, home-based programs 
without clearly established follow-ups, and the lower quality of methodology used for the 
measurements. For instance, the mode of exercise used in the test to evaluate training effects differed 
from that used in exercise training during the intervention,157 which contradicts the principle of test 
specificity. Given the clinical importance of cardiorespiratory fitness,42 it is surprising that none of these 
RCTs measured ?̇?O2peak. The net increase in ?̇?O2peak of 3.4 mL∙kg–1∙min–1 in the present thesis using 
intention-to-treat analysis or as much as 5.0 mL∙kg–1∙min–1 using per-protocol analysis is quite high 
compared with other cancer survivors.58 This is despite the fact that the patients had higher prevalence 
of COPD and heart disease, and had recently undergone major surgery affecting their ability to move and 
breath. In general, an increase in ?̇?O2peak of 3.5 mL∙kg–1∙min–1 corresponds to a 12–17 % improvement in 
survival rate,4,5 and ?̇?O2peak is a strong and independent predictor of survival, also in NSCLC patients.42,99 
In a recent meta-analysis, Strasser and coworkers demonstrated that the pooled effect of resistance 
training on lower-limb muscular strength was a significant mean increase of 14.6 kg (95 % CI = 6.34–22.8 
kg) in adult cancer survivors.162 In the present study, the net increase in 1 RM leg press strength was 29.5 
kg, and the overall increase in total muscle mass was 1.36 kg, indicating strong positive effects after 
progressive resistance training in our patients. Taken together, the present RCT has demonstrated that 
NSCLC patients could perform high-intensity endurance and strength training shortly after major lung 
cancer surgery. Such training seems to be necessary in the NSCLC population if the goal is to increase 
both ?̇?O2peak and muscle strength. High-intensity endurance and strength training may hold considerable 
promise for improving the prognosis of NSCLC patients. Knowing that lung resection has both direct 
(lungs and blood) and indirect (heart and muscles) effects on vital organs, clinicians and health providers 
should encourage patients to improve cardiorespiratory fitness and skeletal muscle strength to increase 
their physical fitness after lung resection. Increasing fitness and strength will help them recover more 
quickly after treatment, increasing the QoL, and prevent late side effects,163  
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6.6 Representativeness 
The decreasing response rates in most of today’s randomly selected surveys may be a challenge and a 
major concern, and several studies have shown that non-respondents differ from respondents in their 
health profiles and socioeconomic status.164 The subjects in paper I and II all participated in an initial 
survey wearing accelerometers. They were drawn from the Norwegian population registry, and were 
randomly selected throughout Norway from the areas surrounding each test center. The participation 
rate after telephone contact from the originally invited population was 66 % . Given that all the 
participants had to come to the examination during the day, and several had to travel quite long 
distances, the participation rate seems high. Nevertheless, a comprehensive nonresponse analysis was 
undertaken, and showed that there was a clear selection bias insofar as the respondents had a higher 
educational status than the nonrespondents. Therefore, the participants in paper I and II may have had 
better health and consequently greater cardiorespiratory fitness than the nonrespondents. 
 
Regarding the NSCLC patients, the baseline characteristics are representative for the lung cancer 
population undergoing surgery, both regarding age, gender, pulmonary function, histology, 
comorbidities, and use of adjuvant therapy.97,135,137 However, the VO2peak was clearly higher than 
previously reported. 42,86,88,150 This may be explained by the use of uphill treadmill walking instead of 
bicycling during CPET, and also higher effort. This is further discussed in chapter 6.3.1.
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7.0 Strength and limitations 
7.1 Part I – Healthy population 
The main strengths in paper I and II were its large and well-described sample of men and women, their 
random inclusion from rural and urban populations, and the wide age range. Furthermore, the end 
criteria used for ?̇?O2peak in paper I were rather strict compared with those of other studies.105,108-111,115 
The limitations in part I were the use of nine different test laboratories, including three different gas 
analyzer models, which may have increased the possibility of different test methods and measurement 
accuracies across the test laboratories. However, some initiatives were taken to minimize these 
differences. First, all the technicians were rigorously trained in all test procedures and they were 
experienced with maximal exercise testing. Second, all the gas analyzers were calibrated to an artificial 
lung. Unfortunately, we detected some differences in the degree of motivating the participants between 
the test laboratories. This finding underlines the importance of paper II, which goal is to increase the 
quality and validity between future studies and test laboratories. 
 
 
7.2 Part II – NSCLC patients 
Strength of paper III and IV are directly measurements of ?̇?O2peak, involving equal amount of men and 
women, and the use of uphill walking during the CPET instead of cycling. In paper IV, we included high-
intensity training in community fitness centers using personal trainers with one-on-one supervision 
individually tailored. This design made it possible to ensure individual exercise progressions from week 
to week.  In addition, the training duration of 20 weeks was quite long. Finally, our dropout rate was low 
compared with the expected rate in both groups. 
There are also some limitations. In paper III, we did not measure stroke volume during exercise to verify 
the conclusions based on findings from the O2 pulse. Normally, a low O2 pulse reflects cardiac limitation if 
the patient does not desaturate.2,147 To confirm the impact on cardiac limitation, we in retrospect 
calculated the change in the patients’ stroke volume by estimating the arteriovenous oxygen 
difference,2,69 finding a 10 % reduction in the stroke volume (P < 0.001) from before to after surgery 
(data not shown). 
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A methodological limitation in the RCT (paper IV) was a low response rate to the QoL questionnaires, 
probably related to too many questions. Furthermore, we cannot rule out the possibility that the 
technicians were not blinded during the last data collection. However, end criteria for maximal effort did 
not differ between the groups, neither before randomization nor after, confirming no different effort 
between the groups. 
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8.0 CONCLUSIONS 
 
Part one of this thesis gave recommendations for new reference values during CPET on a treadmill and 
end criteria for maximal testing. Part two investigated changes in cardiorespiratory fitness after lung 
cancer resection, and studied the effect of a high-intensity endurance and strength training program. We 
believe that the following clinical findings are justified: 
 
Paper I: Results from a large and well-described population were presented regarding different 
maximal cardiorespiratory fitness variables for men and women on a treadmill across all ages 
from 20-to 85 years.  In the 20- to 29-year-old age group, ?̇?O2max (mL∙kg-1∙min-1) was 40.3 ± 7.1 in 
women and 48.6 ± 9.6 in men. A linear decline (8 % per decade) was observed after age 30 years 
in both sexes.  Maximal HR decreased with age by ± 6.3 beat/min per decade. The maximal O2 
pulse was 33 % lower in women and decreased significantly with age in both sexes. Women’s 
maximal ventilation was 66 % that of men and decreased with age after 40 to 49 years in both 
sexes. The breathing reserve was higher in women than in men. This study established reference 
values for ?̇?O2max, maximal HR, O2 pulse, BP, ventilation, breathing reserve, respiratory exchange 
ratio, and blood lactate concentration during maximal exercise on treadmill. 
 
Paper II: A range of maximal end criteria were presented in a random sample of healthy men and 
women aged 20-to 85 years. Forty-two percent of the participants achieved a plateau in VO2 at 
the end of the test. There were no sex-related differences in HRmax, RER, or BORG Scale rating, 
whereas blood lactate concentration was 18 % lower in women. When using RER ≥ 1.15 or 
blood lactate concentration ≥ 8.0 mmol∙L-1, ?̇?O 2max was 4 % and 10 % greater, respectively. A 
blood lactate concentration ≥ 8.0 mmol∙L-1 excluded 63 % of the participants in the 50-85-year-
old cohort. Thus, the choice of end criteria during exercise testing had an impact on sex and the 
number of participants, and some impact on the outcome of the test. Based on these results, 
new recommendations were given according to age and sex for individuals using a continuous 
graded exercise protocol on a treadmill. 
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Paper III: The effect of lung cancer surgery was evaluated regarding maximal cardiorespiratory fitness 
 variables, and the agreement between the predicted postoperative and actually 
 measured ?̇?O2peak were presented. The marked reduction in ?̇?O2peak after lung cancer surgery 
 was significant, and did not improve during six months. The reduction seemed to be caused by a 
 decrease in the patients’ cardiac function, and not by reduced pulmonary function. Predicting 
 postoperative ?̇?O2peak based on the amount of lung segments removed appears not to be 
 recommendable due to poor precision. Predicting postoperative ?̇?O2peak based on the number of 
  lung segments removed showed poor precision when compared with actually measured 
 postoperative ?̇?O2peak. 
 
Paper IV: A randomised controlled supervised high-intensity endurance- and strength training was 
performed in lung cancer patients shortly after surgery. Compared with standard 
postoperative care, high-intensity endurance and strength training was well tolerated and 
induced clinically significant improvements in ?̇?O2peak, DLCO, muscular strength, total muscle 
mass, functional fitness and quality of life.  
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9.0 IMPLICATIONS 
 
Paper I 
Cardiopulmonary exercise tests are commonly used to study an individual’s cardiorespiratory fitness. 
There is today limited knowledge about reference values for ?̇?O2max and other cardiorespiratory fitness 
variables typical used during a CPET, especially for women and elderly. This study gives new reference 
values for both men and women age 20- to 85-years, covering the most important variables used in a 
clinical setting during maximal effort. 
 
Paper II 
This study will have an impact on clinical practice regarding an increased focus on standardised methods 
for reaching and for documenting maximal effort during performance- and during clinical exercise 
testing. Technicians, physicians and researchers should more confidently be able to evaluate the degree 
of maximal effort during a progressive incremental exercise test, and thereby increase the quality and 
validity of the test. 
 
Paper III 
This study gives important information about the impact lung cancer surgery has on the 
cardiorespiratory fitness and its reasons, and that the postoperative ?̇?O2peak is difficult to predict at an 
individual basis. Based on the interpretation of the results, the segment method for predicting 
postoperative ?̇?O2peak is not recommendable. Physicians and health care workers should as early as 
possible mobilise the patient after surgery avoiding inactivity and thereby loss in cardiac output.  
  
Paper IV 
Based on our positive results, and that high-intensity endurance- and strength training were well 
tolerated shortly after surgery, this study might have an impact on future post-operative care of lung 
cancer patients, making them recover quicker after surgery. Given the positive prognostic value of 
improving exercise capacity from other studies,4,5,48 and findings in the present study, clinicians and 
health allied should encourage lung cancer patients to improve their CRF and muscular strength, 
preferably as soon as possible after recover from surgery. 
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 Cardiopulmonary exercise testing (CPET) is a com-mon and reliable noninvasive measure of the car-
diac and respiratory responses during incremental 
exercise. At rest and during exercise, several physio-
logic variables are measured, including pulmonary 
function, ventilatory response, pulmonary gas exchange, 
BP, ECG, and maximal oxygen uptake (  o 2 max). Thus, 
CPET quantitates an individual’s exercise capacity 
and provides valuable diagnostic and prognostic infor-
mation about the cardiorespiratory system. 1 It is also 
a useful predictor of postoperative complications after 
pulmonary resection surgery 2 and in assessing the 
timing of cardiac transplant surgery. 3 
 To interpret the results of CPET, normative ref-
erence values are required. Reference values have 
 Background:  Existing reference values for clinical exercise testing have been derived from small 
nonrandom samples, lacking women and older individuals and some with poor or no maximal end 
criteria. The objective was to study the cardiorespiratory response during maximal exercise in a 
representative predominantly Caucasian sample of men and women. 
 Methods:  Nine hundred four randomly sampled men and women, 20 to 85 years old, exercised on 
a treadmill to exhaustion. Oxygen uptake (  O 2 ), heart rate (HR), BP, blood lactate concentration, 
and ventilatory variables were measured. 
 Results:  Seven hundred fi fty-nine participants met the criteria for an acceptable maximal   O 2 
(  O 2 max) based on a respiratory exchange ratio   1.10 or a Borg score   17. In the 20- to 29-year-
old age group,   O 2 max (mL/kg/min) was 40.3 (  7.1) in women and 48.6 (  9.6) in men. A linear 
decline (8% per decade) was observed after age 30 years in both sexes. Maximal HR decreased 
with age by   6.3 beats/min per decade. The maximal oxygen pulse was 33% lower in women and 
decreased signifi cantly with age in both sexes by 5% and 3% per decade for women and men, 
respectively. Women’s maximal ventilation was 66% that of men and decreased with age after 
40 to 49 years in both sexes. Breathing reserve was higher and blood lactate was lower in women 
than in men. 
 Conclusions:  This study establishes reference values for   O 2 max (absolute, relative to body weight 
and fat-free weight), maximal HR, oxygen pulse, BP, ventilation, breathing reserve, respiratory 
exchange ratio, and blood lactate concentration during maximal exercise on treadmill in a large 
population.   CHEST 2013; 144(1):241–248 
 Abbreviations:  CPET  5 cardiopulmonary exercise test; FFM  5 fat-free mass; HR  5 heart rate; HRmax  5 maximal heart 
rate; MVV  5 maximal voluntary ventilation; RER  5 respiratory exchange ratio;   e max  5 maximal minute ventilation; 
  o 2 max  5 maximal oxygen uptake 
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exercise test. The perceived exertion was rated by Borg scale 6-20 . 22 
A capillary blood sample was taken for lactate analysis about 60 s 
after termination of exercise (Lactate Pro; KDK Corporation or 
ABL 800; Radiometer Medical AS). 
 Three types of gas analyzers were used in the nine test centers: 
Oxycon Pro (Erich Jaeger GmbH; n  5 2), Vmax SensorMedics 
(CareFusion Corporation; n  5 6), and the Moxus Modular V o 2 
system (AEI Technologies, Inc; n  5 1). In addition to daily volume 
and gas calibrations, all analyzers were checked for measurement 
precision and accuracy with a standardized motorized mechanical 
lung (Motorized Syringe with Metabolic Calibration Kit; VacuMed) 
and/or a human calibrator. A correction factor was calculated for 
each gas analyzer to ensure reliable and comparable data between 
the test laboratories. The gas exchange variables were reported as 
30-s averages.   o 2 max was accepted if respiratory exchange ratio 
(RER)   1.10 or the Borg 6-20 score was   17. 22 The oxygen pulse 
was calculated by dividing   o 2 max (in milliliters) by the maximal 
heart rate (HRmax). The breathing reserve (%) was calculated 
using the following equation: ([MVV  2   e max]/MVV)  3 100, where 
  e max is the maximal minute ventilation, and MVV (maximal 
voluntary ventilation) was estimated as FEV 1 multiplied by 35 and 
40. 23 HR was recorded with a Polar Sports Watch (Polar Electro) 
or a 12-lead ECG. 
 Statistical Analysis 
 Cross-sectional data are reported by age and sex, grouped into 
10-year cohorts. Analysis of variance was used to evaluate differ-
ences in the cardiorespiratory variables between age groups tested 
by linear trends. Differences between the sexes were tested with 
the Student  t test. A linear regression analysis was performed 
according to age for   o 2 max and HRmax. The correlation coeffi -
cient ( r ) and CI are reported.  P values of   .05 were considered 
statistically signifi cant. 
 Results 
 This study examined 904 predominantly Caucasian 
subjects. Eighteen were excluded because of poor 
health, and 127 did not meet the criteria for maximal 
effort. Thus, 394 men and 365 women successfully 
achieved the   o 2 max (84%). The mean baseline char-
acteristics are shown according to 10-year age cohorts 
in  Table 1 (women) and  Table 2 (men). 
 Tables 3 and  4 show the average cardiopulmonary 
variables measured at maximal exercise according to 
10-year age cohorts for women and men, respectively. 
There was a signifi cant difference between the sexes in 
  o 2 max,   e max, and maximal oxygen pulse, but no dif-
ference in HRmax, maximal respiratory exchange ratio, 
or Borg scale. Age clearly affected   o 2 max, HRmax, 
maximal oxygen pulse, and   e max ( P  , .001); had less 
infl uence on maximal respiratory exchange ratio, blood 
lactate concentration, and systolic BP; and had no effect 
on the breathing reserve, diastolic BP, or Borg scale. 
 The absolute value of   o 2 max (L/min) in the women 
was, on average, 33% lower than that of the men 
( P  , .001). Predictive equation was described by 
the following equation for men:   o 2 max   5 4.97  2 
0.033  3 year ( r  5 0.65; CI, 0.59-0.70) and for women: 
  o 2 max   5 3.31  2 0.022  3 year ( r  5 0.64; CI, 0.58-0.70). 
previously been reported, either for   o 2 max alone, 4-9 
or in combination with other cardiorespiratory vari-
ables. 10-15 However, the majority of these studies are 
old, 4,7,8,10-12 are based on small samples, 8,10,11,14 are with-
out randomly selected participants, 4,6,8,9,11-15 or included 
low numbers of elderly or female participants. 8,11-13,15 
Moreover, the end criteria for a true maximum effort 
are often poorly described or set too low, 4,6,7,9-11,14,15 
which may produce invalid results. The HUNT Fitness 
Study 5 recently reported   o 2 max data for 4,631 healthy 
individuals aged 20 to 90 years, but it primarily focused 
on   o 2 max and did not include the other cardiorespi-
ratory variables typically used in a clinical exercise 
setting. Consequently, we have been unable to fi nd any 
recent age-related data covering all aspects of CPET 
for both men and women. This lack of reference values 
may limit the clinician’s ability to interpret CPET data. 
Therefore, the aim of this study was to determine the 
cardiorespiratory response during maximal exercise 
in a well-described representative national sample of 
20- to 85-year-old men and women. 
 Materials and Methods 
 This study was part of a multicenter study involving nine regional 
test centers throughout Norway. The study was approved by the 
Regional Committee for Medical Ethics (REK Sør-Øst B, S-08046b), 
the Norwegian Social Science Data Services, and the Norwegian 
Tax Department. All subjects signed written informed consent 
forms before participating. 
 In 2008, 3,485 individuals underwent objective measurements 
of physical activity with the GT1M accelerometer (ActiGraph, 
LLC) and completed a questionnaire regarding exercise habits, 
income, level of education, and health status. 16 The only inclusion 
criteria were age-related, and they were all randomly drawn from 
the areas surrounding each test center by the Norwegian popula-
tion registry. From this sample of predominantly Caucasian indi-
viduals, 1,930 were randomly selected and invited to participate. 
Finally, a total of 904 men and women undertook the examination, 
and 759 successfully completed a maximal exercise test ( Fig 1 ). 
 Before the CPET, information about each participant’s med-
ical and smoking history was gathered. Participants with either 
two or more cardiovascular risk factors combined with an age 
of  . 50 years or with a BP  . 180/110 mm Hg were excluded (n  5 18). 
Height and body weight were measured to the nearest 0.5 cm and 
0.1 kg, respectively, with participants wearing light clothes and no 
shoes. The percentage of fat for estimation of fat-free mass (FFM) 
was determined using three-site skinfold measurements by a skinfold 
caliper. The measurements were recorded at the chest, abdomen, 
and thigh for the men and at the triceps, suprailium, and thigh for 
the women. The following equation was used for percentage 
of fat: (495/body density)  2 450. 17 Sex-specifi c equations were 
used for estimating the body density. 18,19 Resting BP was man-
ually measured in the sitting position (Big Ben; Rudolf Riester 
GmbH). Pulmonary function assessments were made according 
to the American Thoracic Society/European Respiratory Society 
guidelines. 20 
 CPET was performed on a treadmill using a stepwise modifi ed 
Balke protocol until exhaustion. 21 Gas exchange and ventilatory 
variables were measured continuously as the subjects breathed 
into a two-way breathing mask (2700 series; Hans Rudolph, Inc). 
Maximal BP was measured immediately after completion of the 
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 The   o 2 max expressed relative to FFM 
(mL/kgFFM/min) was on average 29.1% and 46.1% 
higher ( P  , .001) than   o 2 max expressed relative to 
body mass for men and women, respectively. 
 The average HRmax was 194 beats/min (  7.84) in 
the 20- to 29-year age cohort, and declined with age 
in both sexes, by about 7.6 beats/min ( P  , .001) per 
cohort ( Fig 2 ). The HRmax showed the following age 
relationship for men: HRmax  5 220  2 0.88  3 year 
 The   o 2 max expressed relative to body mass 
(mL/kg/min) in the 20- to 29-year cohort was 48.6 
(  9.58) for men and 40.3 (  7.14) for women, and 
declined with each 10-year in cohort by, on average, 
4.2 mL/kg/min (9%) and 3.2 mL/kg/min (8%), respec-
tively. The prediction equation for the men was: 
  o 2 max  5 60.9  2 0.43  3 year ( r  5 0.61; CI, 0.54-0.67) and 
for women:   o 2 max   5 48.2  2 0.32  3 year ( r  5 0.61; CI, 
0.54-0.67). 
 Figure 1. Flowchart of the recruitment strategy and inclusion profi le in the study. lab  5 laboratory; 
max  5 maximum. 
 Table 1— Baseline Characteristics of Women by Age 
Characteristic
Age, y
20-29 30-39 40-49 50-59 60-69 70-85
No. of subjects 37 63 87 80 60 41
Age, y 25.6 (2.7) 35.8 (2.6) 45.2 (2.8) 54.9 (2.8) 64.5 (2.6) 76.0 (4. 5)
Height, cm 169.2 (8.4) 167.6 (5.4) 167.3 (6.1) 166.3 (5.3) 164.8 (6.0) 161.1 (6.2)
Weight, kg 66.5 (8.2) 68.8 (12.0) 72.4 (15.7) 71.0 (12.2) 69.1 (11.2) 66.2 (8.8)
BMI, kg/m 2 23.3 (3.5) 24.5 (4.0) 25.8 (5.0) 25.7 (4.3) 25.5 (4.1) 25.6 (3.5)
Waist circumference, cm 81.2 (9.2) 81.9 (10. 8) 84.4 (13.2) 86.8 (11.0) 86.9 (10.4) 87.6 (10.5)
Resting systolic BP, mm Hg 119.4 (9.8) 120.2 (11.3) 129.5 (15.6) 133.7 (13.9) 137.1 (18.6) 144.2 (18.5)
Resting diastolic BP, mm Hg 75.2 (7.2) 76.0 (8.2) 78.5 (9.3) 85.8 (8.8) 83.5 (10.2) 82.4 (9.5)
FVC, L 4.3 (0. 7) 4.1 (0.6) 3.8 (0.7) 3.7 (0. 6) 3.4 (0.5) 3.1 (0.5)
FEV 1 , L 3.5 (0.6) 3.2 (0.5) 3.0 (0.6) 2.8 (0.4) 2.5 (0.3) 2.2 (0.4)
FEV 1 /FVC, % 81.3 (6.5) 79.5 (6.1) 78.6 (6.0) 77.0 (6.1) 74.5 (6.7) 72.6 (6.0)
Activity, accelerometer counts/min 417.3 (164.5) 347.1 (109.6) 371.3 (116.9) 324.3 (88.4) 379.9 (131.8) 284.0 (129.3)
Educational level, No. (%)
 Less than high school 0 (0) 1 (2) 5 (6) 8 (10) 16 (27) 6 (15)
 High school 17 (46) 11 (18) 34 (39) 18 (23) 17 (28) 21 (51)
 University,  , 4 y 9 (24) 14 (22) 25 (29) 30 (38) 10 (17) 8 (20)
 University,   4 y 11 (30) 37 (59) 22 (25) 23 (29) 17 (28) 5 (12)
Smokers, No. (%) 5 (14) 10 (16) 17 (20) 13 (16) 6 (16) 4 (10)
Data are presented as mean (  SD) or No. (% ).
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(CI, 0.77-0.97;  r  5 0.7) and for women: HRmax  5 
208  2 0.66  3 year (CI, 0.76-0.97;  r  5 0.7). The max-
imal oxygen pulse was 33% lower in women than in 
men ( P  , .001) and decreased signifi cantly by age per 
cohort in the order of 0.7 mL/beats for women and 
0.6 mL/beats for men ( P  , .001), except in men aged 
20 to 29 years and 30 to 39 years. 
 The   e max was signifi cantly lower (34%) in women 
( P  , .001) than in men and decreased with age from 
40 to 49 years in both sexes. The breathing reserve 
was 30% (  13.7%) in women and 23% (  12.8%) in 
men ( P  , .001), with no age-related differences. 
 Forty-four percent reached a plateau in oxygen uptake 
at the end of the protocol, defi ned as a leveling off in 
oxygen uptake despite an increase in ventilation at max-
imal work load. The average RER was 1.22 in the 20- to 
49-year-old participants and decreased to 1.13 in the 
oldest age group ( P  5 .002). There were no sex-related 
differences ( P  5 .16). The average blood lactate con-
cen tration was 12.0 mmol/L in 20- to 49-year-old 
men and decreased linearly to 6.2 mmol/L in the oldest 
participants. The blood lactate concentration was sig-
nifi cantly lower (by 19%) in women than in men across 
all age cohorts ( P  , .001), except ages of   60 years. 
 Table 2— Baseline Characteristics of Men by Age 
Characteristic
Age, y
20-29 30-39 40-49 50-59 60-69 70-85
No. of subjects 38 74 91 88 83 24
Age, y 26.5 (2.7) 35.2 (2.9) 44.5 (2.7) 55.3 (2.9) 64.5 (2.5) 74.9 (3.1)
Height, cm 182.4 (5.5) 181.2 (5.8) 178.9 (6.8) 179.2 (6.6) 178.1 (6.5) 176.3 (8.3)
Weight, kg 81.5 (10.8) 84.4 (12.6) 84.8 (12.8) 86.2 (10.1) 85.5 (13.0) 82.5 (11.0)
BMI, kg/m 2 24.5 (3.2) 25.7 (3.8) 26.4 (3.4) 26.8 (2.7) 26.9 (3.5) 26.5 (2.7)
Waist circumference, cm 87.3 (8.6) 90.3 (11.4) 93.6 (9.7) 96.7 (8.7) 98.3 (10.1) 100.7 (8.9)
Resting systolic BP, mmHg 131.1 (10.2) 132.3 (11.4) 131.5 (13.2) 138.0 (15.0) 140.7 (14.9) 143.2 (15.2)
Resting diastolic BP, mm Hg 79.6 (9.1) 80.4 (7.6) 81.5 (9.1) 85.8 (9.7) 85.2 (10.5) 83.5 (6.7)
FVC, L 6.0 (0.7) 5.7 (0.8) 5.3 (0.9) 5.0 (0.7) 4.6 (0.8) 4.3 (0. 8)
FEV 1 , L 4.8 (0.6) 4.5 (0.7) 4.1 (0.7) 3.7 (0.5) 3.4 (0. 6) 3.1 (0.6)
FEV 1 /FVC, % 79.5 (6.7) 79.4 (5.2) 77.9 (5.8) 75.8 (6.5) 73.7 (7.3) 73.1 (6.9)
Activity, accelerometer counts/min 370.0 (125.0) 365.3 (117.1) 368.3 (114.7) 365.2 (161.7) 342.7 (114.0) 332.4 (189.4)
Educational level, No. (%)
 Less than high school 2 (5) 1 (1) 6 (7) 6 (7) 10 (12) 8 (33)
 High school 16 (42) 24 (32) 33 (36) 38 (43) 31 (37) 7 (29)
 University,  , 4 y 8 (21) 14 (19) 22 (24) 20 (23) 28 (34) 6 (25)
 University,   4 y 11 (29) 32 (43) 29 (32) 23 (26) 13 (16) 3 (13)
Smokers, No. (%) 3 (8) 8 (11) 16 (18) 12 (14) 12 (14) 1 (4)
Data are presented as mean (  SD) or No. (%).
 Table 3— Physiologic Responses at Maximal Exercise for Women 
Response
Age, y
20-29 30-39 40-49 50-59 60-69 70-85
No. of subjects 37 63 86 79 59 41
  o 2 max L/min 2.66 (0.47) 2.54 (0.41) 2.33 (0.42) 2.14 (0.41) 1.94 (0.39) 1.54 (0.27)
  o 2 max mL/kg/min 40.3 (7.1) 37.6 (7.5) 33.0 (6.4) 30.4 (5.1) 28.7 (6.6) 23.5 (4.1)
  o 2 max mL/kgFFM/min 55.9 (9.1) 53.5 (8.1) 49.0 (6.9) 46.2 (7.6) 42.4 (8.8) 34.7 (5.8)
  o 2 leveling off, % 38 49 41 47 44 39
Maximal heart rate, beats/min 189.5 (7.1) 184.7 (8.2) 179.6 (10.1) 172.8 (9.8) 165.9 (12.0) 156.8 (14.3)
  e max, L/min 97.7 (15.2) 92.0 (15.0) 83.8 (15.6) 76.9 (14.1) 70.6 (14.6) 55.3 (11.2)
RER,   co 2 /  o 2 1.22 (0.10) 1.22 (0.10) 1.20 (0.10) 1.18 (0.10) 1.18 (0.12) 1.13 (0.12)
Oxygen-pulse, mL/beat 14.0 (2.6) 13.6 (2.2) 12.9 (2.4) 12.3 (2.3) 11.6 (2.3) 9.8 (1.8)
Breathing reserve, from FEV 1  3 40, % 29.7 (12.1) 28.0 (12.7) 29.1 (15.7) 31.2 (11.3) 28.7 (14.7) 37.5 (12.9)
Breathing reserve, from FEV 1  3 35, % 19.2 (14.1) 17.7 (14.5) 18.9 (17.9) 21.3 (12.9) 18.6 (16.8) 28.6 (14.7)
Blood lactate, mmol/L 10.1 (2.6) 10.1 (2.3) 9.0 (2.4) 7.7 (2.4) 7.3 (2.5) 5.7 (2.4)
Systolic BP, mm Hg 159.8 (18.9) 169.6 (18.6) 177.2 (23.0) 182.4 (24.7) 190.2 (24.0) 192.7 (27.5)
Diastolic BP, mm Hg 72.3 (17.1) 75.5 (11.7) 76.2 (22.2) 81.2 (14.8) 80.1 (16.2) 81.0 (20.1)
Borg scale 17.9 (1.8) 17.8 (1.4) 17.3 (1.5) 17.4 (1.3) 17.6 (1.0) 17.5 (1.0)
Data are presented as mean (  SD). FFM  5 fat-free mass; RER  5 respiratory exchange ratio;  co 2  5 CO2 output;   e max  5 maximal minute 
ventilation;  o 2  5 oxygen uptake;   o 2 max  5 maximal oxygen uptake.
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 Discussion 
 This national cohort study presents reference values 
for the interpretation of CPET derived from a ran-
domly selected sample of 759 apparently healthy men 
and women aged 20 to 85 years. We have demon-
strated that the   o 2 max relative to body mass is about 
25% higher in men than in women, the decline in 
  o 2 max (8% per decade) had already started after the 
fi rst age cohort (20-29 years) and was linear through-
out all age cohorts, the women’s   e max was 66% that 
of the men and   e max decreased with age after 40 to 
49 years in both sexes, and the breathing reserve was 
higher in women than in men and did not change with 
age. We have also shown that the end criterion, such 
as RER and the blood lactate, decrease by age in both 
sexes, even though the age-related subjective Borg 
scale was unchanged. 
 The participation rate from the original invited pop-
ulation of 3,485 after telephone contact was 66%. 
Given that all the participants had to come to the 
examination during the day and several had to travel 
quite long distances, the participation rate seems high. 
Nevertheless, a comprehensive nonresponse analysis 
was undertaken, and showed that there was a clear 
selection bias insofar as the respondents had a higher 
educational status than the nonrespondents. There-
fore, the participants in the present study may have 
had better health and consequently greater cardiore-
spiratory fi tness than the nonrespondents. 
 The end criterion chosen for an acceptable   o 2 max 
was an RER   1.10 or a Borg score of   17. Some 
studies have not reported the end criteria for accept-
able tests, 11,14,24 have chosen a low criterion for RER 
(  1.0), 6,7 or based the participants’ maximal limit at 
an imprecise estimation of HR. 6,25,26 These factors 
may increase the likelihood of underestimating or 
overestimating the variables. Compared with other 
studies, these end criteria are strict. This was also 
confi rmed by a higher average HRmax in each age 
group compared with other studies. 6,9,11-14 Although 
HRmax is not a variable that predicts maximum effort 
well, it provides a good picture of the degree of fatigue 
in larger groups. 
 Blood lactate was measured at the end of the test 
to quantify the anaerobic energy consumption. The 
results showed high values in the youngest subjects, 
dropping by 50% in the oldest subjects, demonstrating 
their smaller capacity for blood lactate production. 
 Cardiorespiratory Fitness 
 To our knowledge, only two studies have investi-
gated the CPET response on a treadmill in a large 
healthy population. 12,13 The retrospective study of 
Nelson et al 13 used the same exercise protocol and 
end criteria for a maximal test as used in the current 
study. The   o 2 max relative to body weight was 5% 
lower, on average, than in the comparable age groups 
in our study, which can be largely explained by the 
6% higher body weight of the Canadian men. The 
study by Inbar et al 12 of Israeli men also found a lower 
  o 2 max. The average HRmax of the Israeli men was 
lower at comparable ages and may indicate that the 
CPET was terminated at a lower effort, leading to a 
lower   o 2 max. This emphasizes the importance of 
pushing the subjects to their maximum to ensure 
valid measurements. 
 A new set of   o 2 max values has recently been pub-
lished for an impressively large sample that included 
both men and women. 5 The HUNT Fitness Study 
investigated 4,631 healthy 20- to 90-year-old men and 
 Table 4— Physiologic Responses at Maximal Exercise for Men 
Responses
Age, y
20-29 30-39 40-49 50-59 60-69 70-85
No. of subjects 38 73 91 88 81 23
  o 2 max, L/min 3.91 (0.67) 3.84 (0.55) 3.56 (0.66) 3.14 (0.49) 2.74 (0.48) 2.45 (0.34)
  o 2 max, mL/kg/min 48.6 (9.6) 46.2 (8.5) 42.7 (9.3) 36.8 (6.6) 32.4 (6.4) 30.1 (4.8)
  o 2 max, mL/kg FFM/min 59.3 (9.3) 57.3 (8.3) 54.5 (9.8) 48.4 (8.4) 43.6 (7.7) 41.2 (5.2)
  o 2 leveling off, % 37 37 51 45 44 35
Maximal heart rate, beats/min 193.7 (7.8) 189.4 (8.8) 182.3 (12.1) 170.2 (15.3) 163.0 (14.2) 151.7 (13.1)
  e max, L/min 139.4 (21.4) 140.6 (20.8) 127.4 (27.4) 114.0 (23.1) 101.1 (20.1) 90.2 (16.7)
RER,   co 2 /  o 2 1.23 (0.09) 1.24 (0.10) 1.22 (0.10) 1.19 (0.12) 1.16 (0.10) 1.12 (0.08)
Oxygen-pulse, mL/beat 20.0 (3.4) 20.2 (3.2) 19.3 (3.8) 18.4 (3.1) 16.7 (2.7) 16.2 (2.7)
Breathing reserve, from FEV 1  3 40, % 26.8 (11.2) 21.2 (12.7) 21.6 (12.8) 23.8 (13.7) 24.3 (12.7) 26.6 (11.8)
Breathing reserve, from FEV 1  3 35, % 16.3 (12.8) 9.9 (14.5) 10.4 (14.6) 12.9 (15.6) 13.5 (14.6) 16.1 (13.4)
Blood lactate,mmol/L 11.7 (2.4) 12.6 (2.7) 11.7 (2.8) 9.3 (3.0) 7.5 (2.5) 6.2 (1.9)
Systolic BP, mm Hg 177.2 (19.5) 178.4 (23.1) 185.8 (24.0) 189.1 (25.7) 194.7 (29.2) 204.8 (28.0)
Diastolic BP, mm Hg 75.5 (13.2) 76.5 (16.9) 78.5 (17.0) 80.9 (18.4) 82.0 (18.8) 80.4 (15.3)
Borg scale 17.8 (1.5) 17.9 (1.1) 17.7 (1.2) 17.5 (1.3) 17.3 (1.4) 17.8 (1.1)
Data are presented as mean (  SD). See Table 3 legend for expansion of abbreviations.
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predicted value for HRmax based on this for mula may 
underestimate the average measured HRmax. Further-
more, the HRmax SD was as high as   14.0 beats/min 
in the oldest age cohort (70-85 years). These find-
ings correspond to those of previous studies 7,12 and 
may highlight the inaccuracy of the formula. Hence, 
a physician who stops the exercise test based on the 
predicted HRmax is likely to underestimate the max-
imal effort. This may lead to false negative fi ndings, 
and a significant coronary artery disease might be 
missed. 
 The relationship between HRmax and   o 2 max, 
termed the “oxygen pulse,” refl ects the maximal amount 
of oxygen extracted per heart beat and yields infor-
mation on the maximal cardiac stroke volume. There-
fore, a low oxygen pulse may refl ect cardiac limitations 
if the patient does not desaturate. 31 Our data for men 
are consistent with the recent report of Nelson et al, 13 
who used the same ergometer and end criteria as that 
used in this study. 
 During CPET, the peak minute ventilation is 
impor tant for the determination of the breathing 
reserve in order to interpret pulmonary limitation. 28 
The average breathing reserve was 23% for men and 
30% for women, which are consistent with previous 
fi ndings. 11 This confi rms that untrained subjects do 
not ordinarily have ventilatory limitations on their 
ability to perform work. 32 Unfortunately, the MVV 
was not measured directly, but estimated as FEV 1  3 35 
and 40, which may underestimate the breathing 
reserve. 33 
women on a treadmill. The   o 2 max was, on average, 
9% higher in the HUNT study than in the present 
study for all cohorts and both sexes, even though we 
used a stricter end criterion for   o 2 max and excluded 
all subjects who did not reach the established crite-
rion, in contrast to the HUNT study. However, due 
to the lack of HRmax and blood lactate values, it is 
diffi cult to say whether the participants reached the 
same level of exhaustion as those in the HUNT study. 
Nevertheless, one explanation for the high level of 
  o 2 max in the HUNT study may be the type of gas 
exchange analyzer used (portable MetaMax). It has 
previously been documented in a validation study that 
the portable MetaMax system measures 8% higher 
than the gold standard Douglas bag system. 27 This may 
be the main explanation for the higher   o 2 max values 
reported. 
 Regarding obesity, which is rapidly increasing, obese 
individuals have been shown to have a high absolute 
  o 2 max and a low   o 2 max relative to body weight with 
a lower performance, compared with lean individuals. 28,29 
When comparing the physiologic ability for the tissue 
to maximally consume oxygen,   o 2 max may, there-
fore, better be expressed relative to FFM in obese 
individuals. 30 
 In the current study, HR measured at maximal 
exercise was somewhat higher than those in other 
large population studies. 6,9,11-14 Not surprisingly, the 
variability was large, increasing in each age cohort, 
and differed signifi cantly in all age cohorts from the 
com mon predictive equation HRmax  5 220  2 age. The 
  
 Figure 2. Scatterplot relations of HR max vs age. The line represents the 220  2 age formula. HR max  5 max-
imal heart rate. 
Downloaded From: http://journal.publications.chestnet.org/ on 05/15/2015
journal.publications.chestnet.org CHEST / 144 / 1 / JULY 2013  247 
 Strengths and Limitations 
 The main strengths of the present study were its 
large and well-described sample of men and women, 
their random inclusion from rural and nonrural pop-
ulations, and the wide age range. Furthermore, the 
end criteria used for   o 2 max were rather strict com-
pared with those of other studies, 5,7,10-12,14 and blood 
lactate concentration was measured at the end of the 
test to quantify the anaerobic energy consumption. 
 The limitation of the study was the use of nine dif-
ferent test laboratories, including three different gas 
analyzer models, which may have increased the pos-
sibility of different test methods and measurement 
accuracies across the test laboratories. However, some 
initiatives were taken to minimize these differences. 
First, all the technicians were rigorously trained in all 
test procedures and they were experienced with max-
imal exercise testing. Second, all the gas analyzers 
were calibrated to an artifi cial lung. 
 Conclusions 
 In summary, this is the fi rst investigation to eval-
uate a large and well-described population including 
different maximal cardiorespiratory fi tness variables 
for both men and women on a treadmill across all ages 
from 20 to 85 years. The statistical analysis focused 
on the relationship between age and the different 
physiologic variables used in a typical clinical setting. 
These results can be used as reference variables during 
CPET on a treadmill. 
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Abstract
Objective: To describe different end criteria for reaching maximal oxygen uptake (VO2max) during a continuous graded
exercise test on the treadmill, and to explore the manner by which different end criteria have an impact on the magnitude
of the VO2max result.
Methods: A sample of 861 individuals (390 women) aged 20–85 years performed an exercise test on a treadmill until
exhaustion. Gas exchange, heart rate, blood lactate concentration and Borg Scale6–20 rating were measured, and the impact
of different end criteria on VO2max was studied;VO2 leveling off, maximal heart rate (HRmax), different levels of respiratory
exchange ratio (RER), and postexercise blood lactate concentration.
Results: Eight hundred and four healthy participants (93%) fulfilled the exercise test until voluntary exhaustion. There were
no sex-related differences in HRmax, RER, or Borg Scale rating, whereas blood lactate concentration was 18% lower in women
(P,0.001). Forty-two percent of the participants achieved a plateau in VO2; these individuals had 5% higher ventilation
(P = 0.033), 4% higher RER (P,0.001), and 5% higher blood lactate concentration (P = 0.047) compared with participants who
did not reach a VO2 plateau. When using RER $1.15 or blood lactate concentration $8.0 mmolNL
–1, VO2max was 4%
(P= 0.012) and 10% greater (P,0.001), respectively. A blood lactate concentration $8.0 mmolNL–1 excluded 63% of the
participants in the 50–85-year-old cohort.
Conclusions: A range of typical end criteria are presented in a random sample of subjects aged 20–85 years. The choice of
end criteria will have an impact on the number of the participants as well as the VO2max outcome. Suggestions for new
recommendations are given.
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Introduction
The measurement of maximal oxygen uptake (VO2max) has
been available for more than half a century and provides useful
information about an individual’s maximal cardiorespiratory
fitness and level of physical performance. During the exercise
test, the technicians’ skills and the subjects’ motivation and effort
are important requirements to ensure valid and reliable results
when comparing groups in large epidemiological surveys, as well
as for the accurate interpretation of a maximal test for both
athletes and patients.
The classical plateau described by Taylor and coworkers is
recognized as the gold standard to determine a true VO2max [1].
However, this criterion is not straight forward to use in practical
settings [2]. Therefore, a large variety of other end criteria have
been used, such as an elevated respiratory exchange ratio (RER)
$1.0 [3–5], 1.10 [6,7], or 1.15 [8,9], the achievement of a certain
percentage of the age-adjusted estimate of HRmax [7,10,11], high
postexercise blood lactate levels ($8 mmolNL–1) [8,12], the
subject’s rating of perceived exertion (Borg Scale rating or Visual
Analog Scale) [13], or a combination of the above mentioned
variables [14]. Thus, there is currently no consensus regarding the
assessment of maximal effort during a continuous graded exercise
test on the treadmill – especially among women and the elderly –
and the knowledge about how different end criteria variables are
affected by gender and aging is scarce. Furthermore, the original
recommendations are often based on older studies that used
measurement equipment and test protocols that are different from
those used today [1,15], and the number of participants was low
[7,9,16,17] or consisted of athletes or children and adolescents
[7,15,18–20]. Therefore, the purpose of this study was to describe
the different end criteria that are used often for reaching VO2max
during a maximal progressive graded exercise test on the treadmill
in a healthy sample of 20–85-year-old men and women, and to
explore if the choice of end criteria has an impact on the VO2max
value.
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Materials and Methods
Ethics Statement
The study was approved by the Regional Committee for
Medical Ethics (REK South-Eastern Norway B, S-08046b), the
Norwegian Social Science Data Services AS, and the Norwegian
Tax Department. All individuals signed written informed consent
forms before participating.
Study Design
This study was a cross-sectional multicenter study involving nine
test centers from all regions of Norway. The participants were
healthy men and women aged 20–85 years who participated in the
population-based KAN study carried out in 2008/2009 [21]. The
only inclusion criterion was age-related, and 1,930 of the subjects
were randomly invited to participate in a sub study during 2009–
2010, including a cardiopulmonary exercise test (CPET) on a
treadmill [14]. Finally, a total of 904 men and women met at the
laboratory and 804 completed CPET to exhaustion.
Exercise Test
Height and body weight were measured to the nearest 0.5 cm
and 0.1 kg, respectively, with participant’s wearing no shoes and
light clothes. The exercise test was performed during daytime by
walking and running on a treadmill using a modified Balke
protocol [22]. Four minutes of warm-up were performed with the
treadmill speed set at 4.8 km?h–1 and inclination set at 4%. For
participants who were older than 55 years or were obese, the
speed was set at 3.8 km?h–1. The inclination was then increased
each 60 s by 2%, up to a 20% inclination. If the participant was
still able to continue, the speed was further increased by 0.5 km?h–
1 until exhaustion. Gas exchange and ventilatory variables were
measured continuously as the subjects breathed into a Hans
Rudolph two-way breathing mask (2700 series; Hans Rudolph
Inc., Shawnee, KS, USA). During the last part of the test, the
subject’s effort was largely encouraged by the technician until
voluntary termination. The rating of perceived exertion was
obtained using the Borg Scale6–20 [23]. A capillary blood sample
was taken 60 s after termination of the exercise test and analyzed
for blood lactate concentration using hemolyzed blood (Lactate
Pro; KDK Corporation, Kyoto, Japan; or ABL 800; Radiometer
Medical, Copenhagen, Denmark).
The gas analyzers used were daily volume- and gas calibrated
corrected for barometric pressure, temperature and humidity. A
detailed descriptions regarding measurement accuracy between
gas analyzers is given elsewhere [14]. The gas-exchange variables
were reported as 30 s averages. HR was recorded each minute
using a Polar Sports Watch (Kempele, Finland) or 12-lead ECG.
The highest VO2max during 30 s stage was used, and the highest
RER measured before or corresponding to the last 30 s stage was
reported. A plateau in VO2 was defined as any two 30-sec VO2
values in which the second was not higher than the first, provided
increase in ventilation at maximal effort. Participants who did not
exhibit an increase in ventilation despite achievement of a plateau
Table 1. Baseline characteristics of the participants by 15-
year age cohort for female and male (SD).
Age (year)
Female 20–34 35–49 50–64 65–85
Number of
subjects
62 135 121 71
Age (year) 28.5 (4.2) 42.7 (4.5) 57.6 (4.5) 72.8 (5.4)
Height (cm) 168.4 (7.6) 167.5 (5.7) 166.0 (5.4) 162.0 (6.1)
Weight (kg) 68.0 (10.1) 70.7 (14.4) 70.3 (12.0) 66.7 (9.0)
BMI 24.0 (3.7) 25.1 (4.6) 25.5 (4.1) 25.4 (3.4)
Male
Number of
subjects
72 135 138 70
Age (year) 29.3 (3.7) 42.6 (4.0) 57.6 (4.3) 71.0 (4.9)
Height (cm) 181.7 (5.6) 179.6 (6.5) 179.2 (6.9) 176.3 (6.6)
Weight (kg) 82.7 (11.4) 84.8 (12.7) 86.5 (11.2) 81.1 (11.0)
BMI 25.1 (3.5) 26.3 (3.6) 26.9 (3.0) 26.1 (2.9)
BMI = Body Mass Index.
doi:10.1371/journal.pone.0085276.t001
Table 2. End criteria variables during maximal exercise by 15-year age cohort for female and male (SD).
Age (year)
Female 20–34 35–49 50–64 65–85
VO2 levelling off (%) 40 39 46 37
Heart rate (beat?min21) 188.1 (7.5)a 180.4 (10.4)b 170.6 (10.3)c 157.7 (15.5)
RER (VCO2?VO2
21) 1.21 (0.10)c 1.20 (0.11) 1.17 (0.11) 1.13 (0.12)
Blood lactate concentration (mmol?L21) 9.9 (2.5)b 9.2 (2.5)b 7.4 (2.6)c 6.1 (2.5)
BORG scale6–20 17.8 (1.1) 17.6 (1.3) 17.5 (1.2) 17.2 (1.2)
Male
VO2 levelling off (%) 33 46 46 36
Heart rate (beat?min21) 1.93.1 (8.2)a 183.1 (11.8)b 170.1 (14.0)c 154.3 (14.4)
RER (VCO2?VO2
21) 1.23 (0.1)b 1.22 (0.1)c 1.18 (0.1)c 1.11 (0.1)
Blood lactate concentration (mmol?L21) 12.1 (2.6)b 11.9 (2.8)b 8.8 (2.8)c 6.8 (2.6)
BORG scale6–20 17.9 (1.3) 17.7 (1.2) 17.4 (1.3) 17.2 (1.4)
RER = Respiratory Exchange Ratio; VO2 = Oxygen uptake; VCO2 = Carbon dioxide output; a = the participants’ end criterion was significant higher than the other age
cohorts; b = the participants end criterion was significant higher than the participants older than 49 years; c = the participants’ end criterion was significant higher than
participants older than 64 years.
doi:10.1371/journal.pone.0085276.t002
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Figure 1. Maximal oxygen uptake (VO2max) using different end criteria (dark grey) compared to volitional fatigue (all) (mean6 SD).
The light grey bars show VO2max in those subjects who did not fulfilled the end criterion. The % of participants who fulfilled the criterion is reported
on each bar.
doi:10.1371/journal.pone.0085276.g001
Figure 2. Oxygen uptake (mLNkg21Nmin21) and minute ventilation (LNmin21) from table 3 plotted against time (min). The arrows’
pointing downward indicates a drop in ventilation followed by a levelling off in VO2 marked by a circle. The right pointing arrow indicates the
expecting increase in VO2.
doi:10.1371/journal.pone.0085276.g002
Criteria for Maximum Effort during VO2max
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were not accepted. This to ensure that the subject had reached the
respiratory compensation point caused by metabolic acidosis.
The different end criteria used to study the impact on VO2max
were VO2 leveling off, RERmax $1.0, 1.10, and 1.15, blood
lactate concentration $6.0 and 8.0 mmolNL–1, Borg Scale6–20
rating, and HRmax $95% of the age-predicted HRmax (220– age)
compared with symptom-limiting termination of the test.
Statistical Analysis
Demographic data were presented as mean values 6 standard
derivation (SD), and cross-sectional data were reported according
to age and sex and grouped into 15-year cohorts. Analysis of
variance (ANOVA) was used to evaluate differences in the end-
criteria variables between age groups. A test of trend was
performed with x values equal to the average within each age
category. The effects of the end criteria on VO2max were tested
using Student’s t test. Correlations between the commonly
accepted end criteria were assessed using Pearson’s correlation
coefficient (r). Statistical tests were conducted using SPSS version
18.0 (SPSS, Chicago, Illinois, USA). P values of #0.05 were
considered statistically significant.
The new recommendations for maximal effort are based on
mean values for postexercise blood lactate concentration and RER
–1 SD, which included 84% of the participants. To simplify, the
blood lactate recommendations are reported to the nearest
0.5 mmolNL–1.
Results
This study examined 861 subjects during exercise testing on a
treadmill. Thirty subjects ended the study prematurely or were
excluded because of medical considerations, and 27 participants
were not able to perform the test to voluntary exhaustion. The
participants’ characteristics according to 15-year cohorts are
shown in Table 1.
Maximal Exercise
The main subjective reason for stopping exercise was dyspnea in
women (54%) and muscular fatigue in men (38%). General fatigue
was reported in 28% of the subjects. There was no age-related
influence on the reason for ending the test. The maximum end
criteria variables are given in Table 2.
Table 3. Raw data from baseline to limit of tolerance during a maximal progressive graded exercise test.
Time Speed Elevation VO2 VO2 VE RER HR RPE
(min) (kmNh21) (%) (mLNmin21) (mLNkg21Nmin21) (LNmin21) (VCO2/VO2) (sNmin
21) (BORG)
00:30 4.8 4 672 11.6 20.4 0.92 100
01:00 4.8 4 755 13.1 18.9 0.92 121
01:30 4.8 4 885 15.3 19.0 0.85 121
02:00 4.8 4 1204 20.8 24.5 0.77 121
02:30 4.8 4 1210 20.9 26.2 0.80 121
03:00 4.8 4 1157 20.0 24.8 0.81 122
03:30 4.8 4 1087 18.8 23.2 0.82 123
04:00 4.8 6 966 16.7 20.4 0.80 123
04:30 4.8 6 1314-1 22.7-1 27.9 0.83 124 8
05:00 4.8 8 1227-1 21.2-1 26.1 0.86 128 8
05:30 4.8 8 1319 22.8 29.9 0.91 135 8
06:00 4.8 10 1392 24.1 30.4 0.91 141 8
06:30 4.8 10 1613-2 27.9-2 37.0 0.95 143 8
07:00 4.8 12 1582-2 27.4-2 38.2 0.98 150 11
07:30 4.8 12 1730-3 29.9-3 42.0 0.98 150 11
08:00 4.8 14 1608-3 27.8-3 38.9 0.99 153 11
08:30 4.8 14 1775 30.7 41.8 0.97 155 11
09:00 4.8 16 1848-4 32.0-4 45.1 1.03 156 11
09:30 4.8 16 1791-4 31.0-4 43.1 1.07 160 11
10:00 4.8 18 1656-4 28.6-4 41.3 1.08 163 11
10:30 4.8 18 2065 35.7 54.8 1.12 164 12
11:00 4.8 20 2078 36.0 57.9 1.15 168 12
11:30 4.8 20 2126-5 36.8-5 63.7 1.19 171 12
12:00 5.3 20 2010-5 34.8-5 62.3 1.32 171 14
12:30 5.3 20 2122 36.7 69.2 1.27 175 14
13:00 5.8 20 2259-6 39.1-6 80.4 1.26 175 16
13:30 5.8 20 2187-6 37.8-6 90.2 1.25 177 18
HR = Heart rate; RER = Respiratory Exchange Ratio; RPE = Rating of Perceived Exertion; VE = Ventilation; VO2 = Oxygen uptake.
The bold numbers followed by an elevated number indicate a plateau in oxygen uptake (VO2) during the test. Note that at least six plateau occurred after the 4. minute
during the test, two after RER $1.15.
doi:10.1371/journal.pone.0085276.t003
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Forty-one percent of the women and 42% of the men achieved
a plateau in VO2 at the end of the test. Those who achieved a
plateau (n = 335) had a 4% higher RER (P,0.001) and a 5%
higher postexercise blood lactate concentration (P= 0.047) com-
pared with those who did not reach a plateau; however, there was
no difference in HRmax (P= 0.09), Borg Scale rating (P= 0.36),
and VO2max (P= 0.181) between these two groups. Of the subjects
who attained a plateau in VO2, 38%, 25%, and 9% did not
achieve the commonly accepted end criteria of blood lactate
concentration $8.0 mmolNL–1, RER $1.15, and $95% of the
HRmax predicted, respectively.
The RER was 1.21 (60.11) in the 20–49-year-old group of
participants, and decreased to 1.12 (60.12) in the oldest age group
(P,0.001). There were no sex-related differences (P= 0.09), and
the association with age was weak (r = –0.304, P,0.001). In
addition, there was no association between VO2max in % predicted
(r = –0.009, P= 0.790). Ninety-five percent, 80%, and 65% of the
subjects reached an RER of 1.00, 1.10, and 1.15, respectively.
The postexercise blood lactate concentration was 12.0 (62.7)
mmol?L–1 in 20–49-year-old men and subsequently decreased
linearly to 6.8 (62.6) mmol?L–1 in the oldest age group (P,0.001).
Women had an 18% lower (P,0.001) blood lactate level than
men; however, there was no significant difference between sexes
after age 65. A blood lactate concentration $8.0 mmolNL–1 was
strongly age dependent, excluding 63% of the participants in the
50–85-year-old cohort. Among the subjects who had a lactate
concentration $8.0 mmolNL–1, 18% and 17% failed to achieve an
RER $1.15 and a Borg Scale rating $17, respectively. The
strongest association with blood lactate concentration was
observed for HRmax (r = 0.587, P,0.001) and RER (r = 0.540,
P,0.001). The association between blood lactate concentration
and VO2max in % predicted was low (0.226, P,0.001).
The Borg Scale6–20 rating was 17.6 (61.3), with no differences
according to sex or age. Among those who did not fulfill the Borg
criterion (Borg Scale rating,17), the blood lactate concentration
and RER were 18 mmolNL–1 (P,0.001) and 5% (P,0.001) lower,
respectively, compared with those who did. There was no
association between Borg Scale6–20 and VO2max in % predicted
(0.053, P= 0.151).
The HRmax was191 (68.25) beat?min
–1 in the 20–34-year-old
cohort, with no sex-related differences (P= 0.311), and declined
with age in both sexes by about 8.8 beat?min–1 (P,0.001) per 15-
year cohort (r = –0.711, P,0.001). Nine subjects (1%) did not
reach 85% of the HR predicted, and 79 subjects (10%) did not
reach 95% of the HR predicted.
End Criteria and Impact on Oxygen Uptake
The dark grey bars in Figure 1 shows VO2max using different
end criteria compared to voluntary exhaustion. When using RER
$1.15, the VO2max was 4% greater (P= 0.012) compared to
subjects who did not reach the same criterion. Furthermore, RER
$1.15 excluded 281 subjects (35%) from the population. After age
adjustment, there was no change in VO2max between the different
method (P= 0.923). Correspondingly, when using only a blood
lactate concentration $6.0 or $8.0 mmolNL–1, the VO2max was
4% (P= 0.004) and 10% (P#0.001) greater. The difference was
highest after 50 years of age (8.5%).
The difference between the dark grey and light grey bars in
Figure 1 shows the difference in VO2max between the subjects who
fulfilled and those who did not fulfill the different end criteria. The
largest difference in VO2max was observed between individuals
who fulfilled and those who did not fulfill the blood lactate
concentration criterion and RER $1.0.
Discussion
The purpose of this study was to describe different end criteria
for reaching VO2max during a progressive maximal treadmill test
in a healthy sample of 20–85-year-old men and women, and to
explore if the choice of end criteria had an impact on the VO2max
value. The major findings were that the postexercise blood lactate
concentration and RER decreased with age, despite the fact that
the subjective ratings of exertion related to age remained
unchanged. Furthermore, choosing a blood lactate concentration
$8.0 and $6 mmolNL–1 and/or RER $1.15 yielded a higher
VO2max, but excluded a significant number of participants from
the analysis.
End Criteria Variables for Maximal Oxygen Uptake
The classical criterion for VO2max is achievement of a plateau in
VO2 despite an increase in work rate. A RER above a certain
level, a high level of blood lactic acid, and age-adjusted estimates
of HRmax are also used, especially in subjects who failed to achieve
a plateau [8]. The higher HRmax achieved in each age group
compared with other similar studies [6,19,24] allows us to state the
high validity of our data. It also reflects differences between studies
in the degree of motivating the subjects to exhaustion, which
underline the importance of using equal end-criteria in large
epidemiological studies. There was, however, a substantial range
of maximal values for each of the reported end variables according
to age and sex (blood lactate concentration, 1.2–18 mmolNL–1;
RER, 0.85–1.57; HRmax, 75–137% predicted based on 220-age),
which complicates the interpretation of the results and, thus, may
be of major concern when choosing optimal criteria during
exercise testing.
VO2 Plateau. A plateau in VO2 was found in 42% of the
subjects and was defined as a VO2 leveling off, despite a rise in
ventilation, which is in line with findings from other investigations
[19,20]. Our definition differs from the classical definition of a
plateau described by Taylor and co-workers [1]. Taylor performed
several systematic ‘‘steady state’’ tests over 3–5 days using Douglas
bags, and found that the increase in VO2 during the treadmill
protocol from day to day was approximately 4.261.1 mLNkg–
1Nmin–1. Based on this observation, those authors claimed that an
increase of less than 2 SD of the expected rise in VO2 satisfies a
Table 4. New recommendations for maximal effort for
haemolysed post exercise blood lactate* and respiratory
exchange ratio (RER).
Blood lactate concentration{ AND RER
(mmolNL21) (VCO2/VO2)
Female
20–49 years $7.0 $1.10
50–64 years $5.0 $1.05
$65 years $3.5 $1.00
Male
20–49 years $9.0 $1.10
50–64 years $6.0 $1.05
$65 years $4.0 $1.00
*Measured one minutes after determination; {Does not equal values from full
blood analysis; RER = Respiratory Exchange Ratio; VO2 = Oxygen uptake;
VCO2= Carbon dioxide output.
doi:10.1371/journal.pone.0085276.t004
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plateau, representing less than 2.1 mLNkg–1Nmin–1 to the next level,
or less than 150 mLNmin–1 if the participant’s body mass was 72 kg
[1].
Despite that the Taylor’s method is considered the gold
standard for defining VO2max, there are several reasons why we
did not chose this method during the continuous graded exercise
protocol. First, our protocol included a much smaller increase in
workload. A smaller increase in workload may lead to measure-
ments that exhibit more fluctuation regarding VO2 between each
sampling. As outlined in Table 3, a continuous graded protocol
may lead to the achievement of several VO2 plateaus during the
test, also above RER = 1.15, which may preclude the recording of
a valid VO2max. Second, the body mass of many of the participants
in the current study differed substantially from 72 kg, which
hampers the comparison between studies. Third, the use of minute
ventilation instead of workload was chosen to ensure that the
subjects had reached their respiratory compensation point at the
end of the test, also illustrated in Figure 2. The respiratory
compensation point reflects the final phase of exercise, at which
hyperventilation occurs to decrease the arterial pCO2 resulting
from metabolic acidosis [25]. In addition, the measurement of
ventilation is online at any time, following simultaneously the
subject’s breathing pattern, while expiratory gases will be delayed
to a greater or lesser extent depending on the size of the
ventilation. Thus, if ventilation increases and oxygen uptake is
constant during increased workload, it is reasonable to assume that
the gas exchange has reached its maximum uptake (Figure 2).
Based on the reasons mentioned above, and taking into account
the fast electronic, real time gas analyzers that are available
currently, the cutoff value proposed by Taylor seems to be too
liberal, and should therefore not be used during continuous graded
protocols, especially in elderly patients or in unfit subjects, for
whom the increase in workload is low.
Reaching a plateau in VO2 during a progressive exercise test
places great demands on the anaerobic energy consumption. This
may be a challenge, especially for untrained or elderly subjects,
who are not familiar with the unpleasant feelings associated with
strenuous activities [26]. There was, however, no relationship
between fitness level and age regarding achievement of a plateau
in the current study, with the exception of the oldest age cohort of
men (data not shown). Nevertheless, only 65% of those who
reached a plateau fulfilled the blood lactate concentration criterion
of $8.0 mmolNL–1.
Respiratory Exchange Ratio. In cases of failure to achieve a
plateau in VO2, RER is the most-used secondary criterion for
attaining VO2max [8]. The rise in RER during heavy exercise is
caused by an imbalance between the production and the
elimination of lactic acid, because of the increase in the buffering
of lactate [16]. In addition, as CO2 is generated from muscle work,
the rise in ventilation increases the RER [8]. Therefore, it seems
logical that if the blood lactate concentration is high, the RER
would be high. This is in line with the results of the present study,
which showed that 84% of the individuals with a blood lactate
concentration $8.0 mmolNL–1, had RER $1.15.
Despite the fact that RER $1.15 is the originally recommended
secondary end criterion [9], lower RERmax cutoff values have been
used, such as $1.10 [6], $1.05 [3], or $1.0 [4]. Only 65% of the
subjects enrolled in the present study reached RER $1.15. Even
though the association with age was weak (r = –0.304), there was a
reduction in RER in each age cohort after 50 years of age, despite
the fact that the subjective ratings of perceived exertion was
unchanged. The decrease in RER in the elderly is based on a shift
from type II to type I fibers and corresponding metabolic shift
towards an oxidative (lipid) preferential phenotype. Thus, RER
should be adjusted for age when used as a criterion for establishing
of VO2max.
Blood Lactate Accumulation. Blood lactate is a good
indicator of a high effort, as high blood lactate levels are associated
with fast-twitch fiber recruitment [27] and a progressive or sharp
decrease in intracellular pO2 [28]. Here, the postexercise blood
lactate concentration decreased with increasing age, especially
after 50 years of age. Choosing the well-known 8 mmol?L–1 end
criterion, which is based originally on findings from 14–18-year-
old boys and girls [15], led to the exclusion of 63% of the
participants in the 50–85-year-old cohort. Sidney and Shephard
[29] also found a lower incidence of reaching a high level of blood
lactate concentration in the elderly, even though a plateau in VO2
was achieved in these individuals. Lower blood lactate accumu-
lation in the elderly may be explained by dyspnea, loss of type II
fibers followed by muscular weakness, and lower capacity for
anaerobic glycolysis [25]. Thus, this is an expected finding, and
therefore the potential for lactate accumulation is reduced by age.
Even though the RER value and the incidence of a plateau were
similar between the sexes, women had a significantly lower blood
lactate concentration compared with men. This is in accordance
with previous studies performed using both trained and untrained
subjects [30,31] and suggests that men have a greater capacity
than women to generate ATP via anaerobic glycolysis. In addition,
women have a smaller ratio of muscle mass to total blood volume
[29] and achieve lower workloads on the treadmill compared with
men. A higher workload suggests greater energy turnover and
more glycolytic flux, which may lead to greater lactate levels [32].
Such a difference between sexes should be taken into account
when evaluating maximal effort using blood lactate as a criterion.
The assessment of postexercise blood lactate concentration is a
non-manipulative variable, in contrast to RER (breathing pattern)
or HR (psychological factors). This assessment is easy to perform
and has a high measurement accuracy; thus, it represents a more
objective physiological reflection of the amount of high-intensity
exercise compared with VO2 leveling off, RER, or the percentage
of the HR predicted. Despite the essential nature of this variable,
we have only been able to find one epidemiological study reporting
cardiorespiratory fitness variables in a population with measured
blood lactate levels [33]. Based on the reasons mentioned above,
we recommend that this variable should be used more frequently.
Maximal Heart Rate. HRmax differed significantly in all age
cohorts from the commonly used formula of 220–age. Further-
more, the standard deviation was high (615.0) in the 65–85-year-
old cohort, making it very difficult to justify the use of this variable
as a standard (because of its wide range). These findings are in line
with those of previous studies [5,24], and the use of a certain
percentage of the age-adjusted HRmax has been questioned [8].
The American College of Sports Medicine stated over 20 years
ago that age-predicted HRmax should not be used as an absolute
criterion for maximal effort, which is supported by our data.
Rating of Perceived Exertion. The Borg Scale is widely
used to measure exercise intensity, and there is a relationship
between rating of perceived exertion and physiological measures
such as HR and blood lactate concentration [34]. The Borg Scale
has, however, produced inconsistencies regarding the strength of
the relationships; in addition, its validity has been shown to be
lower than was previously thought [35]. This is in agreement with
the results of the current study, especially those of elderly men and
women who scored high on the Borg Scale despite lower
postexercise blood lactate concentration and RER.
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Choice of End Criteria and Impact on the VO2max Value
Reaching objective variables of maximal effort has been shown
to be difficult for athletes [19,36], elderly people [13,29], obese
individuals [26], sedentary people, and patients [37], and depends
on the measurement method used, sampling interval [38], and
type and duration of the test protocol [20]. Furthermore, the
standards used for each of the maximum criteria exhibited great
variability. Some of these may be too low [5] or totally absent [39],
which may increase the likelihood of underestimating the VO2max
variable; or the opposite, too high, leading to the rejection of
subjects who would actually achieve a valid VO2max, thereby
giving an overestimation of the VO2max. The choice of different
end criteria for maximal effort in the present 20–85-year-old
population had an impact on the number of participants included
in each age cohort, sex, or the results, whereas a blood lactate
concentration $6.0 and $8.0 mmolNL–1 and an RER $1.15 had
the greatest impact on the VO2max result.
Poole and co-workers [17] compared the VO2max results
obtained based on leveling-off criteria, which they defined as a
true VO2max, with the RER, blood lactate concentration, and age-
predicted HRmax in eight healthy young men performing a cycle
ramp protocol until exhaustion. They found that terminating the
exercise test immediately after reaching the RER criteria of 1.10
or 1.15 led to an underestimation of the VO2max of as much as
27% and 16%, respectively, compared with the results obtained
using leveling off. Furthermore, those authors found that the blood
lactate concentration criterion was unusable because of the
rejection of three out of eight participants (range, 5.7–8.4).
However, the 8 mmolNL–1 blood lactate criterion is based on the
use of hemolyzed blood, whereas Poole and co-workers used full
blood (YSI 1500 Sport), which yields significantly lower results
[40]. The two blood lactate techniques mentioned above are
commonly used and should not be compared unless they have
been corrected for the difference. In addition, while measuring gas
exchange, most test laboratories currently use the breath-by-
breath technique, rendering the interpretation of each measure-
ment impossible during the test because of the considerable
variability from measure to measure. Stopping the exercise test
based on the measurement and not because of exhaustion or
voluntary determination is thus not meaningful.
New Recommendations
We have presented new recommendations for postexercise
blood lactate concentrations and RER values (Table 4). These
recommendations are based on the age and sex differences derived
from the present results, as discussed previously, where both
criteria must be fulfilled.
In our opinion, the use of VO2 leveling off is not recommended
because of the achievement of several plateaus during a
continuous graded exercise protocol, which is also supported by
Noakes [41]. Therefore, it is easy to misinterpret these results
during the test (Table 3, Figure 2). We chose the average value of
blood lactate concentration and RER from each sex and age
cohort minus one SD. This was chosen because the SD reflects the
dispersion in each age cohort. However, using all accepted tests
above one negative SD will reject 16% of the participants in each
age group. As the concept of maximal oxygen uptake involves
maximal aerobic energy metabolism, we have experienced that
many will struggle to push enough to reach the needed level of
exhaustion.
Strengths and Limitations
The main strengths of the current study were its large sample of
both fit and unfit men and women, the random inclusion of
participants from rural and nonrural populations, and the wide
age range of the participants.
One of the limitations of the study was the use of nine different
test laboratories, including a large number of technicians, which
may have increased the possibility of different levels of encour-
agement regarding maximal effort, in addition to the possibility of
achieving different measurement accuracies across laboratories.
However, some initiatives were taken to minimize these issues.
First, all the technicians were rigorously trained in all test
procedures and they were experienced with maximal-exercise
testing. Second, all gas analyzers were checked for measurement
precision and accuracy using a standardized motorized mechan-
ical lung (Motorized Syringe with Metabolic Calibration Kit;
VacuMed, Ventura, CA, USA). Third, use of different technicians
reflects the ‘‘real life’’ situation, thus being more representative.
Conclusion
A range of typical end criteria were presented in a random
sample of healthy men and women aged 20–85 years. The choice
of end criteria during exercise testing had an impact on sex and
the number of participants, and some impact on the outcome of
the test. Based on these results, new recommendations are given
according to age and sex for individuals using a continuous graded
exercise test on a treadmill. Studies with other populations should
be applied to confirm our results.
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ABSTRACT 
 
Objectives: To evaluate the effect of lung cancer surgery on cardio-respiratory fitness (CRF) 
measured on a treadmill, and to assess the agreement between the predicted postoperative 
(ppo) and actually measured postoperative peak oxygen uptake (?̇?O2peak). 
Materials and Methods: Before and 4–6 weeks after lung cancer surgery, 70 patients (35 
women) underwent measurements of pulmonary function and CRF via a cardio-pulmonary 
exercise test (CPET) until exhaustion.  In addition, the 23 non-exercising patients underwent 
similar measurements after six months. Predicted postoperative (PPO) ?̇?O2peak calculated 
from the number of functional segments removed was compared with the actually measured 
post-operative values of ?̇?O2peak for accuracy and precision. 
Results: After surgery, the ?̇?O2peak decreased from 23.9±5.8 to 19.2±5.5 mL∙kg
-1∙min-1 
(-19.6±15.7%) (P<0.001). The breathing reserve increased by 5% (P=0.001); the oxygen 
saturation remained unchanged (P=0.30); the oxygen pulse decreased by -1.9 mL∙beat-1 
(P<0.001); the haemoglobin concentration decreased by 0.7 gram∙dL-1 (P=0.001). The oxygen 
pulse was the strongest predictor for change in ?̇?O2peak; adjusted linear squared r
2
=0.77. Six 
months after surgery, the ?̇?O2peak remained unchanged (-3±15%, P=0.27).  
The ppo ?̇?O2peak (mL∙kg
–1∙min–1) was 18.6±5.4 and the actually measured ?̇?O2peak was 
19.2±5.5 (P=0.24). ). However, the limits of agreement were large (CI:-7.4 to 8.2). The 
segment method miscalculated the ppo ?̇?O2peak by more than ±10 and ±20% in 54% and 25% 
of the patients, respectively.  
Conclusion: The significant reduction in ?̇?O2peak and lack of improvement six months after 
lung cancer surgery cannot be explained by the loss of functional lung tissue, but appears to 
reflect a decrease in the patients’ cardiac function. Predicting postoperative ?̇?O2peak based on 
3 
 
the amount of lung tissue removed is not recommendable due to poor precision. 
ClinicalTrials.gov Identifier:NCT01748981 
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postoperative function, surgery 
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1. Introduction 
Globally, 1.61 million people are diagnosed with lung cancer each year, and the 
incidence is increasing.[1] The complications and mortality rate after surgery for this type of 
cancer are relatively high compared with other major surgical procedures and depend on the 
patient’s health prior to surgery and on the extent of the resection.[2] Therefore, pre-operative 
risk assessment and the ability to predict postoperative outcomes are of major clinical 
importance. Cardio-respiratory fitness (CRF) measured as peak oxygen uptake (?̇?O2peak) has 
been reported as being a better predictor of postoperative complications and mortality than the 
traditionally used pulmonary function variables forced expiratory volume in the first second 
(FEV1) and diffusing capacity for carbon monoxide (DLCO).[3, 4] Consequently, current 
guidelines have recommended exercise testing and defined ?̇?O2peak cut-off values for risk 
assessment.[5-7] Moreover, the European Respiratory Society/European Society for Thoracic 
Surgery (ERS/ESTS) guidelines include a modified version of the preoperative Bolliger 
algorithm,[8] in which ?̇?O2peak is one of the pivotal measures. This algorithm has been 
validated, and was recently adjusted to lower thresholds,[9] thus allowing more patients to 
undergo surgery. In addition to predicted postoperative (ppo) FEV1 and DLCO, ppo ?̇?O2peak is 
included in the algorithm. The ppo V̇O2peak is based on the principle that the amount of 
resected functional lung tissue corresponds with the drop in ?̇?O2peak, regardless of whether a 
pulmonary limitation is present or not. However, ?̇?O2peak is generally limited by cardiac 
output, and less by pulmonary factors,[10] which may question the validity of this ppo 
segment method. 
In the few studies that have investigated the relationship between ppo ?̇?O2peak and 
actually measured post-operative ?̇?O2peak, the sample size has been small,[11, 12] and the 
results have been conflicting.[12-15] Furthermore, the ?̇?O2peak cut-off values and the 
agreement between ppo and actually measured ?̇?O2peak values are based on exercise testing 
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using a cycle ergometer instead of a treadmill. Leg discomfort during cycling is an important 
contribution to exercise termination in patients with lung cancer, rather than cardio-
pulmonary limitation.[12, 13, 16, 17] This may explain the unexpectedly low peak heart rates 
[16, 18-20] and high breathing reserves (>40%) reported in previous studies [4, 12, 13]. When 
determining the degree of cardio-pulmonary reserve and ppo ?̇?O2peak, additional knowledge is 
thus warranted.  
The objective of this study was to evaluate the effect of lung cancer surgery on             
cardio-respiratory fitness measured on a treadmill, and to assess the agreement between ppo 
?̇?O2peak and actually measured postoperative ?̇?O2peak. 
 
2. Methods 
This prospective study investigated 70 non-small-cell lung cancer (NSCLC) patients 
who underwent lung cancer surgery at the Oslo University Hospital or Akershus University 
Hospital in Norway from November 2010 to September 2012. Eligible patients were  80 
years of age, had newly diagnosed or suspected NSCLC and had been accepted for surgery. 
Patients were not eligible if they were unable to perform a maximal exercise test on a 
treadmill. The majority of the included patients (n=61) were participants in a randomized 
controlled trial studying the effect of 20 weeks of exercise training starting 4-6 weeks after 
surgery.[21] The results of pre- to post surgery lung function and cardio-pulmonary exercise 
test (CPET) variables of that trial are included in this paper.  In addition, the 6 months results 
of 23 patients who acted as non-exercising sedentary controls are also included in the current 
study (Figure 1). 
The criteria used to determine operability were in accordance with the guidelines of the 
ERS/ESTS.[5] After signing an informed consent form, the patients were enrolled in the study 
and underwent lung cancer surgery through a muscle-sparing lateral thoracotomy or by video-
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assisted thoracoscopic surgery (VATS). The study protocol was approved by the Regional 
Committee for Medical Ethics (REK Sør-Øst B, 2010/2008a) and registered in the 
ClinicalTrials.gov (NCT01748981).  
 
2.1. Measurements 
All patients received salbutamol and ipratropium bromide 30 min before the 
measurements. Among the patients who underwent measurements after 6 months, 33% 
received four cycles of adjuvant chemotherapy between the second and third measurement. 
None of the patients underwent organized exercise rehabilitation during the testing period. 
 
Height and body mass were measured to an accuracy of 0.5 cm and 0.1 kg, respectively, 
with subjects wearing light clothes and no shoes; body mass index (BMI) was calculated as 
body mass/height
2
 (kg/m
2
). 
Spirometry and DLCO were conducted according to guidelines (Vmax SensorMedics, 
Yorba Linda, CA).[22] Maximal voluntary ventilation (MVV) was measured directly by 
breathing as deep and frequent as possible for 12 seconds in standing position. 
CPET was performed by uphill walking on a treadmill (Woodway, Würzburg, 
Germany) until exhaustion. All patients were familiar with treadmill walking before starting 
the test. Three minutes of warm-up and steady-state measurements were conducted with the 
treadmill speed individually set between 1.8 and 3.8 km·h
–1
 and inclination set at 4% based on 
the predicted fitness level of the patients. The inclination was then increased each 60 s by 2%, 
up to 20%. If the participant was still able to continue, the speed was increased by 0.5 km·h
–1
 
until exhaustion. The test was terminated when the individual could no longer continue, even 
with encouragement. Gas exchange and ventilatory variables (VE) were measured 
continuously breath-by-breath while breathing into a Hans Rudolph two-way breathing mask 
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(2700 series; Hans Rudolph Inc, Kansas City, KS). The mask was connected to a metabolic 
cart (Vmax SensorMedics, Yorba Linda, CA) to assess the oxygen and carbon dioxide content 
in expired air to calculate oxygen uptake. HR was recorded each minute using a 12-lead ECG 
(Cardiosoft, GE Marquette Medical Systems, Milwaukee, WI). 
A capillary blood sample was taken 60 s after test termination (ABL 700 series, 
Radiometer, Copenhagen, Denmark) for the measurement of haemoglobin- ([Hb]) and blood 
lactate concentration ([La
-
]). 
 
2.2. Data handling 
 The predicted values for FEV1 and DLCO were taken from the European Community 
for Steel and Coal.[23] The exercise variables were reported as a 30 s average and the ?̇?O2peak 
was expressed as a percentage of predicted based on the equations of Edvardsen and 
colleagues.[24] The breathing reserve (%) was calculated using the following equation: 
([MVV-VEpeak]/MVV) x 100. The oxygen pulse was calculated by dividing ?̇?O2peak (in 
millilitres) by the peak heart rate (HRpeak).  The actual extent of the operation (i.e., wedge 
resection, lobectomy or pneumonectomy) and number of lung segments removed were 
recorded after surgery, and the ppo ?̇?O2peak was calculated using the remaining functional 
segment technique estimated by bronchoscopy, lung perfusion scan or computed tomography: 
 
ppo =  𝑝𝑟𝑒𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑣𝑒 𝑣𝑎𝑙𝑢𝑒 𝑥
(19 − 𝑛 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠 𝑟𝑒𝑠𝑒𝑐𝑡𝑒𝑑)
19 − 𝑢𝑛𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠
 
For patients who underwent wedge resection, a value of 1 was used per functional segment. 
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2.3 Statistical analysis 
Data were analysed using IBM SPSS Statistical Data Editor, version 21.0. Results are 
presented as the mean ± standard deviation. Differences between pre- and post-surgery 
variables were analysed using Student’s paired t test.  
Simple linear regression analyses were used to determine the relationship between the 
change from pre to post surgery values of different CPET variables (independent variables) 
and change in ?̇?O2peak (dependent variable), and multiple linear regression analyses were used 
to study the contribution to the adjusted  squared multiple correlation coefficient by including 
different sets of independent variables. Linear correlations (r
2
) were reported between actually 
measured and ppo variables. In addition, linear regression was used to study the adjusted 
squared linear correlation between number of functional segments removed and per cent 
change in ?̇?O2peak. 
The accuracy and precision of ppo vs actually measured values of pulmonary function 
and ?̇?O2peak were determined, and the limits of agreement were calculated using a Bland–
Altman plot with 95% confidence intervals. P values 0.05 were considered statistically 
significant. 
 
3. Results 
This study examined 35 women and 35 men undergoing lung cancer surgery (Table 1, 
Figure 1). The majority had adenocarcinoma (44%) and squamous cell carcinoma (39%), and 
13 patients (19%) had stage IIIA disease.  
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Table 1. Baseline characteristics of the participants. 
Characteristics Participants (n=70) 
Age, years  
     Mean  66.1±9.0 
     Range 35-80 
BMI, kg∙m-2 24.8±4.8 
Health condition  
     COPD, No. (%) 26 (37) 
     Heart disease, No. (%) 20 (29) 
Surgery procedure  
     Wedge/Lobectomy/Pneumonectomy, n/n/n 2/56/12 
     Thoracotomy/VATS, n/n 59/11 
Pulmonary function and physical characteristics  
     FEV1, % of predicted 88.4±22.4 
     DLco, % of predicted 80.6±20.9 
     ?̇?O2peak, % of predicted 80.6±16.4 
     ?̇?O2peak, mL∙kg
-1∙min-1          23.9±5.8 
 
Data are presented as mean ± SD or No. (%). BMI=Body Mass Index, calculated as body mass in kilogram divided by height 
in meters squared; COPD=Chronic Obstructive Pulmonary Disease; DLCO=carbon monoxide lung diffusion capacity; 
FEV1=forced expiratory volume after one second; VATS=Video Assisted Thoracic Surgery; ?̇?O2peak=peak oxygen uptake. 
Def COPD=FEV1/FVC< 70% and FEV1 < 80% of predicted.[25] 
 
 
3.1 Physical characteristics before surgery 
 Pulmonary function and CPET variables before surgery are presented in Tables 1 and 
2.  The breathing reserve was 35.0±14.1%. The CRF of six patients (8%) was limited by their 
ventilatory capacity, defined as a breathing reserve <15%. At maximal effort during the 
CPET, the respiratory exchange ratio and [La
-
] were 1.13±0.11 and 5.7±2.3 mmol∙L–1, 
respectively. Dyspnoea was the most frequent reason for stopping the exercise test (42%), 
followed by general exhaustion (23%) and leg exhaustion (23%). 
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3.2 Changes after surgery 
 After surgery, 11 patients did not undergo further investigation due to complications, 
metastases, or co-morbidities. For the remaining patients (n=59), change in pulmonary 
function and exercise variables following surgery are presented in Table 2. The ?̇?O2peak 
decreased by -5.0±4.5 mL∙kg-1∙min-1 (-19.6%) (P<0.001).  However, nine patients did not 
exhibit a decrease in ?̇?O2peak (Figure 2). Furthermore, the breathing reserve increased by 
5.3±11.1% (P=0.001); the oxygen saturation (SpO2) remained unchanged (P=0.30); the 
oxygen pulse and haemoglobin concentration [Hb] decreased by -1.9 mL∙beat-1 (P<0.001) and 
-0.7 gram∙dL-1 (P=0.001), respectively.  
 
Table 2. Pulmonary function, cardiorespiratory fitness variables and haemoglobin 
concentration before and four to six weeks after surgery.  
 
Data are presented as mean ± SD. For pulmonary function, n=63 four to six weeks after surgery. CI=confidence interval; 
DLCO=carbon monoxide lung diffusion capacity; FEV1=forced expiratory volume after one second; HRpeak=peak heart rate; 
SpO2=oxygen saturation; VEpeak = peak minute ventilation; ?̇?O2peak=peak oxygen uptake; *=Change from baseline is 
significant at the 0.01 level 
 
 
 
 
Before surgery 
 
After surgery 
 
Change from baseline 
(95% CI) 
Lobectomy 
n=58 
Pulmonectomy 
n=12 
Lobectomy 
n=51 
Pulmonectomy 
n=8 
Lobectomy 
n=51 
Pulmonectomy 
n=8 
FEV1, L 2.4±0.8 2.6±0.7 2.0±0.6 1.7±0.3 -0.4 (-0.5 to -0.3) -0.9 (-1.3 to -0.5) 
DLCO, mmol∙ min
-1∙kPa-1 6.7±2.1 7.2±2.3 5.5±1.6 4.8±1.2 -1.3 (-1.6 to -1.0) -2.7 (-4.1 to -1.3) 
?̇?O2peak, mL·kg
-1·min-1 23.4±5.5 26.2±6.9 19.5±5.4 17.8±6.6 -4.3 (-5.4 to -3.3)* -9.2 (-14.3 to -4.2)* 
VEpeak, L·min
-1 59.8±18.0 67.3±16.0 47.4±14.0 44.4±16.6 -11.3 (-14.8 to -7.8)* -21.6 (-32.8 to -10.3)* 
Breathing reserve, % 35.3±14.9 34.8±11.0 41.8±13.0 41.0±15.3 5.8 (3.0 to 8.6)* 2.5 (-12.0 to 16.9) 
SpO2peak, % 93.4±4.1 90.3±6.7 93.3±3.3 92.9±3.4 -0.6 (-0.2 to 1.5) 0.9 (-3.3 to 1.5) 
Oxygen pulse, mL∙beat-1 11.8±3.5 13.1±3.9 10.0±2.8 9.9±4.6 -1.7 (-2.4 to -1.0)* -2.7 (-4.3 to -1.0)* 
HRpeak,beat·min
-1 146.9±21.1 152.4±21.3 137.4±18.0 127.5±18.6 -9.5 (-12.8 to -6.1)* -24.9 (-40.2 to -9.5)* 
Haemoglobin, g∙dL-1 14.7 ±1.6 14.2±1.8 13.9±1.3 13.6±2.4 -0.7 (-1.1 to -0.2)* -1.1 (-2.4 to -0.3) 
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 The oxygen pulse was the strongest predictor for change in ?̇?O2peak; adjusted linear 
squared r
2
=0.77. Adding change in FEV1, MVV, breathing reserve, DLCO, peak SpO2, and 
[Hb] in a multiple regression model, resulted in only a modest increase in the predicting value 
to an adjusted squared r
2
=0.83, with DLCO as the second contributor.  
In the patients who underwent measurements 6 months after surgery (n=23), the FEV1 
increased by 7±11% (P=0.002), whereas the DLCO and ?̇?O2peak remained unchanged 
compared with the measurement performed 4-6 weeks after surgery; 4±16% (P=0.36) and -
3±15% (P=0.27), respectively.  
 
3.3 Predicted postoperative versus actually measured variables 
The ppo ?̇?O2peak was compared with the actually measured ?̇?O2peak obtained 4–6 weeks 
after surgery (Table 3). There were no significant differences between the ppo and actually 
measured values (satisfactory accuracy); however, the limits of agreement were large (poor 
precision) (Figure 3). The linear correlation between ppo and measured V̇O2peak (in mL∙kg
–
1∙min–1) was r2=0.50 (P<0.001) (r2=0.56, P<0.001, for lobectomy and r2=0.15, P=0.187, for 
pneumonectomy). 
 
Table 3.  Predicted postoperative (ppo) values and actually measured values 4-6 weeks after 
surgery for pulmonary function (n=63) and peak oxygen uptake (n=59) with limits of 
agreement and linear correlation (r
2
). 
 
 ppo value Actually measured 
after surgery 
Difference 
ppo-measured 
P-value Limits of 
agreement 
Linear 
correlation 
FEV1, % of predicted 69.5±19.9 72.9±17.5 -3.4±-13.7 0.06 -23.5 to 30.2 0.55 
DLCO, % of predicted 63.6±18.9 65.4±18.1 -1.7±-12.3 0.27 - 22.3 to 25.8 0.61 
?̇?O2peak, % of predicted 63.1±16.5 65.4±16.9 -2.3±-13.3 0.20 -23.8 to 28.3  0.46 
?̇?O2peak, mL∙kg
-1∙min-1 18.6±5.4 19.2±5.5 -0.6±-4.1 0.24 - 7.4 to 8.7 0.50 
Data are presented as mean ± SD. DLCO=carbon monoxide lung diffusion capacity; FEV1=forced expiratory volume after one 
second; ?̇?O2peak=peak oxygen uptake 
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 Figure 3 demonstrates the poor relationship between the per cent change in actually 
measured V̇O2peak  from before to after surgery and the number of functional lung segments 
removed (r
2
=0.06). The solid black line shows the calculated ppo V̇O2peak using the 
recommended segment method, and demonstrates the large variance between calculated ppo- 
and actually measured values. By use of the segment method for predicting postoperative 
?̇?O2peak, 32 patients (54%) were miss-predicted by ±10%, and 15 patients (25%) were miss-
predicted by >±20% (Figure 3). 
  
4.0 Discussion 
The purpose of this study was to evaluate the effect of lung cancer surgery on ?̇?O2peak 
measured on a treadmill, and to assess the agreement between predicted and actually 
measured ?̇?O2peak values. There was a clinically important[26] and significant reduction in 
?̇?O2peak after surgery, which lasted for more than 6 months. The reduction in ?̇?O2peak cannot 
be explained by the number of lung segments removed. Even though the calculation of ppo 
?̇?O2peak was accurate, the precision of the ppo ?̇?O2peak calculation was poor. Thus, the 
prediction of postoperative  ?̇?O2peak from the number of lung segments removed should be 
questioned. 
 
4.1 Cardio-respiratory fitness 
In the present study, the ?̇?O2peak measured before surgery was 23.9±5.8 mL∙kg
–1∙min–1. 
Despite the inclusion of a high number of female patients (50%), this is, to our knowledge, the 
highest reported ?̇?O2peak in a NSCLC population. In other studies reporting ?̇?O2peak prior to 
surgery, the average value has varied between 11 and 20 mL∙kg–1∙min–1.[3, 11-15, 17, 18, 27]  
We do not have any indications of the Norwegian NSCLC population as being more fit than 
other populations. The age, body mass, level of pulmonary function and proportion of co-
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morbidities are comparable with those of other NSCLC populations. Thus, the high ?̇?O2peak in 
our population might be explained by the test method. All studies mentioned above used 
exercise testing on a cycle ergometer, in contrast to our study using a treadmill. When 
cycling, quadriceps fatigue rather than cardio-pulmonary limitation is an important 
contributor to exercise limitation during CPET in patients with lung cancer.[12, 13, 16, 17] 
Furthermore, the heart rate reserve has been reported to be high when using cycle 
ergometer[4] and, consequently, the cardiopulmonary response to the increasing work rate 
may not have been fully challenged because of leg discomfort. These arguments are reflected 
in the significantly higher peak heart rate observed in the present study compared with other 
studies.[12, 16, 18-20] In addition, leg fatigue was only reported in 23% of the patients, which 
is considerably lower than that reported previously during cycling.[12, 13, 16, 17] Uphill 
walking is a more functional and dynamic exercise mode compared with cycling and 
generates more muscle mass activation, as recruitment of the quadriceps muscle is 
increased.[28] Simultaneously, it generates lower blood pressure and blood lactate 
accumulation, as well as higher cardiac output, giving a 10–20% higher ?̇?O2peak.[28-30] We 
therefore recommend treadmill testing for pre-operative measurement of physical fitness, 
enabling the patient to walk slowly up an increasingly steep incline until exhaustion. 
Preoperativ measurement of ?̇?O2peak is recommended as a tool for risk stratification in all 
guidelines; ERS/ESTS,[5] British Thoracic Society,[7] and the American College of Chest 
Physicians.[31] 
 
4.2 Effect of surgery 
Four to six weeks after surgery, the ?̇?O2peak was decreased by 17% and 34% in patients 
who underwent lobectomy and pneumonectomy, respectively. Our results are fairly consistent 
with those of Nezu and colleagues.[17] In contrast, Brunelli and colleagues found a minimal 
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loss in ?̇?O2peak (5%) measured 4 weeks after surgery, despite significantly larger decreases in 
FEV1 and DLCO.[32] However, the ?̇?O2peak in that study was estimated from a symptom-
limited stair-climbing protocol, using a non-validated equation, thus rendering comparison 
with the present study difficult. 
The reduction in ?̇?O2peak after surgery could not be explained by loss of lung tissue. 
This was demonstrated by the lacking relationship between the pre- to post-operative change 
in both FEV1 and MVV and the change in ?̇?O2peak and, in addition, by a rather unexpected 
increase in breathing reserve, defined as a difference between MVV and peak ventilation of 
less than 15%.[33]  In fact, only two patients had their post-operative exercise capacity 
limited by lung mechanics. Furthermore, there was no change in SpO2 during maximum 
exercise, even though DLCO at rest decreased significantly after surgery. These results are 
consistent with those of Hsia and colleagues, who found only a mild decline in arterial O2 
saturation during exercise after pneumonectomy, indicating high functional reserves for 
diffusion capacity in the lungs during exercise.[34] As cardiac output rises during incremental 
exercise in healthy subjects, a two-fold increase in diffusion capacity in the lungs is observed 
in order to maintain oxygenation,[35] indicating a higher diffusion capacity reserve compared 
with cardiac output. This may explain why the majority of patients undergoing lung resection 
are able to maintain their SpO2 after surgery, even during maximal exercise.  
Unfortunately, we did not measure stroke volume during exercise; however, the oxygen 
pulse, which yields information on the maximal cardiac stroke volume,[36-38] was 
significantly reduced after surgery. In fact, the oxygen pulse was the strongest predictor for 
the decrease in ?̇?O2peak. Normally, a low oxygen pulse reflects cardiac limitation if the patient 
does not desaturate,[39, 40] indicating a negative effect of surgery on the cardiac function. To 
confirm the impact on cardiac limitation, we in retrospect calculated the change in the 
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patients’ stroke volume by estimating the arterio venous oxygen difference,[39, 41] finding a 
10 % reduction in the stroke volume (P<0.001) from before to after surgery (data not shown). 
Anaemia is a factor that decreases the oxygen-carrying capacity of blood, thereby 
affecting ?̇?O2peak negatively.[42] According to the multiple regression analysis, the observed 
decrease in [Hb] following surgery was not an important contributor to the decrease in ?̇?O2peak 
following surgery. Loss of muscle mass may also reduce ?̇?O2peak. A previously reported, dual 
energy X-ray absorptiometry scanning revealed a significant post-operative loss of muscle 
mass in our patients.[21] Thus, the negative effect of surgery on both cardiac function and 
muscle mass may have contributed to the post-operative decrease in  ?̇?O2peak, while, 
according to the lacking correlation with lung mechanics and the increase in breathing 
reserve, the loss of lung tissue seems to be of less importance. 
Prolonged sedentariness leads to a reduction in cardiac output, as well as muscle 
wasting.[21, 43] This may explain the lack of increase in ?̇?O2peak six months after surgery in 
our group of non-exercising patients.[44] Regular high-intensity exercise training following 
lung cancer surgery has, on the other hand, recently been shown to reverse these 
conditions,[21] highlighting the importance of exercise rehabilitation in this group of patients.  
 
4.5 Predicted postoperative ?̇?O2peak 
The second aim of the current study was to evaluate the agreement between predicted 
(ppo) and actually measured postoperative ?̇?O2peak values during a maximal treadmill test in 
patients undergoing lung cancer surgery. Estimation of ppo ?̇?O2peak from the number of lung 
segments removed is included in the ERS/ESTS guidelines for lung cancer surgery, in order 
to predict surgical risk and functional outcome.[5] A ppo ?̇?O2peak value <10 mL∙kg
–1∙min–1 or 
<35% of predicted is used as cut-off values for “high-risk patient”,[5] thus stressing the 
importance of applying an accurate formula. Despite satisfying accuracy in ppo V̇O2peak 
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compared with actually measured V̇O2peak after surgery, we found that the variance was large, 
indicating poor precision. This is in accordance with the lacking correlation between change 
in V̇O2peak and the number of resected lung segments. In fact, the ppo V̇O2peak value was 
miscalculated by more than ±20% in as many as 25% of the patients. The results regarding the 
agreement between ppo and actually measured values of V̇O2peak in the present study are 
consistent with those of Brunelli and colleagues.[15] They concluded that the ppo V̇O2peak was 
largely inaccurate and should be cautioned against,[15] a statement which is supported by our 
results. 
 
5.0 Conclusions 
 The significant reduction in ?̇?O2peak and lack of improvement six months after lung 
cancer surgery cannot be explained by the loss of functional lung tissue, but appears to reflect 
a decrease in the patients’ cardiac function. Predicting postoperative ?̇?O2peak based on the 
amount of lung tissue removed is not recommendable due to poor precision. 
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LEGEND TO FIGURES 
 
 
Figure 1.  
Flow of participants through the study. Measurements after exercise training are not included 
in the data analysis. 
 
 
Figure 2.  
Percent change in peak oxygen uptake (V̇O2peak) from before to after surgery for each patient 
relative to the number of functional lung segments removed. The solid line indicates the per 
cent change in the calculated postoperative V̇O2peak, using the segment method, ±10 per cent 
(dashed line) and ±20 per cent (dotted line). 
  
 
Figure 3.  
Relationship between the mean of actually measured and predicted postoperative oxygen 
uptake (ppo V̇O2peak in % of predicted) and the difference between the actually measured and 
ppo V̇O2peak with 95% confidence interval (1.96 SD). 
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Kan 1
Kartlegging aktivitet Norge
Forespørsel om deltakelse i Kan1
– en kartleggingsundersøkelse av fysisk aktivitet
og fysisk form blant voksne og eldre
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Kan1 –Hoveddel- 2008-04-25
Hva er Kan1-undersøkelsen?
Kan1 er en landsomfattende kartlegging 
av befolkningens aktivitetsnivå og fysiske 
form. Vi har i dag ikke tilstrekkelig 
informasjon på dette feltet til å kunne 
beskrive utviklingstrekk i 
befolkningsgrupper og geografiske 
områder og forskjeller mellom dem. 
Denne undersøkelsen er ett ledd i 
Helsedirektoratets Handlingsplan for 
fysisk aktivitet, hvor et av hovedmålene 
er å etablere et system for kartlegging av 
det fysiske aktivitetsnivået i 
befolkningen. Undersøkelsen 
gjennomføres over hele landet i løpet av 
2008 og 2009 og utføres av følgende 
høgskoler og universiteter:
Hva innebærer deltakelse i 
undersøkelsen for deg?
Deltakelse i undersøkelsen innebærer at 
du svarer på et spørreskjema og går med 
en aktivitetsmåler i syv dager. 
Aktivitetsmåleren er et lite og lett 
apparat som bæres i et elastisk belte 
rundt livet (se bilder neste side). Du går 
med måleren i 7 dager og returnerer den 
deretter sammen med spørreskjemaet i 
vedlagt returkonvolutt (Fase 1). I 
etterkant av Fase 1 vil om lag ¼ av 
deltakerne bli tilfeldig trukket ut og 
invitert til å gjennomføre en 
tilleggsundersøkelse av fysisk form (Fase 
2). Du kan delta i den første delen av 
undersøkelsen, og si nei til videre 
deltakelse.
KAN du delta?
Velger du å delta i Kan1-undersøkelsen 
bidrar du med viktig og ny kunnskap om 
aktivitetsnivå og fysisk form i 
befolkningen. 
Alle kan delta, uansett om man ser på seg 
selv som fysisk aktiv eller ikke. 
Hensikten med undersøkelsen er å 
kartlegge et utvalg som representerer 
hele befolkningen, ikke bare den delen 
som er mest aktiv.
Fordeler og ulemper
Ved deltakelse i undersøkelsen vil du i 
etterkant motta en detaljert 
tilbakemelding på eget aktivitetsnivå. Du 
vil blant annet se hvorvidt du oppfyller 
Helsedirektoratets anbefalinger for fysisk 
aktivitet. Dersom du blir invitert til videre 
deltakelse i Fase 2, vil du få 
tilbakemelding på egen fysisk form. Test 
av fysisk form i Fase 2 kan påføre 
deltakere noe ubehag, da man skal utføre 
enkelte øvelser med høy intensitet.
Hva skjer med informasjonen om deg?  
All informasjon som samles inn om deg, 
vil bli behandlet i henhold til gjeldende 
lover og forskrifter. Alle medarbeidere 
involvert i undersøkelsen har 
taushetsplikt, og opplysningene som 
samles inn, vil kun bli brukt til godkjente 
forskningsformål. Se avsnittet om 
personvern på neste side for mer 
informasjon.
Frivillig deltakelse
Det er frivillig å delta i undersøkelsen. Du 
kan når som helst trekke deg uten å oppgi 
noen grunn. Dersom du ønsker å delta, 
undertegner du samtykkeerklæringen på 
siste side. 
KAN 1 –Kapittel A og B- 2008-04-25
Kriterier for deltakelse
Kriterier for deltakelse er at man er over 
20 år, bor i Norge og er norsk statsborger. 
  
Tidsplan
I perioden april til november 2008 sendes 
spørreskjema og aktivitetsmåler til 
deltakeren. Denne delen av undersøkelsen 
skjer kun per post og kalles Fase 1. Et 
tilfeldig utvalg av deltakerne i Fase 1 
(omtrent ¼) vil bli invitert til en 
undersøkelse av fysisk form (Fase 2). Fase 
2 vil finne sted to til seks måneder etter 
hovedundersøkelsen. Det er fullt mulig å 
si nei til deltakelse i Fase 2, selv om man 
har deltatt i Fase 1. 
Mulige bivirkninger
Det er ingen kjente bivirkninger ved 
deltakelse i undersøkelsen. Test av fysisk 
form i Fase 2 kan påføre deltaker noe 
ubehag idet man skal utføre enkelte 
øvelser med høy intensitet. Eventuelle 
reiseutgifter for deltakere som blir 
invitert til deltakelse i Fase 2, vil bli 
dekket av undersøkelsen. 
Personvern
Undersøkelsen er godkjent av Regional 
komité for medisinsk og helsefaglig 
forskningsetikk Helseregion Sør avdeling 
B, REK Sør B. Undersøkelsen er tilrådd av 
personvernombudet for forskning, Norsk 
samfunnsvitenskapelig datatjeneste A/S.
Opplysninger som registreres om deg, er 
personalia som alder, kjønn, sivil status og 
etnisitet, i tillegg til opplysninger om 
blant annet aktivitet, kosthold og helse. 
Du kan være trygg på at informasjonen du 
bidrar med til undersøkelsen, vil bli 
behandlet med respekt for personvern og 
privatliv, og i samsvar med lover og 
forskrifter.
Innsamlede opplysninger oppbevares slik 
at navn er erstattet med en kode som 
viser til en atskilt navneliste. Det er kun 
autorisert personell knyttet til prosjektet 
som har adgang til navnelisten og som kan 
finne tilbake til deg. Det vil ikke være 
mulig å identifisere deg i resultatene av 
undersøkelsen når disse publiseres.
Rett til innsyn og sletting av  
opplysninger om deg og sletting av  
prøver
Hvis du sier ja til å delta i undersøkelsen, 
har du rett til å få innsyn i hvilke 
opplysninger som er registrert om deg. Du 
har videre rett til å få korrigert 
eventuelle feil i de opplysningene vi har 
registrert. Dersom du trekker deg fra 
undersøkelsen, kan du kreve å få slettet 
innsamlede prøver og opplysninger, med 
mindre opplysningene allerede er inngått 
i analyser eller brukt i vitenskapelige 
publikasjoner. 
Det kan bli aktuelt å innhente 
opplysninger om deg fra nasjonale 
helseregistre: Skade-, kreft-, dødsårsaks-, 
og reseptregisteret. Vi ber om din 
tillatelse til å innhente 
tilleggsinformasjon fra de nevnte registre. 
Alle innsamlede opplysninger 
anonymiseres senest innen 31.12.2020, 
med mindre vi innen da har kontaktet deg 
med forespørsel om noe annet.
Økonomi og Helsedirektoratets rolle
Undersøkelsen er finansiert og initiert av 
Helsedirektoratet.
Bilde 1 og 2. Aktivitetsmåleren i bruk
Kan 1
kartlegging aktivitet Norge
2008
Samtykke til deltakelse i undersøkelsen
Dette eksemplaret underskrives og returneres i vedlagt svarkonvolutt.
Den returnerte samtykkeerklæringen vil bli oppbevart på ett nedlåst sted. 
Jeg er villig til å delta i undersøkelsen 
Vennligst fyll ut opplysningene nedenfor:
(skriv tydelig, helst med blokkbokstaver)
Fornavn:
………………………………………………………………………………………………………………………………………………
Etternavn:
………………………………………………………………………………………………………………………………………………
…………………………………………………………………………
(Signer her)
Jeg bekrefter å ha gitt informasjon om undersøkelsen
…………………………………………………………………………
Professor Sigmund Alfred Anderssen
Prosjektleder
Seksjon for idrettsmedisin
Norges idrettshøgskole
Omslag Samtykkeskjema  24-04-08  09:13  Side 1
 
 
 
 
  
  
 
 
Egenerklæringsskjema Kan1, fase 2 
 
Skjemaet fylles ut av alle som skal delta i fysisk test i fase 2 av 
kartleggingsundersøkelsen Kan1.  
 
Alt. 1. Skjemaet returneres utfylt til følgende adresse så snart som mulig: 
Alt. 2. Skjemaet fylles ut på testdag, i forkant av testing 
Adresse 
Adresse 
 
 
 
 
 
Etternavn: 
 
 
Fornavn: Født: 
Hjemmeadresse: 
Tlf (hjem):                                                             E-mail adresse: 
 
Tlf (mobil): 
 
Navn nærmeste pårørende: 
 
Tlf nærmeste pårørende: 
 
Dine idretts- og mosjonsvaner: 
 
JA    NEI 
 
          1. Mosjonerer du regelmessig med lettere kondisjonsaktiviteter (f.eks gåturer, 
lett jogging)? 
 
           2. Driver du regelmessig hardere kondisjonstrening og/eller konkurrer i 
kondisjonsidretter? 
 
   JA       NEI 
 
                       1.   Kjenner du til at du har en hjertesykdom? 
 
                       2.   Hender det du får brystsmerter i hvile eller i forbindelse med 
fysisk aktivitet? 
 
                       3.   Kjenner du til at du har høyt blodtrykk? 
 
                      4.   Bruker du for tiden medisiner for høyt blodtrykk eller 
hjertesykdom 
                                     (f.eks. vanndrivende tabletter)? 
 
                      5.   Har noen av dine foreldre, søsken eller barn fått hjerteinfarkt 
eller dødd 
                                     plutselig (før fylte 55 år for menn og 65 for kvinner)? 
 
                      6.   Røyker du? 
 
                      7.   Kjenner du til om du har høyt kolesterolnivå i blodet? 
 
                      8.   Har du besvimt i løpet av de siste 6 måneder? 
 
                      9.   Hender det du mister balansen på grunn av svimmelhet? 
 
                     10.  Har du sukkersyke (diabetes)? 
 
                     11.  Kjenner du til noen annen grunn til at din deltakelse i prosjektet 
kan 
                                     medføre helse- eller skaderisiko? 
 
 
 
Gi beskjed straks dersom din helsesituasjon forandrer seg fra nå og til 
undersøkelsen er ferdig. 
 
Dine eventuelle kommentarer til spørsmålene eller andre relevante opplysninger 
om egen helsesituasjon med tanke på å gjennomføre fysiske tester: 
 
__________________________________________________________________ 
 
    __________________________________ 
      Sted og dato 
 
    _______________________________ 
      Underskrift 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
 
Kan 1
Kartlegging aktivitet Norge
Hovedskjema
Kjære Kan1 deltaker,
Ved hjelp av besvarelsen fra deg og andre deltakere vil vi få økt
kunnskap om det fysiske aktivitetsnivået i den norske befolkning.
I tillegg vil vi få bedre forståelse for hvilke forhold som er knyttet
til fysisk aktivitet blant voksne og eldre. 
Du har selvsagt anledning til å unnlate å svare på enkeltspørsmål.
Det er imidlertid viktig at du gir ærlige svar. Informasjonen
i dette spørreskjemaet behandles konfidensielt og ditt navn vil
verken forekomme i datafiler eller i skriftlig materiale.
Det tar 20-30 minutter å fylle ut spørreskjemaet.
Vennligst følg instruksene underveis. 
Skjemaet skal leses ved hjelp av en datamaskin. Bruk sort eller
blå penn ved utfylling. Det er viktig at du fyller ut skjemaet riktig:
• Ved avkrysning, sett ett kryss innenfor rammen av boksen
ved det svaralternativet som passer best
X Riktig
X Galt
Om du krysser av i feil boks, retter du ved å fylle
boksen slik
• Skriv tydelige tall innenfor rammen av boksen
7   4       Riktig
7 4   Galt      
• Bruk blokkbokstaver hvis du skal skrive A B C D E F
På forhånd takk for hjelpen!
Omslag 4  15-04-08  14:45  Side 2
T   T 
T   T 
 - 1 - 
Bakgrunnsinformasjon 
 
 
1) Kjønn:       Kvinne 2) Fødselsår:   19 
   Mann  
 
 
3) Høyde:                     cm        4) Vekt:                             ,         kg 
 
 
 
5)  Hvilken utdanning er den høyeste du har fullført? (Sett ett kryss)  
 
   Mindre enn 7 år grunnskole 
   Grunnskole 7-10 år, framhaldsskole eller folkehøgskole 
  Realskole, middelskole, yrkesskole, 1-2 årig videregående skole 
   Artium, økonomisk gymnas, allmennfaglig retning i videregående skole 
   Høgskole/universitet, mindre enn 4 år 
   Høgskole/universitet, 4 år eller mer 
 
    
6) Hva er din hovedaktivitet? (Sett ett kryss)  
 
  Yrkesaktiv heltid   Hjemmeværende 
   Yrkesaktiv deltid    Pensjonist/trygdet 
   Arbeidsledig    Student/militærtjeneste 
 
 
 
7) Hvor høy var husholdningens samlede bruttoinntekt siste år? (sett ett kryss)  
    Ta med alle inntekter fra arbeid, trygder, sosialhjelp og lignende  
 
  Under 125.000 kr    401.000 – 550.000 kr 
  125.000 – 200.000 kr    551.000 – 700.000 kr 
  201.000 – 300.000 kr    701.000 – 850.000 kr 
  301.000 – 400.000 kr   Over 850.000 kr   Ønsker ikke svare 
  
T   T 
T   T 
 - 2 - 
   1001 – 5000     30.001 – 100.000 
   5001 – 10.000    Mer enn 100.000 
 
 10.001 – 20.000   
 
9) Hvordan vurderer du din egen helse sånn i alminnelighet? (sett ett kryss)  
 
  Meget god      God     Verken god eller dårlig     Dårlig     Meget dårlig   
 
 
10) I hvilken grad begrenser din helse dine hverdagslige gjøremål? (sett ett kryss) 
 
  I stor grad           I noen grad          I liten grad             Ikke i det hele tatt 
 
 
11) Mener du at fysisk aktivitet er viktig for å kunne vedlikeholde egen helse? 
     (sett ett kryss) 
  Ja, meget viktig for meg 
  Egentlig tenker jeg ikke så mye på det 
  Nei, det er ikke så viktig for meg 
 
 
12) Har du, eller har hatt: (sett gjerne flere kryss) 
 
  Astma  Allergi      
  Kronisk bronkitt/emfysem/KOLS    Psykiske plager du har søkt hjelp for 
  Hjerteinfarkt   Sukkersyke (diabetes type I)
              
 Angina Pectoris (hjertekrampe)   Sukkersyke (diabetes type II)
              
 Hjerneslag/hjerneblødning (”drypp”)    Benskjørhet/osteoporose
               
 Kreft   Revmatiske lidelser  
  Spiseforstyrrelser   
  Annet:  ______________________________________________________________  
 
8) Hvor mange innbyggere er det i din bostedskommune? (sett ett kryss)
   Under 1000    20.001 – 30.000 
T   T 
T   T 
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• planlagte aktiviteter (gå på tur, svømming, dansing) 
• trening (for å bedre kondisjon, muskelstyrke og andre ferdigheter) 
 
Det er flere nesten like spørsmål - det er meningen 
 
 
 
13) Er du aktivt medlem av et idrettslag eller en idrettsklubb? (sett ett kryss) 
  Ja    
  Nei, men jeg har vært medlem før    
  Nei, jeg har aldri vært medlem (gå til spm 15) 
 
 
14) Når ble du medlem for første gang? 
      
  
Jeg ble medlem da jeg var              år gammel 
 
 
 
15) Dersom du er fysisk aktiv, hvilke aktiviteter driver du vanligvis med:  
 (Sett gjerne flere kryss) 
 
  Turgåing  Ballspill  Padling/roing  
  Dans  Stavgang  Sykling/spinning 
  Golf  Svømming  Jogging 
  Langrenn  Vanngymnastikk  Skøyter/bandy/hockey 
  Yoga/pilates  Alpint/snowboard  Trening til musikk i sal 
  Tennis  Kampsport (karate, judo ol)  Squash/Badminton/Bordtennis 
  Treningsstudio (styrketrening, tredemølle, ergometersykkel, elipsemaskin ol)  
   Annet, 
hva:___________________________________________________________   
  
 
 
Fysisk aktivitet 
 
De neste spørsmålene omhandler fysisk aktivitet. Fysisk aktivitet omfatter både: 
 
• fysisk aktivitet i hverdagen (i arbeid, fritid og hjemme, samt hvordan du forflytter deg til 
og fra arbeid og fritidssysler) 
T   T 
T   T 
 - 4 - 
16) Hvor ofte trener du på de måtene som er nevnt under?  
(Sett ett kryss for hvor ofte du er aktiv på hver måte) 
  
 Aldri Sjelden 1-3  
g/mnd 
1  
dag/uke 
2-3 
dag/uke 
4-6 
dag/uke 
Daglig 
I idrettslag……………….        
På treningssenter………        
På jobben eller skolen…        
Hjemme………………….        
I nærmiljøet……………..        
I svømmehall……………        
Sykler…………………….        
Danser…………………...        
Skitur……………………..        
Fottur……………………..        
 
 
 
 
           
 
 
 
 
 
 
 
 
 
17) Hvor mange timer den siste uken har du vært i fysisk aktivitet i hjemmet eller i 
tilknytning til hjemmet? Det er kun aktiviteter som varer i minst 10 minutter i strekk 
som skal rapporteres 
 
 Ingen < 1  
time 
1-2 
timer 
3-4 
timer 
> 4 
timer 
Lett aktivitet - ikke svett/andpusten………..      
Hard aktivitet - svett/andpusten…………….      
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18)   Angi bevegelse og kroppslig anstrengelse i din fritid. Hvis aktiviteten varierer 
meget f.eks mellom sommer og vinter, så ta et gjennomsnitt.  
Spørsmålet gjelder bare det siste året (sett ett kryss i den ruta som passer best) 
 
Lese, ser på fjernsyn eller annen stillesittende beskjeftigelse?..............................  
Spaserer, sykler eller beveger deg på annen måte minst 4 timer i uka?  
(Her skal du regne med gang eller sykling til arbeidsstedet, søndagsturer mm)… 
 
 
Driver mosjonsidrett, tyngre hagearbeid e.l?  
(Merk at aktiviteten skal vare minst 4 timer i uka)……………………….…………… 
 
 
Trener hardt eller driver konkurranseidrett regelmessig og flere ganger i uka…….  
 
 
 
 
 
 
 
 
 
 
19a)  Hvor mange dager i løpet av de siste 7 dager har du drevet med meget anstrengende 
fysiske aktiviteter som tunge løft, gravearbeid, aerobics eller sykle fort? Tenk bare på 
aktiviteter som varer minst 10 minutter i strekk 
  Dager per uke                      
 Ingen (gå til spørsmål 20a) 
 
 
19b) På en vanlig dag hvor du utførte meget anstrengende fysiske aktiviteter, hvor lang tid 
brukte du da på dette? 
 
    Timer                Minutter    Vet ikke/husker ikke 
 
 
20a) Hvor mange dager i løpet av de siste 7 dager har du drevet med middels anstrengende 
fysiske aktiviteter som å bære lette ting, sykle eller jogge i moderat tempo eller 
mosjonstennis? Ikke ta med gange, det kommer i neste spørsmål. 
 Dager per uke 
Når du svarer på spørsmålene 19 - 22: 
 
Meget anstrengende – er fysisk aktivitet som får deg til å puste mye mer enn vanlig 
Middels anstrengende – er fysisk aktivitet som får deg til å puste litt mer enn vanlig 
 
Det er kun aktiviteter som varer minst 10 minutter i strekk som skal rapporteres 
 Ingen (gå til spørsmål 21a) 
T   T 
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20b) På en vanlig dag hvor du utførte middels anstrengende fysiske aktiviteter, hvor 
lang tid brukte du da på dette? 
 
     Timer      Minutter  Vet ikke/husker ikke 
 
 
 
21a) Hvor mange dager i løpet av de siste 7 dager, gikk du minst 10 minutter i strekk 
for å komme deg fra ett sted til et annet? Dette inkluderer gange på jobb og 
hjemme, gange til buss, eller gange som du gjør på tur eller som trening i fritiden 
 Dager per uke 
 Ingen (gå til spørsmål 22) 
 
 
 
21b) På en vanlig dag hvor du gikk for å komme deg fra et sted til et annet, hvor lang 
tid brukte du da totalt på å gå? 
 
      Timer           Minutter Vet ikke/husker ikke 
 
 
 
 
 
 
 
 
 
 
 
 
 
22)  Dette spørsmålet omfatter all tid du tilbringer i ro (sittende) på jobb, hjemme, på 
kurs, og på fritiden. Det kan være tiden du sitter ved et arbeidsbord, hos venner, 
mens du leser eller ligger for å se på TV. 
 
I løpet av de siste 7 dager, hvor land tid brukte du vanligvis totalt på å sitte på en 
vanlig hverdag? 
 
                      Timer           Minutter  Vet ikke/husker ikke 
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23)  Nedenfor følger en rekke grunner for å drive med fysisk aktivitet. Vennligst sett 
 ett eller flere kryss for den (de) grunnen(e) som er viktige for deg. 
 
 Forebygge helseplager    Komme i bedre form  
 Holde vekten nede     Anbefalt av lege, fysioterapeut eller liknende  
 For å se veltrent ut     Fysisk og psykisk velvære 
 Øke prestasjonsevnen   For å treffe og omgås andre mennesker 
 Gjøre fritiden trivelig   Oppbygging etter sykdom/skade 
 For å ha det gøy    Oppleve spenning/utfordring 
 Føler jeg må    For å få frisk luft 
 
 
 
 
 
 
 
 
 
 
 
 
24)  Nedenfor følger en rekke grunner for å ikke drive med fysisk aktivitet. 
Vennligst sett ett eller flere kryss for den (de) grunnen(e) som er viktig(e) for deg. 
 
 Har ikke tid      Synes jeg er for gammel  
 Har ikke råd     På grunn av min fysiske helse  
 Transportproblemer    Har ingen å være fysisk aktiv sammen med 
 Negative erfaringer    Tidspunktet passer meg ikke 
 Bevegelsesproblemer   Kjenner ikke til noe tilbud 
 Tror ikke jeg får det til   Engstelig for å gå ut 
 Orker ikke     Mangel på tilbud innen mine interesseområder 
 Redd for å bli skadet (falle, forstue) 
 Vil heller bruke tiden min til andre ting 
 Andre grunner, hva: _____________________________________________________ 
 
T   T 
T   T 
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De neste spørsmålene handler om dine vaner knyttet til transport og omfatter dine vanlige 
måter å komme fra et sted til et annet, inkludert hvordan du kommer deg til og fra jobb, 
butikker, kino, fritidssysler og så videre. 
 
Merk at du skal angi dine transportvaner separat for sommer og vinter. 
 
 
 
25a) Hvor mange dager i en vanlig uke reiser du med et motorisert transportmiddel 
som tog, buss, bil eller trikk? 
 
Om sommeren     Om vinteren 
  
 
         Dager per uke                  Dager per uke 
  
 
25b) På en vanlig dag hvor du reiser med motorisert transportmiddel, hvor lang tid 
bruker du da totalt i transportmiddelet? 
 
Om sommeren     Om vinteren 
 
Timer    Minutter     Timer        Minutter 
  
 
26a) Hvor mange dager i en vanlig uke sykler du minst 10 minutter i strekk for å 
komme fra et sted til ett annet?  
 
Om sommeren     Om vinteren 
Dager per uke     Dager per uke  
 
 
26b) På en vanlig dag hvor du sykler for å komme deg fra et sted til ett annet, hvor 
lang tid bruker du da totalt på å sykle? 
 
Om sommeren     Om vinteren 
 
 
Timer       Minutter   Timer     Minutter 
 
 
 
Transport aktiviteter 
 
T   T 
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27a) Hvor mange dager i en vanlig uke går du minst 10 minutter i strekk for å komme 
fra et sted til ett annet? 
 
Om sommeren     Om vinteren 
 Dager per uke     Dager per uke 
 
 
27b) På en vanlig dag hvor du går for å komme deg fra et sted til ett annet, hvor lang 
tid bruker du da totalt på å gå? 
 
Om sommeren     Om vinteren 
   
 
      Timer     Minutter   Timer        Minutter 
 
 
28) Dersom du er yrkesaktiv, hvordan kommer du deg vanligvis til og fra arbeid? 
  Bil/motorsykkel       Offentlig transport (tog, buss, og liknende) 
  Sykkel    Til fots 
  Ikke aktuelt 
 
TV, PC og søvnvaner 
 
De neste spørsmålene handler om dine vaner knyttet til bruk av TV og PC utenom jobb. I 
tillegg vil vi kartlegge dine søvnvaner 
 
 
 
29) Utenom jobb: Hvor mange timer ser du vanligvis på TV og sitter med PC på en 
hverdag? (Sett ett kryss) 
  Mindre enn 1 time   3 - 4 timer 
  1 - 2 timer      4 - 5 timer 
  2 - 3 timer    Mer enn 5 timer  
 
30) Utenom jobb: Hvor mange timer ser du vanligvis på TV og sitter med PC på en 
helgedag? (Sett ett kryss) 
 Mindre enn 1 time   3 - 4 timer 
 1 - 2 timer    4 - 5 timer 
 2 - 3 timer    Mer enn 5 timer  
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31) Hvor mange timer i døgnet sover du vanligvis på en hverdag? 
(Sett ett kryss) 
 Mindre enn 3 timer    8 - 10 timer 
 3 - 5 timer    10 timer eller mer 
 5 - 8 timer 
 
32) Hvor mange timer i døgnet sover du vanligvis på en helgedag eller fridag? 
 (Sett ett kryss) 
 Mindre enn 3 timer   8 - 10 timer 
  3 - 5 timer    10 timer eller mer 
  5 - 8 timer 
 
Kosthold, røyk og alkohol 
 
I denne delen av spørreskjemaet er det fokus på kosthold og dine røyke- og 
alkoholvaner. Vi er klar over at kostholdet varierer fra dag til dag. Prøv derfor så godt du 
klarer å ta ett gjennomsnitt av dine spisevaner og ha det siste året i tankene når du 
svarer. 
 
 
 
33) Har du røykt/røyker du daglig? (sett ett kryss)    
 
  Ja, nå                  Ja, tidligere            Aldri (Gå videre til spørsmål 3 )  
    
 
34) Hvis du har røykt daglig tidligere, hvor lenge siden er det du sluttet?    
  
      år  
 
 
35) Hvis du røyker daglig nå eller har røykt tidligere:  
  
 Hvor mange sigaretter røyker eller røykte du vanligvis daglig?    
           Antall sigaretter 
 Hvor gammel var du da du begynte å røyke? 
        Alder i år 
 Hvor mange år til sammen har du røykt daglig?        
                  Antall år 
  
 
6
T   T 
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37) Hvor ofte drikker du alkohol? (Sett ett kryss som stemmer best med dine vaner) 
  Aldri 
  Månedlig eller sjeldnere 
  2 - 4 ganger pr måned 
  2 - 3 ganger per uke 
  4 ganger i uken eller oftere 
 
 
38) Når du drikker alkohol, hvor mange ”drinker” tar du vanligvis? 
 En ”drink” tilsvarer en ½ liter pils, ett glass vin, ett drammeglass 
 (Dersom du ikke drikker alkohol skal du ikke krysse) 
 
 1 - 2                3 - 4              5 - 6             7 - 8            9 eller mer 
 
 
39) Hvor mange enheter med frukt og grønnsaker spiser du i gjennomsnitt hver dag?      
(Med enhet menes for eksempel 1 frukt, 1 glass juice, 2-3 poteter, 1 skål bær, 1 porsjon 
grønnsaker, 1 porsjon salat) 
 
 
Antall porsjoner frukt   
 
 
Antall porsjoner grønnsaker 
 
 
 
40) Hvor ofte pleier du å spise følgende måltider i løpet av en uke?  
(Sett ett kryss for hvert måltid) 
  
 Aldri/ 
Sjelden 
1  
g/uke 
2  
g/uke 
3 
g/uke 
4 
g/uke 
5 
g/uke 
6 
g/uke 
Hver 
dag 
Frokost…….         
Lunsj……….         
Middag…….         
Kveldsmat…         
 
36) Bruker du snus? (sett ett kryss) 
  Ja, daglig         Av og til       Aldri
T   T 
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41) Hvor ofte spiser du vanligvis disse matvarene? 
      (Sett ett kryss per linje) 
 0-1  
g/mnd 
2-3  
g/mnd 
1-3  
g/uke 
4-6  
g/uke 
1-2 
g/dag 
Poteter (kokte, stekte, potetmos)………………..…….      
Pasta/ris…………………………………………….…      
Kjøtt (reint kjøtt av storfe, lam, svin, vilt)…………….…      
Kvernet kjøtt (pølser, hamburger, kjøttdeig, kjøttkaker)      
Kylling………………………………………………….      
Grønnsaker (ikke poteter)………………………….....      
Frukt og bær………………………………………….      
Mager fisk (torsk, sei, ol)………………………………      
Fet fisk (laks, ørret, makrell, sild, kveite, uer, ol)………      
Grovt brød……………………………………………      
Salt snacks (potetgull, saltstenger, ol)………………      
Godteri/sjokolade…………………………………….      
Kaker/kjeks…………………………………………..      
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42) Hvor mye drikker du vanligvis av følgende? (Sett ett kryss for hver linje) 
 
 Sjelden/ 
aldri 
1-3  
glass pr 
mnd 
1-3  
glass pr 
uke 
4-6  
glass pr 
uke 
1-3  
glass pr 
dag 
4-6 
glass pr 
dag  
>7  
glass pr 
dag 
Helmelk…………        
Lettmelk…………        
Ekstra lett melk…        
Skummet melk…        
Juice……………..        
Vann………………        
Brus med sukker…        
Brus uten sukker…        
Kaffe………………        
Te…………………        
Pils………………        
Vin…………………        
Brennevin…………        
 
 
Holdninger til fysisk aktivitet 
 
I denne siste delen er det fokus på dine holdninger til fysisk aktivitet. Du nærmer deg slutten 
av skjemaet. Hold ut ☺ 
 
 
 
43) Tenk deg alle former for fysisk aktivitet. Ta stilling til påstanden: Jeg er sikker på at jeg        
kan gjennomføre planlagt fysisk aktivitet selv om: 
 
 Ikke i det hele tatt  Veldig sikker 
 1 2 3 4 5 6 7 
Jeg er trett………………………………        
Jeg føler meg nedtrykt…………………..        
Jeg er bekymret………………………….        
Jeg er sint på grunn av noe……………        
Jeg føler meg stresset…………………        
T   T 
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Om jeg er regelmessig fysisk aktiv eller ikke er helt opp til 
meg…………………………………………………………………. 
 
      
Hvis jeg ville, hadde jeg ikke hatt noen problemer med å 
være regelmessig fysisk aktiv…………………………………… 
 
       
Jeg ville likt å være regelmessig aktiv, men jeg vet ikke riktig 
om jeg kan få det til ………………………………………………
 
       
Jeg har full kontroll over å være regelmessig fysisk aktiv…….       
Å være regelmessig fysisk aktiv er vanskelig for meg…………       
 
 
45) I hvilken grad beskriver disse påstandene deg som person? 
(Sett ett kryss for hver påstand) 
 Passer dårlig Passer bra 
 1 2 3 4 5 
Jeg ser på meg selv som en person som er opptatt av fysisk 
aktivitet……………………………………………………………………. 
 
    
Jeg tenker på meg selv som en person som er opptatt av å holde 
seg i god fysisk form…………………………………………………..… 
 
     
Å være fysisk aktiv er en viktig del av hvem jeg er …………………..     
 
 
46) Har familien din (medlemmer i husstanden): 
(Sett ett kryss for hver påstand) 
 Aldri Sjelden Noen få 
ganger 
Ofte Veldig 
ofte 
Passer 
ikke 
Oppmuntret deg til å være fysisk aktiv…........       
Diskutert fysisk aktivitet sammen med deg….       
Forandret planene sine slik at dere kunne 
drive fysisk aktivitet sammen………………… 
 
      
Overtatt oppgaver for deg, slik at du fikk mer 
tid til å være fysisk aktiv…………………….… 
 
      
Sagt at fysisk aktivitet vil være bra for helsen 
din…………………………………………….…. 
 
      
Snakket om hvor godt de liker å være fysisk 
aktive…………………………………………….       
44) Tenk på alle former for fysisk aktivitet. For hver påstand, angi i hvilken grad du er 
enig/uenig. (Sett ett kryss for hver påstand) 
 Helt enig  Helt uenig 
 1 2 3 4 5 6 7 
T   T 
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47) Har vennene dine/bekjente/familiemedlemmer utenfor husstanden:  
      (Sett ett kryss for hver påstand) 
 Aldri Sjelden Noen få 
ganger 
Ofte Veldig 
ofte 
Passer
ikke 
Foreslått at dere skulle drive fysisk aktivitet 
sammen…………………….……………………. 
 
      
Oppmuntret deg til å være fysisk aktiv…………       
Gitt deg hjelpsomme påminnelser om fysisk 
aktivitet som: ”Skal du mosjonere i kveld?”….. 
 
      
Forandret planene sine slik at dere kunne 
drive fysisk aktivitet sammen………………..… 
 
      
Sagt at fysisk aktivitet vil være bra for helsen 
din………………………………………….……. 
 
      
Snakket om hvor godt de liker å være fysisk 
aktive………………………………………………       
 
 
48) Er det i ditt nærmiljø:  
     (Sett ett kryss for hver påstand) 
 Helt 
uenig 
Litt 
uenig 
Litt 
enig 
Helt 
enig 
Trygge steder å gå (park/friområde, turvei, fortau) som er tilstrekkelig 
opplyst………………………………………………………………………. 
 
    
Mange steder der du kan være fysisk aktiv (utendørs, svømmehall 
etc.)………………………………………………………………………… 
 
    
Flere tilrettelagte tilbud om trening og fysisk aktivitet  
(som kunne være aktuelle for deg)……………………………………… 
 
    
Greit å gå til butikker  
(10-15 min å gå, fortau langs de fleste veiene)………………………….
 
    
Lett tilgang til gang- eller sykkelveier…………………………………….     
Så mye trafikk i gatene at det er vanskelig eller lite hyggelig å gå……     
Fotgjengeroverganger og lyssignal som gjør det enklere å krysse 
veien………………………………………………………………………….     
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49) Omtrent hvor lang tid vil det ta deg å gå hjemmefra til: 
      (Sett ett kryss for hver linje) 
 
 1-5 min 6-10  
min 
11-20 
min 
21-30 
min 
> 30  
min 
Vet ikke 
Butikk for dagligvarer…………………       
Et friområde/park/turvei………………       
Helsestudio/treningssenter/svømme-
hall/idrettshall/utendørs idrettsanlegg 
 
      
Skog/mark/fjell…………………………       
 
 
 
50) I hvilken utstrekning mener du at daglig fysisk aktivitet kan ha gunstig effekt for å    
forebygge følgende sykdommer: (Sett ett kryss for hver linje) 
 
 Stor effekt Liten effekt Ingen effekt Vet ikke 
Hjerte- og karsykdom…………………       
Muskel- og skjelettlidelser……………       
Diabetes type 2………………….……       
Kreft……………………………..……..       
Høyt blodtrykk…………………..…….       
Psykiske lidelser………………………       
Overvekt og fedme……………………       
Mage-/tarmsykdommer…………….…       
Astma og allergi…………………….…       
KOLS……………………………………       
 
 
 
 
 
Etter at du har fylt ut spørreskjemaet og gått med aktivitetsmåleren
i 7 dager, legger du skjemaet og aktivitetsmåleren i den vedlagte
konvolutten og returnerer den til oss.
Tusen takk for hjelpen
:-)
:-)
T T
T T
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26. august 2010. Søknaden er vurdert i henhold til lov av 20. juni 2008 nr. 44, om medisinsk og 
helsefaglig forskning (helseforskningsloven) kapittel 3, med tilhørende forskrift om organisering av 
medisinsk og helsefaglig forskning av 1. juli 2009 nr 0955. 
 
Prosjektleder: Stipendiat Elisabeth Edvardsen 
Forskningsansvarlig: Oslo universitetssykehus  
Et antall pasienter opereres årlig for lungekreft i Norge. Det er mangelfull kunnskap om hvordan 
operasjonen påvirker lungefunksjon og dermed generell funksjonsstatus og livskvalitet. Det er også 
lite kunnskap om disse pasientenes fysiske aktivitetsnivå og om effekt av tilpasset trening. I denne 
studien vil man studere pasientene før og etter operasjon med de best tilgjengelige metoder. En 
intervensjonsgruppe vil få trening mens en annen gruppe fungerer som kontroll. Nydiagnostiserte 
pasienter med operabel lungekreft ved Oslo universitetssykehus og Akershus universitetssykehus 
vil bli forespurt om å delta i prosjektet. Det er utarbeidet et informasjonsskriv med 
samtykkeerklæring etter vanlig standard.  
Data skal innhentes i prosjektet ved undersøkelser, testing og ved bruk av spørreskjemaet 
”Lungekreftstuiden”.  
En belastning for pasientene kan ligge i å måtte gjennomgå prøve for å finne maks O2-opptak. 
Ellers vurderes deltakelse i prosjektet å ha få ulemper i forhold til nytten for den enkelte og for 
fordelen med å få ny kunnskap om rehabilitering av denne pasientgruppen.  
Komiteen har vurdert prosjektet. Det kan være et problem at kontrollgruppen ikke får den 
intervensjonen som en mener det er sannsynlig kan ha en positiv effekt. Men i og med at det ikke 
finnes noen etablert kunnskap, og at formålet med prosjektet er å finne ut om det har noen effekt, 
må det være akseptabelt å ha en kontrollgruppe som ikke får det samme tilbudet. Det blir også greit 
gjort rede for fordelingen til de to gruppene i informasjonsskrivet.  
 
Vedtak: 
Komiteen godkjenner at prosjektet gjennomføres i samsvar med det som framgår av søknaden 
Dersom det skal gjøres endringer i prosjektet i forhold til de opplysninger som er gitt i søknaden, 
må prosjektleder sende endringsmelding til REK. 
Forskningsprosjektets data skal oppbevares forsvarlig, se personopplysningsforskriften kapittel 2, 
og Helsedirektoratets veileder for «Personvern og informasjonssikkerhet i forskningsprosjekter 
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innenfor helse- og omsorgssektoren». Personidentifiserbare data slettes straks det ikke lenger er 
behov for dem og senest ved prosjektets avslutning. 
Godkjenningen gjelder til 30.6.2012. Prosjektet skal sende sluttmelding på eget skjema, se 
helseforskningsloven § 12, senest et halvt år etter prosjektslutt. 
 
 
Vennligst oppgi vårt saksnummer/referansenummer i korrespondansen. 
 
 
 
Med vennlig hilsen 
 
 
 
Gunnar Nicolaysen (sign) 
Professor 
Leder 
Jørgen Hardang 
Komitésekretær 
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Forespørsel om deltakelse i forskningsprosjektet 
Kardiorespiratorisk form og effekt av rehabilitering etter operasjon for 
lungekreft  
 
 
Bakgrunn og hensikt 
Dette er et spørsmål til deg om å delta i en forskningsstudie som har til hensikt å undersøke forandring 
i lungefunksjon og fysisk kapasitet etter operasjon for lungekreft, samt studere effekt av trening og 
rehabilitering etter operasjon. 
 
Du er nå under vurdering eller vurdert til operasjon for lungekreft, planlagt gjennomført en av de 
nærmeste dagene. Operasjonen vil medføre endring i lungefunksjonen din, samt evnen til å mette 
blodet med oksygen.  Dette kan påvirke pusten og kondisjonen etter operasjonen.  Man har imidlertid 
liten kunnskap om sammenhengen mellom mengde lungevev som må fjernes og tap av funksjon.  
Samtidig vet man at trening og rehabilitering har vist god effekt på overlevelse og økt livskvalitet, men 
dette er ikke studert eller forsøkt tidligere hos pasienter som er operert for lungekreft.  Derfor ønsker 
vi å invitere deg til deltakelse i et forskningsprosjekt som går ut på å studere endringer i lungefunksjon 
og kondisjon etter operasjon, samt undersøke om trening og rehabilitering kan ha positiv effekt på 
arbeidskapasitet og livskvalitet. Det er Oslo Universitetssykehus som er ansvarlig for studien. Den 
gjennomføres i samarbeid med Norges idrettshøgskole. 
 
Hva innebærer studien? 
Studien innebærer at du må møte til en utvidet helseundersøkelse tre ganger i løpet av de neste seks 
månedene. Første undersøkelse vil bli foretatt før operasjon, den andre ca fire uker etter operasjon og 
den tredje etter ca 6 mnd. Helseundersøkelsen omfatter en grundig måling av lungefunksjonen samt 
gange på tredemølle fra lett til tung belastning for bestemmelse av arbeidskapasitet. Man vil under 
belastningen også måle pusteevne og studere oksygenopptaket i lungene. Det vil bli tatt en enkel 
blodprøve fra fingertuppen for måling av melkesyrenivå og blodprosent. I forbindelse med 
helseundersøkelsen vil man også måle kroppssammensetning for vurdering av størrelsen på 
muskelmassen. Målingen foregår liggende ved at en maskin skanner kroppen i ca fem minutter, og 
hensikten er å se hvordan muskelmassen endrer seg etter operasjon. 
 
Ved 2. helseundersøkelse, ca fire uker etter operasjon, vil du bli tilfeldig trukket ut til deltakelse i 
enten en treningsgruppe eller en kontrollgruppe.  Treningsgruppen skal trene tre ganger pr uke i ca 20 
uker hvor hovedmålet er å øke kondisjon og muskelstyrke. Treningen vil foregå individuelt med 
personlig trener og fysioterapeut og i mindre grupper bl.a. sammen med andre opererte 
lungekreftpasienter. Man vil starte forsiktig og intensiteten vil være tilpasset eget funksjonsnivå basert 
på testresultatet etter operasjon og rekonvalesens. Deretter vil intensiteten øke både med tanke på 
kondisjon og muskelstyrke. Ca 6 mnd etter operasjon gjennomføres den siste helseundersøkelsen.  
Kontrollgruppen vil følge sykehusets vanlige rutine etter operasjon for lungekreft, og vil ikke få tilbud 
om trening. Kontrollgruppen deltar for øvrig i alle undersøkelser på sykehuset. 
Etter operasjon vil du ved to anledninger registrere dagligdags aktivitetsnivå over en uke. Dette vil 
foregå ved at du bærer en aktivitetsmåler (skritteller) festet til livet og som registrerer bevegelse. Du 
må også fylle ut et spørreskjema vedrørende fysisk aktivitet, kosthold og røykevaner, symptomer og 
plager i forbindelse med sykdomsforløpet, samt svare på spørsmål om hvordan du har det i tiden før 
og etter operasjon (livskvalitet).  
 
Relevante opplysninger fra din pasientjournal vil bli innhentet i studien. Opplysninger som registreres 
om deg vil være din diagnose, operasjonsforløp, lungefunksjonsstatus og data vedrørende fysisk form. 
I tillegg vil man registrere eventuelle komplikasjoner og dødsårsak under og etter operasjon koblet opp 
mot funksjonell status. Opplysninger om deg kan senere bli koblet med Dødårsakregisteret og 
Kreftregisteret. 
 
Hvis man i løpet av studien skulle avdekke uforutsette medisinske funn, vil legen din bli informert 
umiddelbart, og adekvat behandling vil straks bli igangsatt.  
 
 
Mulige fordeler og ulemper 
Fordelen ved deltakelse i studien er at helsetilstanden din vil bli grundig fulgt opp fra før til 6 mnd 
etter operasjon, og du vil få god innsikt i egen helsesituasjon gjennom behandlingen uansett hvilken 
gruppe du trekker. Trekkes du til deltakelse i treningsgruppen, vil du gjennom et strukturert 
treningsprogram få mulighet til å bedre din fysiske form, med de gunstige innvirkninger vi mener dette 
kan ha på mange kroppslige funksjoner. Du vil også få tildelt en personlig treningsveileder og 
fysioterapeut som vil følge deg tett gjennom hele treningsperioden. Trekker du tilhørighet i 
kontrollgruppen vil du ikke få tilbud om ukentlige treningsøkter, men vil være del av en gruppe som 
møtes ca hver 6. uke for samtale, informasjon og veiledning i forhold til sykdomsforløp. Uansett 
gruppetilhørighet vil du ha mulighet for å treffe likesinnede pasienter i samme situasjon som deg. 
Erfaringer fra studien vil senere kunne hjelpe andre i samme situasjon. 
 
 
Hva skjer med informasjonen om deg 
Alle målinger og registreringer tatt av deg og informasjonen som registreres om deg utleveres til Oslo 
Universitetssykehus og skal kun brukes slik som beskrevet i hensikten med studien. Alle 
opplysningene vil bli behandlet uten navn og fødselsnummer eller andre direkte gjenkjennende 
opplysninger. En kode knytter deg til dine opplysninger gjennom en navneliste. Det er kun autorisert 
personell knyttet til prosjektet som har adgang til navnelisten og som kan finne tilbake til deg. Det vil 
ikke være mulig å identifisere deg i resultatene av studien når disse publiseres. Hvis du sier ja til å 
delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om deg. Du har videre 
rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du trekker deg fra 
studien uansett tidspunkt, kan du kreve å få slettet innsamlede opplysninger. Opplysningene blir slettet 
senest i 2020. 
 
 
 Frivillig deltakelse 
Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn trekke tilbake ditt 
samtykke til å delta i studien. Dette vil ikke få konsekvenser for din videre behandling. Dersom du 
ønsker å delta, undertegner du samtykkeerklæringen på neste side. Om du nå sier ja til å delta, kan du 
senere trekke tilbake ditt samtykke uten at det påvirker din øvrige behandling. 
Studien ledes av Elisabeth Edvardsen i samarbeid med professor Ole Henning Skjønsberg og 
Seksjonsoverlege Fredrik Borchsenius på Lungemedisinsk avdeling, Ullevål sykehus. Dersom du har 
spørsmål til studien eller senere ønsker å trekke deg, kan du kontakte prosjektleder Elisabeth 
Edvardsen på tlf 922 09 595 eller 22 11 92 80. 
 
 
 
 
 
 
 
Samtykke for deltakelse i studien 
 
Jeg er villig til å delta i studien  
 
 
------------------------------------------------------------------------------                      ------------------------- 
Signert av prosjektdeltaker                                                                               Dato 
 
 
 
 
Bekreftelse på at informasjon er gitt deltakeren i studien   
Jeg bekrefter å ha gitt informasjon om studien 
 
-------------------------------------------------------------------------------                    ------------------------- 
Prosjektleder                                                                                                  Dato 
 Forespørsel om deltakelse i forskningsprosjektet 
Kardiorespiratorisk form før og etter operasjon for lungekreft  
 
Bakgrunn og hensikt 
Dette er et spørsmål til deg om å delta i en forskningsstudie som har til hensikt å undersøke forandring 
i lungefunksjon, fysisk form og aktivitetsnivå etter operasjon for lungekreft. 
  
Du er nå under vurdering eller vurdert til operasjon for lungekreft, planlagt gjennomført en av de 
nærmeste dagene. Operasjonen vil medføre endring i lungefunksjonen din, samt evnen til å mette 
blodet med oksygen.  Dette kan påvirke pusten og kondisjonen etter operasjonen.  Man har imidlertid 
liten kunnskap om sammenhengen mellom mengde lungevev som må fjernes og tap av lungefunksjon.  
I tillegg vet vi lite om hvordan en slik operasjon påvirker den fysiske formen. 
Derfor ønsker vi å invitere deg til deltakelse i et forskningsprosjekt som går ut på å studere endringer i 
lungefunksjon og kondisjon etter operasjon, samt kartlegge aktivitetsnivå etter operasjon. Det er Oslo 
Universitetssykehus som er ansvarlig for studien. Den gjennomføres i samarbeid med Norges 
idrettshøgskole. 
 
Hva innebærer studien? 
Studien innebærer at du må møte til en utvidet helseundersøkelse tre ganger i løpet av de neste seks 
månedene. Første undersøkelse vil bli foretatt før operasjon, den andre ca fire-seks uker etter 
operasjon og den tredje etter ca 6 mnd. Helseundersøkelsen omfatter en grundig måling av 
lungefunksjonen samt gange på tredemølle fra lett til tung belastning for bestemmelse av 
arbeidskapasitet. Man vil under belastningen også måle pusteevne og studere oksygenopptaket i 
lungene. Det vil bli tatt en enkel blodprøve fra fingertuppen for måling av melkesyrenivå og 
blodprosent. I forbindelse med helseundersøkelsen vil man også måle kroppssammensetning for 
vurdering av størrelsen på muskelmassen. Målingen foregår liggende ved at en maskin skanner 
kroppen i ca fem minutter, og hensikten er å se hvordan muskelmassen endrer seg etter operasjon. 
 
Etter operasjon vil du ved to anledninger registrere dagligdags aktivitetsnivå over en uke. Dette vil 
foregå ved at du bærer en aktivitetsmåler (skritteller) festet til livet og som registrerer bevegelse. Du 
må også fylle ut et spørreskjema vedrørende fysisk aktivitet, kosthold og røykevaner, symptomer og 
plager i forbindelse med sykdomsforløpet, samt svare på spørsmål om hvordan du har det i tiden før 
og etter operasjon (livskvalitet).  
 
Relevante opplysninger fra din pasientjournal vil bli innhentet i studien. Opplysninger som registreres 
om deg vil være din diagnose, operasjonsforløp, lungefunksjonsstatus og data vedrørende fysisk form. 
I tillegg vil man registrere eventuelle komplikasjoner og dødsårsak under og etter operasjon koblet opp 
mot funksjonell status. Opplysninger om deg kan senere bli koblet med Dødårsakregisteret og 
Kreftregisteret. 
 
 
Mulige fordeler og ulemper 
Fordelen ved deltakelse i studien er at helsetilstanden din vil bli grundig fulgt opp fra før til 6 mnd 
etter operasjon. Du vil få god innsikt i egen helsesituasjon gjennom behandlingen.. Hvis man i løpet av 
studien skulle avdekke uforutsette medisinske funn, vil legen din bli informert umiddelbart, og adekvat 
behandling vil straks bli igangsatt. Erfaringer fra studien vil senere kunne hjelpe andre i samme 
situasjon. 
 
Hva skjer med informasjonen om deg 
Alle målinger og registreringer tatt av deg og informasjonen som registreres om deg utleveres til Oslo 
Universitetssykehus og skal kun brukes slik som beskrevet i hensikten med studien. Alle 
opplysningene vil bli behandlet uten navn og fødselsnummer eller andre direkte gjenkjennende 
opplysninger. En kode knytter deg til dine opplysninger gjennom en navneliste. Det er kun autorisert 
personell knyttet til prosjektet som har adgang til navnelisten og som kan finne tilbake til deg. Det vil 
ikke være mulig å identifisere deg i resultatene av studien når disse publiseres. Hvis du sier ja til å 
delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om deg. Du har videre 
rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du trekker deg fra 
studien uansett tidspunkt, kan du kreve å få slettet innsamlede opplysninger. Opplysningene blir slettet 
senest i 2020. 
 
Frivillig deltakelse 
Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn trekke tilbake ditt 
samtykke til å delta i studien. Dette vil ikke få konsekvenser for din videre behandling. Dersom du 
ønsker å delta, undertegner du samtykkeerklæringen på neste side. Om du nå sier ja til å delta, kan du 
senere trekke tilbake ditt samtykke uten at det påvirker din øvrige behandling. 
Studien ledes av Elisabeth Edvardsen i samarbeid med professor Ole Henning Skjønsberg og 
Seksjonsoverlege Fredrik Borchsenius på Lungemedisinsk avdeling.  
Dersom du har spørsmål til studien eller senere ønsker å trekke deg, kan du kontakte prosjektleder 
Elisabeth Edvardsen på tlf 452 66 452 eller 922 09 595. 
 
 
Samtykke for deltakelse i studien 
 
Jeg er villig til å delta i studien  
 
 
------------------------------------------------------------------------------                      ------------------------- 
Signert av prosjektdeltaker                                                                               Dato 
 
 
 
Bekreftelse på at informasjon er gitt deltakeren i studien   
Jeg bekrefter å ha gitt informasjon om studien 
 
-------------------------------------------------------------------------------                    ------------------------- 
Prosjektleder                                                                                                  Dato 
Lungefunksjon, fysisk form og effekt av 
rehabilitering etter operasjon for lungekreft
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2SKAL DU OPERERES FOR LUNGEKREFT?
Da ønsker vi å invitere deg til deltakelse i et forskningsprosjekt
Hvordan endres lungefunksjonen og den 
fysiske formen etter operasjon for lungekreft?
Er trening etter operasjon gunstig for opererte 
lungekreftpasienter, og kan fysisk aktivitet 
påvirke livskvaliteten under den videre 
behandlingen?
Dette er noen av de spørsmålene vi ønsker å 
få svar på ved å invitere deg til å delta i dette 
forsknings-prosjektet.
Bakgrunn
Vi vet fra andre undersøkelser at fysisk aktivitet 
og trening øker hjertets pumpekapasitet og bedrer 
oksygenopptaket i muskulaturen.  Dette fører 
til at man blir mindre andpusten under fysiske 
anstrengelser, noe som er gunstig for personer med 
redusert lungekapasitet.  I tillegg gir fysisk aktivitet 
bedre søvnkvalitet, styrker kroppens immunforsvar, 
gir gunstig vektregulering og reduserer angst og 
depresjoner. Fysisk aktivitet kan dermed gi økt 
livskvalitet.
Målsetning
Målsetning med studien er å undersøke hvor mye 
lungefunksjonen og kondisjonen endres etter at man 
har fjernet deler av- eller en hel lunge, samt studere 
effekt av trening hos lungekreftpasienter. Dette har ikke 
blitt studert på denne pasientgruppen tidligere.
3Vi planlegger å inkludere ca 100 lungekreftpasienter 
under 80 år som opereres ved Oslo universitetssykehus 
og Akershus universitetssykehus.  Ca 50 pasienter 
trekkes til deltakelse i treningsgruppen og ca 50 
pasienter til kontrollgruppen.  
Alle deltakere skal gjennomføre en kartlegging av 
lungefunksjonen og den fysiske formen før operasjon, 
fire uker etter operasjon og etter 6 mnd. I tillegg skal 
ulike spørreskjema besvares i løpet av perioden. 
Ca fire uker etter operasjonen vil du bli trukket enten 
til treningsgruppe eller kontrollgruppe.
Kontrollgruppen vil følge det vanlige behandlings-
opplegget som gis for lungekreftpasienter i dag.
Deltakere i treningsgruppen skal trene totalt tre 
ganger i uken og vil bestå av individuell veiledning 
av fysioterapeut og egen personlig trener i tillegg til 
gruppetrening sammen med andre pasienter. 
Treningen vil bestå av styrke-, kondisjon-, balanse-, 
og bevegelighetstrening og være tilpasset både din 
sykdoms-situasjon og dagsform. Alle fysioterapeuter 
og personlige trenere i prosjektet har god utdannelse 
innen sitt fagfelt og kan derfor gi deg gode råd i forhold 
til smerte, forebygging av skader, hjelp til å redusere 
engstelse, samt oppmuntre deg til å være så aktiv som 
mulig.
Kontakt oss!
Hvis du har spørsmål vedrørende studien kan 
du kontakte prosjektleder Elisabeth Edvardsen 
på e-post:  falc@nih.no eller ringe FALC 
telefonen på nummer:  452 66 452
 Norges idrettshøgskole | Sognsveien 220 | 0863 Oslo
 Telefon: +47 23 26 20 00 | Fax: 22 23 42 20 | www.nih.no
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MÅLING AV KROPPSSAMMENSETNING 
DXA - UNDERSØKELSE 
 
 
I forbindelse med din deltakelse i lungekreftstudien vil du måle 
kroppssammensetningen din – såkalt DXA. DXA er en spesiell form for 
røntgenundersøkelse som gir et mål på kroppens sammensetning av 
muskulatur, ben og fettvev. 
 
Undersøkelsen tar ca 20-30 minutter, 
er helt smertefri og innebærer liten 
strålebelastning.  Du må ligge helt i 
ro på en undersøkelsesbenk mens 
apparatet beveger seg med en 
summende lyd over deg. 
Fordi røntgenstrålene bremses av 
metall må du ta av deg alt av metall, 
for eksempel bukse med glidelås, beltespenne, smykker og lignende. 
 
DXA-undersøkelsen foregår på Ullevål universitetssykehus ved 
Ortopedisk senter.  En medhjelper i studien vil følge deg og være med 
deg under hele undersøkelsen. 
 
 
